def14c
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14C INFORMATION
Information Statement Pursuant to Section 14(c) of
the
Securities Exchange Act of 1934
Check the appropriate box:
o Preliminary
Information Statement
o Confidential,
for Use of the Commission Only (as permitted by
Rule 14c-5(d)(2))
þ Definitive
Information Statement
HCA INC.
(Name of Registrant as Specified in
Its Charter)
Payment of Filing Fee (Check the appropriate box):
|
|
þ
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act
Rules 14c-5(g)
and 0-11.
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
HCA
INC.
One Park Plaza
Nashville, Tennessee 37203
RE: Notice of Action by Written Consent of Stockholders
Dear Stockholder:
We are notifying our stockholders of record on June 16,
2010 that our Board of Directors has approved and a stockholder
representing approximately 97% of our outstanding common stock
on June 16, 2010 has executed a written consent approving:
(1) our Amended and Restated Certificate of Incorporation,
(2) an increase in the number of authorized shares of our
common stock from One Hundred Twenty-Five Million (125,000,000)
to One Billion Eight Hundred Million (1,800,000,000), as
reflected in our Amended and Restated Certificate of
Incorporation and (3) the adoption of the 2006 Stock
Incentive Plan for Key Employees of HCA Inc. and its Affiliates,
as Amended and Restated (the Stock Incentive Plan).
A copy of the Amended and Restated Certificate of Incorporation,
in substantially the form to be filed with the Secretary of
State of the State of Delaware, is attached to this information
statement as Appendix A. A copy of the Stock
Incentive Plan is attached to this information statement as
Appendix B.
Under the General Corporation Law of the State of Delaware,
stockholder action may be taken by written consent without a
meeting of stockholders. The written consent of the holder of a
majority of our outstanding common stock is sufficient under the
General Corporation Law of the State of Delaware and our
existing Amended and Restated Certificate of Incorporation and
Bylaws to approve the action described above. Accordingly, the
action described above will not be submitted to you and our
other stockholders for a vote. This letter and the accompanying
information statement are intended to notify you of the
aforementioned stockholder action in accordance with applicable
Securities and Exchange Commission (SEC) rules as a
result of our common stock being registered with the SEC.
Pursuant to the applicable SEC rules, this corporate action will
be effective 20 calendar days after the date of the initial
mailing of the accompanying information statement, or on or
about July 12, 2010.
Under Section 228(e) of the General Corporation Law of the
State of Delaware, where stockholder action is taken without a
meeting by less than unanimous written consent, prompt notice of
the taking of such corporate action must be given to those
stockholders who have not consented in writing and who, if the
action had been taken at a meeting, would have been entitled to
notice of the meeting if the record date for such meeting had
been the date that written consents signed by a sufficient
number of holders to take the action were delivered to the
corporation as provided in subsection (c) of
Section 228. This letter is also intended to serve as the
notice required by Section 228(e) of the General
Corporation Law of the State of Delaware.
An information statement containing a detailed description of
the matters adopted by written consent accompanies this notice.
You are urged to read the information statement in its entirety
for a description of the action taken by the holder of a
majority of the voting power of the Company. HOWEVER, WE ARE
NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US
A PROXY. We are only furnishing you an information statement
as a matter of regulatory compliance with SEC rules. No action
is required of you. The Company will mail or make available this
information statement to stockholders on or about June 22,
2010.
References to HCA, the Company,
we, us, or our in this
notice and information statement refer to HCA Inc. and its
affiliates unless otherwise indicated by context.
By order of the Board of Directors,
John M. Franck II
Vice President and Corporate Secretary
Nashville, TN
June 22, 2010
NOTICE OF
INTERNET AVAILABILITY OF INFORMATION STATEMENT
MATERIALS
Important Notice Regarding the Availability of Information
Statement Materials
Pursuant to rules promulgated by the SEC, we have elected to
provide access to this information statement both by sending you
this information statement and by notifying you of the
availability of such on the Internet.
This information statement is available at:
https://materials.proxyvote.com/404119.
The proposals acted upon by written consent were for approval of
(1) our Amended and Restated Certificate of Incorporation,
(2) an increase in the number of authorized shares of our
common stock from One Hundred Twenty-Five Million (125,000,000)
to One Billion Eight Hundred Million (1,800,000,000), as
reflected in our Amended and Restated Certificate of
Incorporation and (3) the adoption of the 2006 Stock
Incentive Plan for Key Employees of HCA Inc. and its Affiliates,
as Amended and Restated.
This corporate action will be effective 20 calendar days after
the date of the initial mailing of this information statement,
or on or about July 12, 2010. We are not soliciting you for
a proxy or for consent authority. We are only furnishing an
information statement as a matter of regulatory compliance with
SEC rules.
INDEX
|
|
|
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
53
|
|
|
|
|
53
|
|
|
|
|
53
|
|
HCA
INC.
One Park Plaza
Nashville, Tennessee 37203
INFORMATION
STATEMENT
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT
TO SEND US A PROXY. NO ACTION IS REQUIRED OF YOU.
QUESTIONS
AND ANSWERS
|
|
|
Q: |
|
Why did I receive the information statement? |
|
A: |
|
We sent you the information statement as a matter of regulatory
compliance with SEC rules and Delaware law to inform you of the
action taken by the holder of a majority of our outstanding
common stock by written consent. |
|
Q: |
|
Does this mean HCAs stock is publicly traded? |
|
|
|
A: |
|
No. Due to the number of HCA stockholders, most of whom are
employees, the Companys stock is required to be registered
with the SEC, and the Company is required to make certain
disclosures with the SEC, such as the information statement.
However, HCAs stock is not currently publicly traded.
However, on May 7, 2010, HCA filed with the SEC a
Registration Statement on
Form S-1
giving notice of a proposed initial public offering of
HCAs common stock. It is not currently determinable when
or if the Registration Statement will be declared effective by
the SEC, or if the offering will occur. However, upon the
effectiveness of the Registration Statement and listing of our
common stock on the New York Stock Exchange (NYSE),
HCAs common stock will be publicly traded. |
|
|
|
Q: |
|
Who sent me this information statement? |
|
A: |
|
The information statement was sent to you and paid for by HCA. |
|
Q: |
|
Do I need to return anything? |
|
A: |
|
No. The information statement is merely to inform you of
the action taken by written consent by holders of a majority of
the Companys outstanding common stock. No action is
required by you. |
|
Q: |
|
When was this information statement mailed or made available
to stockholders? |
|
|
|
A: |
|
This information statement was first mailed or made available to
stockholders on or about June 22, 2010. |
|
|
|
Q: |
|
What is an action taken by written consent? |
|
A: |
|
Pursuant to Delaware law, any action required to be taken at an
annual or special meeting may be taken without a meeting,
without prior notice and without a vote, if a consent in writing
is signed by the holders of the outstanding stock having more
than the minimum number of votes necessary to authorize such
action at a meeting at which all shares entitled to vote thereon
were present and voted. |
|
Q: |
|
Why was there no special meeting? |
|
A: |
|
Because Delaware law allows action to be taken by written
consent, and holders of a majority of our outstanding shares of
common stock acted by written consent, a special meeting was not
necessary. |
|
Q: |
|
What actions were taken by written consent? |
|
|
|
A: |
|
The holder of a majority of our outstanding common stock
executed a written consent approving (1) our Amended and
Restated Certificate of Incorporation, (2) an increase in
the number of authorized shares of our common stock from One
Hundred Twenty-Five Million (125,000,000) to One Billion Eight
Hundred Million (1,800,000,000), as reflected in our Amended and
Restated Certificate of Incorporation and (3) the adoption
of the Stock Incentive Plan. |
|
|
|
Q: |
|
Do I need to vote on these matters? |
|
A: |
|
No. Since holders of a majority of our common stock have
already executed a written consent, your vote is not necessary. |
|
Q: |
|
How many votes were required to approve the proposals? |
|
A: |
|
The approval and adoption of the action taken by written consent
requires the consent of the holders of a majority of the shares
of our outstanding common stock. |
|
Q: |
|
How many shares were voted for the actions? |
|
|
|
A: |
|
The record date for the action taken by written consent is
June 16, 2010. We had 94,635,289 outstanding shares of our
common stock on the record date. Each share of our common stock
is entitled to one vote. The holder of 91,845,692 shares of
our common stock, representing approximately 97% of our
outstanding common stock shares entitled to vote on
June 16, 2010 executed a written consent. The written
consent of the holder of a majority of our outstanding common
stock will be sufficient under the General Corporation Law of
the State of Delaware and our existing Amended and Restated
Certificate of Incorporation and Bylaws to approve the actions
described above. |
|
|
|
Q: |
|
When will the corporate action be effected? |
|
|
|
A: |
|
Pursuant to applicable SEC rules, the earliest date on which
this corporate action may be effected is 20 calendar days
after the date of the initial mailing of this information
statement. Accordingly, we anticipate the action taken by
written consent being effective on or about July 12, 2010.
The written consent contemplates that the Amended and Restated
Certificate of Incorporation and the Stock Incentive Plan will
be effective immediately prior to and subject to the
effectiveness of the registration statement relating to the
anticipated initial public offering of our common stock. |
|
|
|
Q: |
|
Am I entitled to dissenters rights? |
|
A: |
|
No. |
2
BACKGROUND
On November 17, 2006, we completed our merger (the
Merger) with Hercules Acquisition Corporation,
pursuant to which we were acquired by Hercules Holding II, LLC
(Hercules Holding), a Delaware limited liability
company owned by a private investor group comprised of
affiliates of, or funds sponsored by, Bain Capital Partners, LLC
(Bain Capital), Kohlberg Kravis Roberts &
Co. (KKR), Merrill Lynch Global Private Equity
(MLGPE) (each a Sponsor), affiliates of
Citigroup Inc. (Citigroup) and Bank of America
Corporation (together, the Sponsor Assignees) and
affiliates of HCA founder, Dr. Thomas F. Frist, Jr.,
(the Frist Entities, and together with the Sponsors
and the Sponsor Assignees, the Investors) and by
members of management and certain other investors (the
Management Participants). The Merger, the financing
transactions related to the Merger and other related
transactions are collectively referred to in this information
statement as the Recapitalization. The Merger was
accounted for as a recapitalization in our financial statements,
with no adjustments to the historical basis of our assets and
liabilities. As a result of the Recapitalization, our
outstanding capital stock is owned by the Investors and the
Management Participants. On April 29, 2008, we registered
our common stock pursuant to Section 12(g) of the
Securities Exchange Act of 1934, as amended (the Exchange
Act), thus subjecting us to the reporting requirements of
Section 13(a) of the Exchange Act. Our common stock is not
currently traded on a national securities exchange.
On May 7, 2010, HCA filed with the SEC a Registration
Statement on
Form S-1
giving notice of a proposed initial public offering of
HCAs common stock (the Registration
Statement). It is not currently determinable when or if
the Registration Statement will be declared effective by the
SEC, or if the offering will occur. However, upon the
effectiveness of the Registration Statement and listing of our
common stock on the NYSE, HCAs common stock will be
publicly traded. The Amended and Restated Certificate of
Incorporation, the increase in authorized shares and the Stock
Incentive Plan were approved by our Board of Directors and
majority stockholder to be effective immediately prior to and
subject to the effectiveness of the registration statement
relating to the anticipated initial public offering of our
common stock.
ACTION
1 AMENDMENT AND RESTATATEMENT OF CERTIFICATE OF
INCORPORATION
Our Board of Directors has approved and the holder of
91,845,692 shares of our common stock, representing
approximately 97% of the shares of our common stock entitled to
vote on the record date, has executed a written consent
approving an amendment and restatement of our Amended and
Restated Certificate of Incorporation in order to effect a 5.5
for 1 stock split and to make certain changes to the Amended and
Restated Certificate of Incorporation to reflect the
Companys status as a publicly traded company following
completion of its proposed initial public offering. The full
text of the Amended and Restated Certificate of Incorporation is
set forth as Appendix A of this information
statement. The Amended and Restated Certificate of Incorporation
was approved by our Board of Directors and majority stockholder
to be effective and filed immediately prior to the effectiveness
of the anticipated initial public offering of our common stock.
Reasons
for the Amended and Restated Certificate of
Incorporation
On May 7, 2010, HCA filed with the SEC a Registration
Statement on
Form S-1
giving notice of a proposed initial public offering of
HCAs common stock. It is not currently determinable when
or if the Registration Statement will be declared effective by
the SEC, or if the offering will occur. If the offering does not
occur, the Amended and Restated Certificate of Incorporation
will not be filed with the Delaware Secretary of State and will
not become effective. However, upon the effectiveness of the
Registration Statement and listing of our common stock on the
NYSE, HCAs common stock will be publicly traded.
The Board of Directors of the Company deemed it advisable and in
the best interest of the Company and its stockholders to amend
and restate the Companys Amended and Restated Certificate
of Incorporation to effect a 5.5 for 1 stock split and to add
certain provisions and make certain changes suitable to the
Companys anticipated status as a publicly traded company
following the proposed initial public offering. A summary of the
Amended and Restated Certificate of Incorporation is set forth
below, but such summary is qualified in its entirety by
reference to the Amended and Restated Certificate of
Incorporation, itself, a copy of which is attached as
Appendix A and incorporated herein by reference.
3
Summary
of Amended and Restated Certificate of Incorporation
Common
Stock
The Amended and Restated Certificate of Incorporation authorizes
the issuance of One Billion Eight Hundred Million
(1,800,000,000) shares of common stock, par value $.01 per
share.
Voting Rights. Under the terms of the Amended
and Restated Certificate of Incorporation, each holder of the
common stock is entitled to one vote for each share on all
matters submitted to a vote of the stockholders, including the
election of directors. Our stockholders do not have cumulative
voting rights. Because of this, the holders of a majority of the
shares of common stock entitled to vote and present in person or
by proxy at any annual meeting of stockholders can elect all of
the directors standing for election, if they should so choose.
Dividends. Subject to preferences that may be
applicable to any then outstanding preferred stock, holders of
common stock are entitled to receive ratably those dividends, if
any, as may be declared from time to time by the Board of
Directors out of legally available assets or funds.
Liquidation. In the event of our liquidation,
dissolution, or winding up, holders of common stock will be
entitled to share ratably in the net assets legally available
for distribution to stockholders after the payment of all of our
debts and other liabilities and the satisfaction of any
liquidation preference granted to the holders of any outstanding
shares of preferred stock.
Rights and Preferences. Holders of common
stock have no preemptive or conversion rights, and there are no
redemption or sinking fund provisions applicable to the common
stock. The rights, preferences, and privileges of the holders of
common stock are subject to, and may be adversely affected by,
the rights of the holders of shares of any series of preferred
stock which we may designate in the future.
Preferred
Stock
The Amended and Restated Certificate of Incorporation authorizes
our Board of Directors, without further action by the
stockholders, to issue up to Two Hundred Million
(200,000,000) shares of preferred stock, par value $.01 per
share, in one or more classes or series, to establish from time
to time the number of shares to be included in each such class
or series, to fix the rights, preferences, and privileges of the
shares of each such class or series and any qualifications,
limitations, or restrictions thereon.
Stock
Split
The Amended and Restated Certificate of Incorporation provides
that, upon the filing and effectiveness of the Amended and
Restated Certificate of Incorporation with the Secretary of
State of the State of Delaware (the Effective Time),
a forward split (the Forward Split) of our issued
and outstanding common stock (including treasury stock) will
occur whereby each outstanding share of common stock of the
Company (the Old Common Stock) shall be
automatically split up, reclassified and converted into
5.5 shares of common stock (the New Common
Stock), thereby increasing the number of outstanding
shares of our common stock to approximately
520,494,089 shares (based on June 16, 2010 outstanding
shares).
The Forward Split shall occur without any further action on the
part of the Company or the holders of shares of New Common Stock
and whether or not certificates representing such holders
shares prior to the Forward Split are surrendered for
cancellation. No fractional interest in a share of New Common
Stock shall be deliverable upon the Forward Split. Stockholders
who otherwise would have been entitled to receive any fractional
interests in the New Common Stock, in lieu of receipt of such
fractional interest, shall be entitled to receive from the
Company an amount in cash equal to the fair value of such
fractional interest as of the Effective Time.
The Forward Split will be effected on a
stockholder-by-stockholder
(as opposed to
certificate-by-certificate)
basis. Certificates or book-entries dated as of a date prior to
the Effective Time representing outstanding shares of Old Common
Stock shall, immediately after the Effective Time, represent a
number of shares equal
4
to the same number of shares of New Common Stock as is
reflected on the face of such certificates or book-entries,
multiplied by 5.5 and rounded down to the nearest whole number.
The Company may, but shall not be obliged to, issue new
certificates evidencing the shares of New Common Stock
outstanding as a result of the Forward Split unless and until
the certificates evidencing the shares held by a holder prior to
the Forward Split are either delivered to the Company or its
transfer agent, or the holder notifies the Company or its
transfer agent that such certificates have been lost, stolen or
destroyed and executes an agreement satisfactory to the Company
to indemnify the Company from any loss incurred by it in
connection with such certificates.
Board of
Directors
The Amended and Restated Certificate of Incorporation provides
for a Board of Directors of not less than three members, the
exact number to be determined from time to time by resolution
adopted by the affirmative vote of a majority of the total
number of directors then in office. The Amended and Restated
Certificate of Incorporation provides that directors will be
elected to hold office for a term expiring at the next annual
meeting of stockholders and until a successor is duly elected
and qualified or until his or her earlier death, resignation,
disqualification or removal. Newly created directorships and
vacancies may be filled, so long as there is at least one
remaining director, only by the Board of Directors.
Amendment
to Bylaws
The Amended and Restated Certificate of Incorporation provides
that the Board of Directors is expressly authorized to make,
alter, amend, change, add to or repeal the Bylaws of the Company
by the affirmative vote of a majority of the total number of
directors then in office. Prior to the Trigger Date (as defined
below), any amendment, alteration, change, addition or repeal of
the Bylaws of the Company by the stockholders of the Company
shall require the affirmative vote of the holders of a majority
of the outstanding shares of the Company entitled to vote on
such amendment, alteration, change, addition or repeal. On or
following the Trigger Date, any amendment, alteration, change,
addition or repeal of the Bylaws of the Company by the
stockholders of the Company shall require the affirmative vote
of the holders of at least seventy-five percent (75%) of the
outstanding shares of the Company, voting together as a class,
entitled to vote on such amendment, alteration, change, addition
or repeal.
For purposes of the Amended and Restated Certificate of
Incorporation, (i) Trigger Date is defined as
the first date on which Hercules Holding (or its successor)
ceases, or in the event of a liquidation of Hercules Holding,
the Equity Sponsors (as defined below) and their affiliates,
collectively, cease, to beneficially own (directly or
indirectly) shares representing a majority of the then issued
and outstanding common stock of the Company (it being understood
that the retention of either direct or indirect beneficial
ownership of a majority of the then issued and outstanding
shares of common stock by Hercules Holding (or its successor) or
the Equity Sponsors and their affiliates, as applicable, shall
mean that the Trigger Date has not occurred) and (ii) the
Equity Sponsors shall mean each of Bain Capital,
KKR, BAML Capital Partners, Citigroup, Bank of America
Corporation, and Dr. Thomas F. Frist, Jr. and their
respective affiliates, subsidiaries, successors and assignees
(other than the Company and its subsidiaries).
Limitation
of Liability
The Amended and Restated Certificate of Incorporation provides
that, to the fullest extent permitted by the General Corporation
Law of the State of Delaware, no director of the Company shall
be liable to the Company or its stockholders for monetary
damages arising from a breach of fiduciary duty owed to the
Company or its stockholders.
Indemnification
The Amended and Restated Certificate of Incorporation provides
that:
|
|
|
|
|
we will indemnify our directors and officers to the fullest
extent permitted by the General Corporation Law of the State of
Delaware;
|
5
|
|
|
|
|
we may advance expenses to our directors and officers in
connection with a legal proceeding to the fullest extent
permitted by law; and
|
|
|
|
the rights provided in our Amended and Restated Certificate of
Incorporation are not exclusive.
|
The Amended and Restated Certificate of Incorporation also
permits us to secure insurance on behalf of any officer,
director, employee or other agent for any liability arising out
of his or her actions in connection with their services to us,
regardless of whether the Company would have the power to
indemnify such person against such expenses, liability or loss
under the General Corporation Law of the State of Delaware.
Special
Meetings of Stockholders
The Amended and Restated Certificate of Incorporation provides
that special meetings of stockholders of the Company may be
called only by either the Board of Directors, pursuant to a
resolution adopted by the affirmative vote of the majority of
the total number of directors then in office, or by the Chairman
of the Board or the Chief Executive Officer of the Company;
provided that, prior to the Trigger Date, special meetings of
stockholders of the Company may also be called by the secretary
of the Company at the request of the holders of a majority of
the outstanding shares of common stock.
Action on
Written Consent
Pursuant to the Amended and Restated Certificate of
Incorporation, prior to the Trigger Date, stockholders may take
action by written consent; however, following the Trigger Date,
any action required or permitted to be taken at an annual or
special meeting of stockholders of the Company may be taken only
upon the vote of the stockholders at an annual or special
meeting duly called and may not be taken by written consent of
the stockholders.
Corporate
Opportunities
The Amended and Restated Certificate of Incorporation provides
that we renounce any interest in the business opportunities of
the Investors and of our directors who are affiliated with the
Investors, other than directors employed by us, and that neither
our directors affiliated with the Investors, other than
directors employed by us, nor the Investors have any obligation
to offer us those opportunities, except that the forgoing have
an obligation to communicate business opportunities offered to
such persons expressly in his or her capacity as a director or
officer of the Company.
Amendment
to Amended and Restated Certificate of Incorporation
The Amended and Restated Certificate of Incorporation provides
that on or following the Trigger Date, the affirmative vote of
the holders of at least seventy-five percent (75%) of the voting
power of all outstanding shares of the Company entitled to vote
generally in the election of directors, voting together in a
single class, shall be required to adopt any provision
inconsistent with, to amend or repeal any provision of, or to
adopt a bylaw inconsistent with certain specified provisions of
the Amended and Restated Certificate of Incorporation.
Effective
Date
The Amended and Restated Certificate of Incorporation will
become effective as of the date it is filed with the Secretary
of State of the State of Delaware, which we expect to occur
immediately prior to and subject to the effectiveness of the
registration statement relating to the anticipated initial
public offering of our common stock.
ACTION
2 INCREASE IN NUMBER OF AUTHORIZED SHARES OF
COMMON STOCK
Our Board of Directors has approved and the holder of
91,845,692 shares of our common stock, representing
approximately 97% of the shares of our common stock entitled to
vote on the record date, has executed a written consent
approving an increase in the number of our authorized shares of
common stock
6
from One Hundred Twenty-Five Million (125,000,000) to One
Billion Eight Hundred Million (1,800,000,000), as reflected in
our Amended and Restated Certificate of Incorporation discussed
in Action 1 above. The increase in authorized shares was
approved by our Board of Directors and majority stockholder to
be effective and the Amended and Restated Certificate of
Incorporation be filed immediately prior to and subject to the
effectiveness of the anticipated initial public offering of our
common stock as discussed in Action 1 above.
Reasons
for the Increase in Authorized Shares of Common Stock
Our Board of Directors deemed it advisable and in the best
interests of the Company to increase the number of authorized
shares of common stock in order to provide flexibility to issue
shares of common stock in connection with our proposed initial
public offering and the shares to be issued as a result of the
5.5 for 1 stock split discussed in more detail in Action 1
above. In addition, our Board considers the increase in the
number of authorized shares of common stock desirable and in the
best interests of the Company because it would give the Company
the necessary flexibility on an ongoing basis to issue common
stock in connection with stock dividends and splits,
acquisitions, equity financings and for other general corporate
purposes. Except for the shares to be issued in connection with
the Companys initial public offering and as a result of
the 5.5 for 1 stock split, the Company currently has no oral or
written plans, arrangements or understandings for the issuance
of the additional shares of common stock to be authorized
pursuant to this action. The increase in authorized shares will
ensure that the Company will continue to have an adequate number
of authorized and unissued shares of common stock available for
future use.
As is the case with the shares of common stock which are
currently authorized but unissued, the Board will have authority
to issue the additional shares of common stock from time to time
without further action on the part of stockholders except as may
be required by applicable law or by the rules of the NYSE or any
other stock exchange or market on which the Companys
securities may then be listed or authorized for quotation.
The additional number of authorized shares could have the effect
of making it more difficult for a third party to take over the
Company in a transaction not approved by the Board of Directors.
Stockholders do not have any preemptive or other rights to
subscribe for any shares of common stock which may in the future
be issued by the Company.
ACTION
3 APPROVAL OF 2006 STOCK INCENTIVE PLAN FOR KEY
EMPLOYEES OF HCA INC.
AND ITS AFFILIATES, AS AMENDED AND RESTATED
Our Board of Directors has approved and the holder of
91,845,692 shares of our common stock, representing
approximately 97% of the shares of our outstanding common stock
entitled to vote on the record date, has executed a written
consent approving the Stock Incentive Plan. The 2006 Stock
Incentive Plan for Key Employees of HCA Inc. and its Affiliates
(the Original Plan) was initially entered into by
the Company on November 17, 2006 in connection with the
Merger.
This summary relates to shares of HCAs common stock, par
value $.01 per share (Shares or Common
Stock), which may be offered to participants pursuant to
the Stock Incentive Plan. All references to Shares
and Common Stock and numbers of shares generally in
this summary are intended to refer to shares of New Common Stock
on a post-split basis.
The amendments, among other things:
|
|
|
|
|
provide that the Compensation Committee (the
Committee) may delegate its duties and powers to
administer the Stock Incentive Plan to a subcommittee thereof
consisting of directors meeting applicable independence
standards of Rule
16b-3 of the
Exchange Act, NYSE listed company rules and Section 162(m)
of the Internal Revenue Code of 1986, as amended (the
Code);
|
|
|
|
|
|
provide that a member of the Board of Directors annual
retainer, meeting fees
and/or other
awards or compensation may be in the form of stock options,
restricted shares, restricted share units
and/or other
stock-based awards as determined by the Board of Directors;
|
7
|
|
|
|
|
provide that the Committee may grant performance-based awards
pursuant to Section 162(m) of the Code, subject to certain
terms and limitations (see Description of Awards
below);
|
|
|
|
|
|
increase the number of shares available for issuance under the
Original Plan by 40,000,000 shares (see Securities to
be Offered below);
|
|
|
|
|
|
limit the number of shares with respect to which Incentive Stock
Options may be granted to no more than 1,000,000 per fiscal year;
|
|
|
|
provide that the Committee may allow grants to be made in
assumption of, or substitution for, outstanding awards
previously granted by the Company or an acquired company, and
that such grants will not reduce the number of shares available
for issuance under the Stock Incentive Plan and also provide
that shares under an acquired companys plan may be used
for grants to employees of such acquired company and shall not
reduce the number of shares available for issuance under the
Stock Incentive Plan;
|
|
|
|
allow the Committee, after a change in control to
(i) accelerate payment of earned, but unpaid
Performance-Based Awards, (ii) end all in-progress
performance periods for Performance-Based Awards and either
(A) deem that all Performance-Based Awards should be paid
at target or (B) determine to what extent all
Performance-Based Awards have been earned;
|
|
|
|
provide that the Committee may specify in a grant that the
participants rights, payments and benefits are subject to
reduction, cancellation, forfeiture or recoupment upon the
occurrence of certain specified events; and
|
|
|
|
extend the termination date of the Stock Incentive Plan to the
date that is ten years from the effective date.
|
The amendments to the Stock Incentive Plan also include
additional amendments to add certain provisions and make certain
changes suitable to the Companys anticipated status as a
publicly traded company following the proposed initial public
offering of our common stock, as well as miscellaneous
clarifications to plan language. The Stock Incentive Plan will
become effective immediately prior to and subject to the
effectiveness of the registration statement related to the
anticipated initial public offering of our common stock.
The Original Plan authorized the issuance of up to
10,656,130 shares (on a pre-split basis), or 10% of the
fully diluted number of shares of our then authorized common
stock as of the effective date of the Original Plan. Increasing
the number of shares available for issuance under the Stock
Incentive Plan will enable the Company to continue to attract,
retain, and motivate key officers, employees and directors.
As of May 31, 2010:
|
|
|
|
|
311,876 shares (on a pre-split basis) were available for
grant in the aggregate under the Original Plan; and
|
|
|
|
|
|
options representing 10,249,626 shares (on a pre-split
basis) were outstanding under the Original Plan.
|
General
Plan Information
The principal features of the Stock Incentive Plan are
summarized below, but such summary is qualified in its entirety
by reference to the Stock Incentive Plan itself, a copy of which
is attached as Appendix B and incorporated herein by
reference.
All awards of stock options, stock appreciation rights and other
stock-based awards made to Stock Incentive Plan participants and
all shares of Common Stock issued upon exercise of such awards
are subject to the terms and conditions (including certain
restrictions) set forth in the Stock Incentive Plan, the Grant
Agreement (as hereinafter defined), the Management
Stockholders Agreement and the Sale Participation
Agreement (both as defined in the Stock Incentive Plan), to the
extent applicable to the awards and such Shares.
8
The purposes of the Stock Incentive Plan are:
(i) to promote the long term financial interests and growth
of HCA and its subsidiaries by attracting and retaining
management and other personnel with the training, experience and
ability to enable them to make a substantial contribution to the
success of HCAs business;
(ii) to motivate management personnel by means of
growth-related incentives to achieve long range goals; and
(iii) to further the alignment of interests of participants
with those of the stockholders of HCA through opportunities for
increased stock, or stock-based, ownership in HCA.
The Stock Incentive Plan was approved by the stockholders of HCA
on June 21, 2010 and will become effective immediately
prior to and subject to the effectiveness of the registration
statement relating to anticipated initial public offering of our
common stock, and unless terminated earlier by HCAs Board
of Directors, the Stock Incentive Plan will terminate the date
that is ten years from the effective date. However, awards
granted on or prior to the termination may extend beyond that
date.
The Stock Incentive Plan is not subject to the provisions of the
Employee Retirement Income Security Act of 1974, as amended.
The Committee (or, if the Board of Directors takes an action in
place of the Committee, the Board of Directors) conducts the
general administration of the Stock Incentive Plan in accordance
with the Stock Incentive Plans provisions. The Committee
is appointed by and serves at the pleasure of the HCA Board of
Directors. The Committee may adopt its own rules of procedure,
and action of a majority of the members of the Committee taken
at a meeting, or action taken without a meeting by unanimous
written consent, constitutes action by the Committee. The
Committee has the power and authority to administer, construe
and interpret the Stock Incentive Plan, and to make rules for
carrying it out and to make changes in such rules. The Committee
may correct any defect or supply any omission or reconcile any
inconsistency in the Stock Incentive Plan in the manner and to
the extent the Committee deems necessary or desirable. Any such
interpretations, rules and administration must be consistent
with the basic purposes of the Stock Incentive Plan. The
Committee has the full power and authority to establish the
terms and conditions of any grant under the Stock Incentive
Plan, consistent with the provisions of the Stock Incentive
Plan, and to waive any such terms and conditions at any time
(including, without limitation, accelerating or waiving any
vesting conditions).
The Committee may delegate its duties and powers in whole or in
part to any subcommittee thereof consisting solely of at least
two individuals who are intended to qualify as
Non-Employee Directors within the meaning of
Rule 16b-3
under the Exchange Act (or any successor rule thereto),
independent directors within the meaning of NYSE
listed company rules and outside directors within
the meaning of Section 162(m) of the Code (or any successor
section thereto), to the extent
Rule 16b-3
under the Exchange Act and Section 162(m) of the Code,
respectively, are applicable to the Company and the Stock
Incentive Plan; provided, however, that the Board of Directors
may, in its sole discretion, take any action designated to the
Committee under the Stock Incentive Plan as it may deem
necessary. The Committee may delegate to HCAs Chief
Executive Officer and to other senior officers of HCA its duties
under the Stock Incentive Plan, subject to applicable law and
such conditions and limitations as the Committee may prescribe,
except that only the Committee may designate and make awards to
Stock Incentive Plan participants. The Committee may employ
counsel, consultants, accountants, appraisers, brokers or other
persons. The Committee, HCA and the officers and directors of
HCA shall be entitled to rely upon the advice, opinions or
valuations of any such persons. All actions taken and all
interpretations and determinations made by the Committee in good
faith shall be final and binding upon all Stock Incentive Plan
participants and their beneficiaries or successors.
Subject to the provisions of the Stock Incentive Plan, the
Committee may from time to time grant awards of stock options,
stock appreciation rights, other stock-based awards, dividend
equivalent rights, non-employee director grants or
performance-based awards to Stock Incentive Plan participants,
in such form and having such terms, conditions and limitations
as the Committee may determine. The terms, conditions and
limitations of each award under the Stock Incentive Plan must be
evidenced by a written agreement executed by HCA and the
participant (Grant Agreement), in a form approved by
the Committee, consistent, however, with the
9
terms of the Stock Incentive Plan; provided, however, that such
Grant Agreement will contain provisions dealing with the
treatment of awards in the event of the termination of
employment or other service relationship, death or disability of
a participant, and may also include provisions concerning the
treatment of awards in the event of a change in control of HCA.
The Committee has the authority to make amendments to any terms
and conditions applicable to outstanding awards as are
consistent with the Stock Incentive Plan, provided that no such
action may modify such awards that disadvantages participants in
more than a de minimis way but less than a material way
without approval by a majority of affected participants and,
provided further, that, except for adjustments under the
adjustment provisions of the Stock Incentive Plan or as a result
of a merger, consolidation or similar event, no such action may
materially disadvantage a participant with respect to
outstanding awards without the participants consent except
as such modification is provided for or contemplated in the
terms of the Grant Agreement or the Stock Incentive Plan.
Securities
to be Offered
The total number of shares of Common Stock available for awards
under the Stock Incentive Plan is the sum of (i)
40,000,000 shares and (ii) the number of shares
available for grant under the Stock Incentive Plan as of the
effective date of the amendment and restatement of the Stock
Incentive Plan, subject to adjustment as provided for in the
Stock Incentive Plan. The number of shares of Common Stock with
respect to which options may be granted after the effective date
of the Stock Incentive Plan is no more than 1,000,000 per fiscal
year. Unless restricted by applicable law, shares of Common
Stock related to awards that are forfeited, terminated, settled
for cash, canceled without the delivery of shares of Common
Stock, expire unexercised, are withheld to pay taxes or exercise
prices or are repurchased by HCA will immediately become
available for new awards.
Awards may, in the discretion of the Committee, be made under
the Stock Incentive Plan in assumption of, or in substitution
for, outstanding awards previously granted by the Company or any
of its subsidiaries or a company acquired by the Company or with
which the Company combines. The number of shares of Common Stock
underlying awards made in assumption of, or in substitution for,
outstanding awards previously granted by a company acquired by
the Company or any of its subsidiaries or with which the Company
or any of its subsidiaries combines shall not be counted against
the aggregate number of shares of Common Stock available for
awards under the Stock Incentive Plan, nor shall the shares of
Common Stock subject to such substitute awards become available
for new awards under the circumstances described in the prior
paragraph. In addition, in the event that a company acquired by
the Company or any of its subsidiaries or with which the Company
or any of its subsidiaries combines has shares available under a
pre-existing plan approved by stockholders and not adopted in
contemplation of such acquisition or combination, the shares
available for grant pursuant to the terms of such pre-existing
plan (as adjusted, to the extent appropriate, using the exchange
ratio or other adjustment or valuation ratio or formula used in
such acquisition or combination to determine the consideration
payable to the holders of common stock of the entities party to
such acquisition or combination) may be used for awards and
shall not reduce the shares of Common Stock authorized for
issuance under the Stock Incentive Plan; provided that awards
using such available shares shall not be made after the date
awards or grants could have been made under the terms of the
pre-existing plan, absent the acquisition or combination, and
shall only be made to individuals who were not employees or
directors of the Company or any of its subsidiaries prior to
such acquisition or combination.
In the event of any change in or exchange of, the outstanding
Common Stock by reason of a stock dividend, stock split,
extraordinary distribution, reorganization, recapitalization,
merger, consolidation, spin-off, combination, combination or
transaction or exchange of shares of Common Stock, any equity
restructuring (as defined under Financial Accounting Standards
Board Accounting Standards Codification (FASB ASC)
Topic 718) or other corporate change, or any distribution
to stockholders other than regular cash dividends, or any
transaction similar to any of the foregoing, the Committee will
in an equitable and proportionate manner as it deems reasonably
necessary to address on an equitable basis the effect of such
event, and in such manner as is consistent with
Section 162(m), 422, and 409A of the Code and the
regulations thereunder, make such substitution or adjustment, if
any, (a) as to the number and kind of shares of Common
Stock subject to the Stock Incentive Plan and available for or
covered by awards, (b) as to share prices per share of
Common
10
Stock related to outstanding awards, or by providing for an
equivalent award in respect of securities of the surviving
entity of any merger, consolidation, or other transaction or
event having a similar effect, or (c) by providing for a
cash payment to the holder of an outstanding award, and make
such other revisions to outstanding awards as it deems, in good
faith, are equitably required (including, without limitation, to
the exercise price of stock options).
The Stock Incentive Plan provides that, unless the Committee
determines otherwise, no benefit or promise under the Stock
Incentive Plan will be secured by any specific assets of HCA,
nor shall any assets of HCA, be designated as attributed or
allocated to the satisfaction of HCAs obligations under
the Stock Incentive Plan. Neither the Stock Incentive Plan nor
any award thereunder will create or be construed to create a
fiduciary relationship between the Company or any subsidiary or
affiliate thereof and a participant or any other person. To the
extent that any person acquires a right to receive payments from
the Company or any subsidiary or affiliate thereof pursuant to
an award, such right will be no greater than the right of any
secured general creditor of the Company or any subsidiary or
affiliate thereof.
The Committee may, in its sole discretion, specify in any grant
made on or after the effective date of the amendment and
restatement of the Stock Incentive Plan that the
participants rights, payments, and benefits shall be
subject to reduction, cancellation, forfeiture or recoupment
upon the occurrence of certain specified events, in addition to
any otherwise applicable vesting or performance conditions of a
grant. Such events may include, but shall not be limited to,
termination of employment for cause, termination of the
participants provision of services to the Company or any
of its subsidiaries, breach of noncompetition, confidentiality,
or other restrictive covenants that may apply to the
participant, or restatement of the Companys financial
statements to reflect adverse results from those previously
released financial statements, as a consequence of errors,
omissions, fraud, or misconduct.
No awards shall be made under the Stock Incentive Plan beyond
ten years after the effective date of the Stock Incentive Plan,
but the terms of awards made on or before the expiration of the
Stock Incentive Plan may extend beyond such expiration. At the
time an award is made or amended or the terms or conditions of
an award are changed in accordance with the terms of the Stock
Incentive Plan or the Grant Agreement, the Committee may provide
for limitations or conditions on such award.
Unless otherwise expressly provided in the Stock Incentive Plan
or in an applicable Grant Agreement, any grant made under the
Stock Incentive Plan, and the authority of the Board of
Directors or the Committee to amend, alter, adjust, suspend,
discontinue or terminate any such grant or to waive any
conditions or rights under any such grant shall, continue after
the tenth anniversary of the effective date of the Stock
Incentive Plan.
Who May
Participate
Grants under the Stock Incentive Plan may be awarded to
Employees or other persons having a relationship with HCA or any
of its subsidiaries or affiliates. As of June 16, 2010,
approximately 1,660 individuals were eligible to participate in
the Stock Incentive Plan. However, the Company has not at the
present time determined who will receive the shares of Common
Stock that will be authorized for issuance under the Stock
Incentive Plan or how they will be allocated.
Employees are persons, including officers, in the
regular employment of HCA (or any subsidiary or affiliate of
HCA), who, in the opinion of the Committee, are, or are expected
to be, involved in the management, growth or protection of some
part or all of the business of HCA. As used herein and in the
Stock Incentive Plan, the term participant means an
Employee, non-employee member of the Board of Directors,
consultant or other person having a relationship with HCA (or
any subsidiary or affiliate of HCA), to whom one or more awards
have been made pursuant to the Stock Incentive Plan and remain
outstanding.
Description
of Awards
Stock Options. Options to purchase Common
Stock (Stock Options) may be granted to participants
under the Stock Incentive Plan. At the time of grant, the
Committee shall determine the option exercise period, the option
exercise price, vesting requirements, and such other terms,
conditions or restrictions on the grant or
11
exercise of the option as the Committee deems appropriate
including, without limitation, the right to receive dividend
equivalent payments on vested options. The exercise price per
share of a Stock Option will be determined by the Committee and
may not be less than the fair market value of HCAs Common
Stock on the date the Stock Option is granted (subject to later
adjustment pursuant to the Stock Incentive Plan). In addition to
other restrictions contained in the Stock Incentive Plan, a
Stock Option granted under the Stock Incentive Plan may not be
exercised more than 10 years after the date it is granted.
Payment of the Stock Option exercise price shall be made
(i) in cash, (ii) with the consent of the Committee,
in shares of Common Stock (any such Shares valued at fair market
value on the date of exercise) having an aggregate fair market
value equal to the aggregate exercise price for the shares of
Common Stock being purchased and that the participant has held
for at least six months (or such other period of time as may be
required to attain tax or financial reporting treatments that
are not considered to be adverse to the Company),
(iii) through the withholding of shares of Common Stock
(any such shares of Common Stock valued at fair market value on
the date of exercise) otherwise issuable upon the exercise of
the Stock Option in a manner that is compliant with applicable
law, (iv) if there is a public market for the shares of
Common Stock at such time, to the extent permitted by, and
subject to such rules as may be established by the Committee,
through delivery of irrevocable instructions to a broker to sell
shares of Common Stock obtained upon the exercise of the Stock
Option and to deliver promptly to the Company an amount out of
the proceeds of such sale equal to the aggregate exercise price
for the shares of Common Stock being purchased, or (v) a
combination of the foregoing methods, in each such case in
accordance with the terms of the Stock Incentive Plan, the Grant
Agreement and of any applicable guidelines of the Committee in
effect at the time.
Stock Appreciation Rights. The Committee may
grant Stock Appreciation Rights (as hereinafter defined)
independent of, or in connection with, the grant of a Stock
Option or a portion thereof. Each Stock Appreciation Right shall
be subject to such other terms as the Committee may determine;
however, the exercise price per Share of a Stock Appreciation
Right shall in no event be less than the fair market value on
the date the Stock Appreciation Right is granted. Each Stock
Appreciation Right granted independent of a Stock Option shall
be defined as a right of a Stock Incentive Plan participant,
upon exercise of such Stock Appreciation Right, to receive an
amount equal to the product of (i) the excess of
(A) the fair market value on the exercise date of one share
of Common Stock over (B) the exercise price per share of
such Stock Appreciation Right, multiplied by (ii) the
number of shares of Common Stock covered by the Stock
Appreciation Right. Payment of the Stock Appreciation Right
shall be made in shares of Common Stock or in cash, or partly in
shares of Common Stock and partly in cash (any such Shares
valued at the fair market value on the date of the payment), all
as shall be determined by the Committee.
Other Stock-Based Awards. The Committee may
grant or sell awards of Shares, awards of restricted Shares and
awards that are valued in whole or in part by reference to, or
are otherwise based on the fair market value of, Shares
(including, without limitation, restricted stock units). Such
Other Stock-Based Awards shall be in such form, and
dependent on such conditions, as the Committee may determine,
including, without limitation, the right to receive, or vest
with respect to, one or more Shares (or the equivalent cash
value of such Shares) upon the completion of a specified period
of service, the occurrence of an event
and/or the
attainment of performance objectives. Other Stock-Based Awards
may be granted alone or in addition to any other awards under
the Stock Incentive Plan. Subject to the provisions of the Stock
Incentive Plan, the Committee shall determine to whom and when
Other Stock-Based Awards will be made, the number of Shares to
be awarded under (or otherwise related to) such Other
Stock-Based Awards; whether such Other Stock-Based Awards shall
be settled in cash, Shares or a combination of cash and Shares;
and all other terms and conditions of such awards (including,
without limitation, the vesting provisions thereof and
provisions ensuring that all Shares so awarded and issued shall
be fully paid and non-assessable).
Dividend Equivalent Rights. The Committee may
grant Dividend Equivalent Rights either alone or in connection
with the grant of a Stock Option, Stock Appreciation Right,
Other Stock-Based Award, or director grant described in the
paragraph below. A Dividend Equivalent Right shall
be the right to receive a payment in respect of one Share
(whether or not subject to a Stock Option) equal to the amount
of any dividend paid in respect of one Share held by a
stockholder of HCA. Each Dividend Equivalent Right shall be
subject to such terms as the Committee may determine. All
dividend or dividend equivalents which are not paid currently
12
may, at the Committees discretion, accrue interest, be
reinvested into additional Shares, or, in the case of dividends
or dividend equivalents credited in connection with
Performance-Based Awards be credited as additional
Performance-Based Awards and be paid to the participant if and
when, and to the extent that, payment is made pursuant to such
grant. The total number of Shares available for grant under the
Stock Incentive Plan shall not be reduced to reflect any
dividends or dividend equivalents that are reinvested into
additional Shares or credited as Performance-Based Awards.
Director Grants. The Board of Directors may
provide that all or a portion of any member of the Board of
Directors annual retainer, meeting fees
and/or other
awards or compensation as determined by the Board of Directors,
be payable (either automatically or at the election of such
member) in the form of non-qualified Stock Options, restricted
shares, restricted share units
and/or Other
Stock-Based Awards, including unrestricted Shares. The Board of
Directors shall determine the terms and conditions of any such
grants, including the terms and conditions which shall apply
upon a termination of such Board of Directors members
service as a member of the Board of Directors, and shall have
full power and authority in its discretion to administer such
grants, subject to the terms of the Stock Incentive Plan and
applicable law.
Performance-Based Awards. During any period
when Section 162(m) of the Code is applicable to the
Company and the Stock Incentive Plan, the Committee, in its sole
discretion, may award grants which are denominated in Shares or
cash (which, for avoidance of doubt, may include a grant of
Stock Options, Stock Appreciation Rights, Other Stock-Based
Awards, or Dividend Equivalent Rights) (such grants,
Performance-Based Awards), which grants may, but for
the avoidance of doubt are not required to, be granted in a
manner which is intended to be deductible by the Company under
Section 162(m) of the Code (or any successor section
thereto). Such Performance-Based Awards shall be in such form,
and dependent on such conditions, as the Committee shall
determine, including, without limitation, the right to receive,
or vest with respect to, one or more Shares or the cash value of
the grant upon the completion of a specified period of service,
the occurrence of an event
and/or the
attainment of performance objectives. Performance-Based Awards
may be granted alone or in addition to any other awards granted
under the Stock Incentive Plan. Subject to the provisions of the
Stock Incentive Plan, the Committee shall determine to whom and
when Performance-Based Awards will be made, the number of Shares
or aggregate amount of cash to be awarded under (or otherwise
related to) such Performance-Based Awards, whether such
Performance-Based Awards shall be settled in cash, Shares or a
combination of cash and Shares, and all other terms and
conditions of such grants (including, without limitation, the
vesting provisions thereof and provisions ensuring that all
Shares so awarded and issued, to the extent applicable, shall be
fully paid and non-assessable).
A participants Performance-Based Award shall be determined
based on the attainment of written performance goals approved by
the Committee for a performance period established by the
Committee (A) while the outcome for that performance period
is substantially uncertain and (B) no more than
90 days after the commencement of the performance period to
which the performance goal relates or, if less, the number of
days which is equal to 25 percent of the relevant
performance period. The performance goals, which must be
objective, shall be based upon one or more of the following
criteria: (i) consolidated income before or after taxes
(including income before interest, taxes, depreciation and
amortization); (ii) EBITDA; (iii) adjusted EBITDA;
(iv) operating income; (v) net income; (vi) net
income per Share; (vii) book value per Share;
(viii) return on members or stockholders
equity; (ix) expense management; (x) return on
investment; (xi) improvements in capital structure;
(xii) profitability of an identifiable business unit or
product; (xiii) maintenance or improvement of profit
margins; (xiv) stock price; (xv) market share;
(xvi) revenue or sales; (xvii) costs;
(xviii) cash flow; (xix) working capital;
(xx) multiple of invested capital; (xxi) total return;
and (xxii) such other objective performance criteria as
determined by the Committee in its sole discretion to the extent
such criteria would be a permissible performance criteria under
Section 162(m) of the Code. The foregoing criteria may
relate to the Company, one or more of its subsidiaries or one or
more of its or their divisions or units, or any combination of
the foregoing, and may be applied on an absolute basis
and/or be
relative to one or more peer group companies or indices, or any
combination thereof, all as the Committee shall determine. The
Committee may appropriately adjust any evaluation of performance
under criteria set forth in the Stock Incentive Plan to exclude
any of the following events that occurs during a performance
period: (1) gains or losses on sales of assets,
(2) asset impairments or write-downs, (3) litigation
or claim
13
judgments or settlements, (4) the effect of changes in tax
law, accounting principles or other such laws or provisions
affecting reported results, (5) accruals for reorganization
and restructuring programs, (6) any extraordinary
non-recurring items as described in FASB ASC Topic
225-20
and/or in
managements discussion and analysis of financial condition
and results of operations appearing in the Companys annual
report to stockholders for the applicable year, and (7) the
effect of adverse or delayed federal, state or local
governmental or regulatory action; provided that the Committee
commits to make any such adjustments within the 90 days
following the commencement of each performance period (or such
other time as may be required or permitted by
Section 162(m) of the Code).
The maximum amount of a Performance-Based Award during a fiscal
year to any participant shall be: (x) with respect to
Performance-Based Awards that are denominated in Shares,
1,000,000 per fiscal year and (y) with respect to
Performance-Based Awards that are denominated in cash,
$5,000,000 per fiscal year. To the extent that a
Performance-Based Award may be earned over a period that is
longer than one fiscal year, the foregoing limitations shall
apply to each full or partial fiscal year during or in which
such grant may be earned.
The Committee shall determine whether, with respect to a
performance period, the applicable performance goals have been
met with respect to a given participant and, if they have,
during any period when Section 162(m) of the Code is
applicable to the Company and the Stock Incentive Plan and such
Performance-Based Award is intended to be deductible by the
Company under Section 162(m) of the Code, shall so certify
and ascertain the amount of the applicable Performance-Based
Award. No Performance-Based Awards will be paid for such
performance period until such certification, to the extent
applicable, is made by the Committee. The amount of the
Performance-Based Award actually paid to a given participant may
be less than the amount determined by the applicable performance
goal formula, at the discretion of the Committee. The amount of
the Performance-Based Award determined by the Committee for a
performance period shall be paid to the participant at such time
as determined by the Committee in its sole discretion after the
end of such performance period; provided, however, that a
participant may, if and to the extent permitted by the Committee
and consistent with the provisions of Sections 162(m) and
409A of the Code, to the extent applicable, elect to defer
payment of a Performance-Based Award.
Determination
of Fair Market Value of Common Stock
The fair market value of the Common Stock means, on
a per Share basis, on any given date, the closing trading price
of the Common Stock on the NYSE, unless otherwise determined by
the Board of Directors.
Assignment
of Awards
Other than as specifically provided in the Management
Stockholders Agreement between the participant and HCA or
Sale Participation Agreement between the participant and
Hercules Holdings, if applicable to a grant, no benefit under
the Stock Incentive Plan shall be subject in any manner to
anticipation, alienation, sale, transfer, assignment, pledge,
encumbrance, or charge, and any attempt to do so shall be void.
If no Management Stockholders Agreement or Sale
Participation Agreement is applicable to a grant, then except as
otherwise provided in the Stock Incentive Plan, a Grant
Agreement, or by the Committee at or after grant, no grant shall
be assigned, alienated, pledged, attached, sold or otherwise
transferred or encumbered by a participant, except by will or
the laws of descent and distribution; provided, however, that no
such transfer of a grant by will or by laws of descent and
distribution shall be effective to bind the Company unless the
Company shall have been furnished with written notice thereof
and an authenticated copy of the will
and/or such
other evidence as the Committee may deem necessary or
appropriate to establish the validity of the transfer. No
benefit under the Stock Incentive Plan shall, prior to receipt
thereof by the participant, be in any manner liable for or
subject to the debts, contracts, liabilities, engagements, or
torts of the participant.
14
Resale
Restrictions
Any resales of Shares received by participants pursuant to the
Stock Incentive Plan may be limited as provided in an applicable
Management Stockholders Agreement. Additionally, to the
extent the Common Stock described herein is not then registered
with the SEC, any resales of Shares received by participants
pursuant to the Stock Incentive Plan must be made in reliance
upon exemptions from registration under the Securities Act of
1933, as amended (the Securities Act). Additional
restrictions on transfer may be imposed by state, local or
foreign securities commissions or regulators, as applicable. To
the extent a participant is an affiliate of HCA (as
defined in the Securities Act), additional restrictions may be
imposed on resale, regardless of whether the Common Stock is
then registered under the Securities Act, including as provided
in Rule 144 under the Securities Act.
Change in
Control Provisions
In the event of a Change in Control, as defined in
the Stock Incentive Plan, (i) if determined in the
applicable Grant Agreement or otherwise determined by the
Committee in its sole discretion, any outstanding awards then
held by participants which are unexercisable or otherwise
unvested or subject to lapse restrictions may automatically be
deemed exercisable or otherwise vested or no longer subject to
lapse restrictions, as the case may be, as of immediately prior
to such Change in Control and (ii) the Committee may, to
the extent determined by the Committee to be permitted under
Section 409A of the Code, but shall not be obligated to,
(A) cancel such awards for fair value (as determined in the
sole discretion of the Committee) which, in the case of Stock
Options and Stock Appreciation Rights, may equal the excess, if
any, of value of the consideration to be paid in the Change in
Control transaction to holders of the same number of Shares
subject to such Stock Options or Stock Appreciation Rights (or,
if no consideration is paid in any such transaction, the fair
market value of the Shares subject to such Stock Options or
Stock Appreciation Rights) over the aggregate option price of
such Stock Options or the aggregate exercise price of such Stock
Appreciation Rights, as the case may be, (B) provide for
the issuance of substitute awards that will substantially
preserve the otherwise applicable terms of any affected awards
previously granted under the Stock Incentive Plan as determined
by the Committee in its sole discretion or (C) provide that
for a period of at least 15 days prior to the Change in
Control, any Stock Options or Stock Appreciation Rights shall be
exercisable as to all Shares subject thereto and that upon the
occurrence of the Change in Control, such Stock Options or Stock
Appreciation Rights shall terminate and be of no further force
and effect; provided, however, that subpart (ii) shall not
apply to a Change in Control under clause (C)
of such definition that occurs due to a gradual sell down of
voting stock of the Company by the Investors (as defined in the
Stock Incentive Plan) or their affiliates.
In connection with the foregoing, the Committee may, in its
discretion, provide that in the event of a Change in Control,
(i) any outstanding Performance-Based Awards relating to
performance periods ending prior to the Change in Control which
have been earned but not paid shall become immediately payable
and (ii) all
then-in-progress
performance periods for Performance-Based Awards that are
outstanding shall end, and either (A) any or all
Participants shall be deemed to have earned an award equal to
the relevant target award opportunity for the performance period
in question, or (B) at the Committees discretion, the
Committee shall determine the extent to which performance
criteria have been met with respect to each such
Performance-Based award.
A Change in Control shall mean (as defined in the
Stock Incentive Plan), in one or more of a series of
transactions, (i) the transfer or sale of all or
substantially all of the assets of HCA to a person (or group of
persons acting in concert) who is not an Investor, an affiliate
of any of the Investors or any entity in which any Investor
holds, directly or indirectly, a majority of the economic
interests in such entity (an Unaffiliated Person);
(ii) a merger, consolidation, recapitalization or
reorganization of HCA with or into another Unaffiliated Person,
or a transfer or sale of the voting stock of HCA, an Investor,
or any affiliate of any of the Investors to an Unaffiliated
Person, in any such event that results in more than 50% of the
Common Stock of HCA (or any resulting company after a merger)
being held by an Unaffiliated Person; or (iii) a merger,
consolidation, recapitalization or reorganization of HCA with or
into another Unaffiliated Person, or a transfer or sale by HCA,
an Investor or any affiliate of any of the Investors, in any
such event after which the Investors and their affiliates
(x) collectively own less than 15% of the Common Stock of
and (y) collectively have the
15
ability to appoint less than 50% of the directors to the Board
of Directors of HCA (or any resulting company after a merger).
Amendment
and Termination
HCAs Board of Directors may at any time amend, suspend or
terminate the Stock Incentive Plan except that no such action,
other than an action under the adjustment provisions of the
Stock Incentive Plan or as a result of a merger, consolidation
or similar event, may be taken which would, without stockholder
approval, increase the aggregate number of shares of Common
Stock available for awards under the Stock Incentive Plan,
decrease the price of outstanding awards, change the
requirements relating to the Committee, extend the term of the
Stock Incentive Plan or otherwise require the approval of the
stockholders of the Company to the extent such approval is
required by or desirable to satisfy the requirements of, in each
case, any applicable law, regulation or other rule, including,
the listing standards of the securities exchange, which is, at
the applicable time, the principal market for shares of Common
Stock. However, no amendment, suspension or termination of the
Stock Incentive Plan may disadvantage participants in more than
a de minimis way but less than a material way without the
consent of a majority of the affected participants and no such
action shall materially disadvantage a participant (without
their consent) with respect to any outstanding grants, other
than as contemplated by the Stock Incentive Plan or the Grant
Agreement.
Withholding
Taxes
HCA shall have the right to deduct from any payment made under
the Stock Incentive Plan any federal, state or local income or
other taxes required by law to be withheld with respect to such
payment. It shall be a condition to the obligation of HCA to
deliver Shares upon the exercise of a Stock Option that the
participant pays to HCA such amount as may be requested by HCA
for the purpose of satisfying any liability for such withholding
taxes; provided, however, that a participant may satisfy the
statutory amount of such taxes due upon exercise of any Stock
Option through the withholding of Shares (valued at fair market
value on the date of exercise) otherwise issuable upon the
exercise of such Stock Option. For awards other than Stock
Options, the Committee may in its discretion permit a
participant to satisfy or arrange to satisfy, in whole or in
part, the tax obligations incident to an grant by:
(a) electing to have the Company withhold Shares or other
property otherwise deliverable to such participant pursuant to
the grant (provided, however, that the amount of any Shares so
withheld shall not exceed the amount necessary to satisfy
required federal, state local and foreign withholding
obligations using the minimum statutory withholding rates for
federal, state, local
and/or
foreign tax purposes, including payroll taxes, that are
applicable to supplemental taxable income)
and/or
(b) tendering to the Company Shares owned by such
participant (or by such participant and his or her spouse
jointly) and purchased or held for the requisite period of time
as may be required to avoid the Companys or the
affiliates or subsidiaries incurring an adverse
accounting charge, based, in each case, on the fair market value
of the Shares on the payment date as determined by the
Committee. All such elections shall be irrevocable, made in
writing, signed by the participant, and shall be subject to any
restrictions or limitations that the Committee, in its sole
discretion, deems appropriate.
Certain
Federal Income Tax Consequences
The following is a brief summary of certain federal income
tax aspects of awards under the Stock Incentive Plan based upon
the United States federal income tax laws in effect on the date
hereof. This summary is not intended to be exhaustive and the
exact tax consequences to any participant will depend upon his
or her particular circumstances and other factors. Participants
may also be subject to certain United States state and local
taxes and foreign taxes, which are not described herein. The
Stock Incentive Plan participants are encouraged to consult
their own tax advisors with respect to any state tax
considerations or particular federal tax implications of awards
granted under the Stock Incentive Plan.
PURSUANT TO THE MANAGEMENT STOCKHOLDERS AGREEMENT WHERE
APPLICABLE, TO THE EXTENT THAT ANY SHARES TO BE TRANSFERRED
TO THE PARTICIPANT ARE SUBJECT TO A SUBSTANTIAL RISK OF
FORFEITURE (WITHIN THE MEANING OF TREASURY
REGULATION SECTION 1.83-3(c)
APPLICABLE TO THE TRANSFER OF SUCH STOCK) AT THE TIME OF
16
SUCH TRANSFER, THE PARTICIPANT IS REQUIRED, UNLESS HCA SHALL
AGREE OTHERWISE WITH SUCH PARTICIPANT, TO MAKE A
SECTION 83(b) ELECTION WITH RESPECT TO SUCH
SHARES WITHIN THIRTY DAYS AFTER THE TRANSFER.
Stock Options. The grant of a non-qualified
stock option with an exercise price equal to the fair market
value of the Common Stock on the date of grant is not generally
a taxable event. Subject to the discussion
Section 83(b) Considerations below, on the
exercise of a Stock Option, a participant will recognize
ordinary income to the extent that the fair market value of the
Common Stock acquired pursuant to the exercise of the Stock
Option, as of the exercise date, is greater than the exercise
price of the Stock Option. Any income recognized by the
participant as a result of the exercise of a Stock Option
(including by reason of making the Section 83(b) Election
(as defined below)) will be compensation income and will be
subject to income and employment tax withholding at the time the
Common Stock is acquired. If a Stock Option held by a
participant is purchased by HCA, such participant will recognize
ordinary income in an amount equal to the amount paid by HCA for
such option.
Section 83(b)
Considerations. Participants who acquire shares
of Common Stock subject to a substantial risk of
forfeiture (within the meaning of Treasury
Regulation Section 1.83-3(c))
through the exercise of Stock Options are generally required,
under the Management Stockholders Agreement, to make a
Section 83(b) election (a Section 83(b)
Election) with respect to such shares of Common Stock
within 30 days after the date of purchase. If Common Stock
acquired upon the exercise of a Stock Option is subject to a
substantial risk of forfeiture and a participant was not
required to make a Section 83(b) Election, such participant
would be subject to tax at ordinary income rates on the excess,
if any, of the fair market value of the Common Stock, on the
date or dates that the Common Stock becomes free of the transfer
and forfeiture restrictions, over the price paid for such Common
Stock. A participant would be required to include that amount in
income whether or not such Common Stock was sold or marketable
on such date or dates. In contrast, a participant who makes the
Section 83(b) Election will be required to include in
income the difference, if any, between the fair market value of
the Common Stock acquired on the exercise date and the exercise
price of the Stock Option and would not be subject to United
States federal income tax upon the lapsing of any such transfer
or forfeiture restrictions. Any further appreciation in the fair
market value of such Common Stock generally will be taxed as a
capital gain, rather than as ordinary income, as discussed more
fully below. In addition, a participant who makes a
Section 83(b) Election may choose when to recognize such
capital gain, because once the Section 83(b) Election has
been made, no other taxable event occurs with respect to such
Common Stock until the disposition of such Common Stock.
A Section 83(b) Election may be disadvantageous, however,
if the participant was required to include amounts in income as
a result of making the Section 83(b) Election and the
Common Stock subsequently decreases in value, inasmuch as any
losses recognized on a subsequent disposition of such Common
Stock would be capital losses, the deductibility of which is
subject to certain limitations. Additionally, if the participant
ultimately forfeits the Common Stock (pursuant to restrictions
in the Management Stockholders Agreement), no deduction
will be available to such participant with respect to any income
inclusion that resulted from the Section 83(b) Election.
There can be no assurances as to whether the applicable tax
rates will change or whether the value of the Common Stock will
appreciate. A participant who purchases Common Stock subject to
a substantial risk of forfeiture is urged to consult his or her
personal tax advisor regarding the effects of a
Section 83(b) Election.
The following discussion assumes that the Section 83(b)
Election is made when applicable.
Sale of Common Stock. The sale or other
taxable disposition of Common Stock acquired upon the exercise
of a Stock Option will be a taxable event. In general, the
participant selling such Common Stock will recognize gain or
loss equal to the difference between the amount realized by such
participant upon such sale or disposition and the
participants adjusted tax basis in such Common Stock. A
participants adjusted tax basis in Common Stock purchased
upon exercise of a Stock Option will generally be the amount
paid for such shares plus the amount, if any, of ordinary income
recognized on purchase. Any gain or loss resulting from a sale
or disposition of Common Stock obtained by the participant,
either purchased or through the exercise of an Option, generally
will be taxed as capital gain or loss if such Common Stock was a
capital asset in the
17
hands of the participant and will be taxed as long-term capital
gain or loss if at the time of any such sale or disposition the
participant has held such Common Stock for more than one year.
The time that such participant holds a Stock Option (rather than
the Common Stock attributable to such Stock Option) is not taken
into account for purposes of determining whether the participant
has held such Common Stock for more than one year. In addition,
there are limits on the deductibility of capital losses by the
participant. The tax consequences described above may differ,
however, in the case of a sale or other taxable disposition of
Common Stock to HCA, particularly if the participant has not
experienced a meaningful reduction in his or her proportionate
interest in HCA as a result of such transaction.
Stock Appreciation Rights. When a Stock
Appreciation Right is granted, there are no income tax
consequences for the participant or HCA. The exercise of a Stock
Appreciation Right will result in the participant recognizing
ordinary income on the value of the Stock Appreciation Right at
the time of exercise. HCA will be allowed a deduction for the
amount of ordinary income recognized by a participant with
respect to a Stock Appreciation Right. The participant also is
subject to capital gains treatment on the subsequent sale of any
Common Stock acquired through the exercise of a Stock
Appreciation Right award. For this purpose, the
participants basis in the Common Stock is its fair market
value at the time the Stock Appreciation Right is exercised (or
at the time of grant, if an election under Section 83(b) is
made).
Other Stock-Based Awards. A participant who is
granted any other stock-based award will generally recognize, in
the year of grant (or, if later, payment in case of restricted
stock units and similar awards), ordinary income equal to the
fair market value of the cash or other property received. If
such other stock-based award is in the form of property that is
subject to restrictions, the participant might not recognize
ordinary income until the restrictions lapse, unless the
participant makes a Section 83(b) Election. HCA is entitled
to a deduction for the amount of ordinary income recognized by
the participant with respect to the other stock-based award in
the same year as the ordinary income is recognized by the
participant.
Dividend Equivalent Rights. A participant who
is granted Dividend Equivalent Rights either alone or in
connection with the grant of a Stock Option, Stock Appreciation
Right or certain other stock-based awards generally will
recognize, in the year such Dividend Equivalent Rights are paid
in cash, compensation income equal to the amount of the payment;
provided, that if the Dividend Equivalent Rights are paid in the
form of Common Stock subject to transfer and forfeiture
restrictions, the considerations set forth above in
Certain Federal Income Tax Consequences
Section 83(b) Considerations will apply. Dividends
paid to a participant on account of Dividend Equivalent Rights
granted with respect to other stock-based awards with respect to
which the participant has made a valid Section 83(b)
Election may qualify for the reduced tax rates applicable to
qualified dividends if certain other conditions are
met. Participants eligible to make Section 83(b) Elections
are urged to consult their personal tax advisors regarding the
effects of a Section 83(b) Election. HCA is entitled to a
deduction for the amount of ordinary income recognized by the
participant with respect to the Dividend Equivalent Rights in
the same year as the ordinary income is recognized by the
participant.
Performance-Based Awards. Payments made under
performance awards are taxable as ordinary income at the time an
individual attains the performance goals and the payments are
made available to, and are transferable by, the participant.
Participants receiving performance awards settled in shares of
the Companys common stock will recognize ordinary income
equal to the fair market value of the shares of the
Companys common stock received as the performance goals
are met and such shares vest, less any amount paid by the
participant for the performance shares, unless the participant
makes an election under Section 83(b) of the Code to be
taxed at the time of the grant. A Section 83(b) election
may not be available with respect to certain forms of
performance awards. The participant is also subject to capital
gain or loss treatment on the subsequent sale of any of the
Companys common stock awarded to a participant as a
performance award. Unless a participant makes a
Section 83(b) election, his or her basis in the stock is
its fair market value at the time the performance goals are met
and the shares become vested.
Section 162(m) of the Code generally disallows a public
companys tax deduction for compensation paid in excess of
$1 million in any tax year to its chief executive officer
and certain other most highly compensated executives. However,
compensation that qualifies as performance-based
compensation is excluded from this $1 million
deduction limit and therefore remains fully deductible by the
company that pays it. HCA generally
18
intends that options granted with an exercise price at least
equal to 100% of fair market value of the underlying shares of
common stock at the date of grant qualify as
performance-based compensation so that these awards
will not be subject to the Section 162(m) deduction
limitations. In addition, the Committee may also grant certain
performance awards pursuant to the Stock Incentive Plan that may
qualify as performance-based compensation. HCA will
not necessarily limit executive compensation to amounts
deductible under Section 162(m) of the Code, however, if
such limitation is not in the best interests of HCA and its
stockholders.
The Stock Incentive Plan is not intended to be qualified under
Section 401(a) of the Code.
Securities
Authorized for Issuance Under Equity Compensation
Plans
The following table provides certain information as of
December 31, 2009 with respect to our equity compensation
plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c)
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
(a)
|
|
|
|
|
|
Securities
|
|
|
|
Number of
|
|
|
(b)
|
|
|
Remaining for
|
|
|
|
Securities to be
|
|
|
Weighted
|
|
|
Future Issuance
|
|
|
|
Issued Upon
|
|
|
Average Exercise
|
|
|
Under Equity
|
|
|
|
Exercise of
|
|
|
Price of
|
|
|
Compensation
|
|
|
|
Outstanding
|
|
|
Outstanding
|
|
|
Plans (Excluding
|
|
|
|
Options,
|
|
|
Options,
|
|
|
Securities
|
|
|
|
Warrants and
|
|
|
Warrants and
|
|
|
Reflected in
|
|
Plan Category
|
|
Rights
|
|
|
Rights
|
|
|
Column (a))
|
|
|
Equity compensation plans approved by security holders
|
|
|
11,527,000
|
|
|
$
|
52.78
|
|
|
|
392,400
|
|
Equity compensation plans not approved by security holders
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
11,527,000
|
|
|
$
|
52.78
|
|
|
|
392,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The following table sets forth information regarding the
beneficial ownership of our common stock as of May 31, 2010
for:
|
|
|
|
|
each person who is known by us to own beneficially more than 5%
of the outstanding shares of our common stock;
|
|
|
|
each of our directors;
|
|
|
|
each of our executive officers named in the Summary Compensation
Table; and
|
|
|
|
all of our directors and executive officers as a group.
|
The percentages of shares outstanding provided in the tables are
based on 94,635,289 shares of our common stock, par value
$0.01 per share, outstanding as of May 31, 2010. Beneficial
ownership is determined in accordance with the rules of the SEC
and generally includes voting or investment power with respect
to securities. Shares issuable upon the exercise of options that
are exercisable within 60 days of April 30, 2010 are
considered outstanding for the purpose of calculating the
percentage of outstanding shares of our common stock held by the
individual, but not for the purpose of calculating the
percentage of outstanding shares held by any other individual.
The address of each of our directors and executive officers
listed below is
c/o HCA Inc.,
One Park Plaza, Nashville, Tennessee 37203.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
Name of Beneficial Owner
|
|
Shares
|
|
|
Percent
|
|
|
Hercules Holding II, LLC
|
|
|
91,845,692
|
(1)
|
|
|
97.1
|
%
|
Christopher J. Birosak
|
|
|
|
(1)
|
|
|
|
|
Jack O. Bovender, Jr.
|
|
|
552,843
|
(2)
|
|
|
*
|
|
Richard M. Bracken
|
|
|
563,580
|
(3)
|
|
|
*
|
|
John P. Connaughton
|
|
|
|
(1)
|
|
|
|
|
James D. Forbes
|
|
|
|
(1)
|
|
|
|
|
Kenneth W. Freeman
|
|
|
|
(1)
|
|
|
|
|
Thomas F. Frist III
|
|
|
|
(1)
|
|
|
|
|
William R. Frist
|
|
|
|
(1)
|
|
|
|
|
Christopher R. Gordon
|
|
|
|
(1)
|
|
|
|
|
Samuel N. Hazen
|
|
|
243,143
|
(4)
|
|
|
*
|
|
R. Milton Johnson
|
|
|
354,442
|
(5)
|
|
|
*
|
|
Michael W. Michelson
|
|
|
|
(1)
|
|
|
|
|
James C. Momtazee
|
|
|
|
(1)
|
|
|
|
|
Stephen G. Pagliuca
|
|
|
|
(1)
|
|
|
|
|
W. Paul Rutledge
|
|
|
179,935
|
(6)
|
|
|
*
|
|
Nathan C. Thorne
|
|
|
|
(1)
|
|
|
|
|
Beverly B. Wallace
|
|
|
163,664
|
(7)
|
|
|
*
|
|
All directors and executive officers as a group (28 persons)
|
|
|
2,441,244
|
(8)
|
|
|
2.5
|
%
|
|
|
|
* |
|
Less than one percent. |
|
(1) |
|
Hercules Holding holds 91,845,692 shares, or approximately
97.1%, of our outstanding common stock. Hercules Holding is held
by a private investor group, including affiliates of Bain
Capital, KKR and MLGPE (previously the private equity arm of
Merrill Lynch & Co., Inc., which is a wholly-owned
subsidiary of Bank of America Corporation), and affiliates of
HCA founder Dr. Thomas F. Frist, Jr., including
Mr. Thomas F. Frist III and Mr. William R. Frist,
who serve as directors. Messrs. Connaughton, Gordon and
Pagliuca are affiliated with Bain Capital, whose affiliated
funds may be deemed to have indirect beneficial ownership of
23,373,333 shares, or 24.7%, of our outstanding common
stock through their interests |
20
|
|
|
|
|
in Hercules Holding. Messrs. Freeman, Michelson and
Momtazee are affiliated with KKR, which indirectly holds
23,373,332 shares, or 24.7%, of our outstanding common
stock through the interests of certain of its affiliated funds
in Hercules Holding. Messrs. Birosak, Forbes and Thorne are
affiliated with Bank of America Corporation, which indirectly
holds 23,373,333 shares, or 24.7%, of our outstanding
common stock through the interests of certain of its affiliated
funds in Hercules Holding and 980,393, or 1.0%, of our
outstanding common stock through Banc of America Securities LLC.
Thomas F. Frist III and William R. Frist may each
be deemed to indirectly, beneficially hold
17,804,125 shares, or 18.8%, of our outstanding common
stock through their interests in Hercules Holding. Each of such
persons, other than Hercules Holding, disclaims membership in
any such group and disclaims beneficial ownership of these
securities, except to the extent of its pecuniary interest
therein. The principal office addresses of Hercules Holding are
c/o Bain
Capital Partners, LLC, 111 Huntington Avenue, Boston, MA 02199,
c/o Kohlberg
Kravis Roberts & Co. L.P., 2800 Sand Hill Road,
Suite 200, Menlo Park, CA 94025,
c/o Merrill
Lynch Global Private Equity, Four World Financial Center, Floor
23, New York, NY 10080 and
c/o Dr. Thomas
F. Frist, Jr., 3100 West End Ave., Suite 500,
Nashville, TN 37203. |
|
(2) |
|
Includes 242,721 shares issuable upon exercise of options.
Effective December 15, 2009, Mr. Bovender retired as
executive Chairman of the Board. |
|
(3) |
|
Includes 482,097 shares issuable upon exercise of options. |
|
(4) |
|
Includes 209,171 shares issuable upon exercise of options. |
|
(5) |
|
Includes 311,669 shares issuable upon exercise of options. |
|
(6) |
|
Includes 147,185 shares issuable upon exercise of options. |
|
(7) |
|
Includes 161,264 shares issuable upon exercise of options. |
|
(8) |
|
Includes 2,013,633 shares issuable upon exercise of
options. Does not include shares beneficially owned by
Mr. Bovender, who retired as executive Chairman of the
Board effective December 15, 2009. |
EXECUTIVE
COMPENSATION
Compensation
Risk Assessment
In consultation with the Compensation Committee, members of
Human Resources, Legal, Enterprise Risk Management and Internal
Audit, management conducted an assessment of whether the
Companys compensation policies and practices encourage
excessive or inappropriate risk taking by our employees,
including employees other than our named executive officers.
This assessment included a review of the risk characteristics of
our business and the design of our incentive plans and policies.
Although a significant portion of our executive compensation
program is performance-based, the Compensation Committee has
focused on aligning the Companys compensation policies
with the long-term interests of the Company and avoiding rewards
or incentive structures that could create unnecessary risks to
the Company.
Management reported its findings to the Compensation Committee,
which agreed with managements assessment that our plans
and policies do not encourage excessive or inappropriate risk
taking and determined such policies or practices are not
reasonably likely to have a material, adverse effect on the
Company.
Compensation
Discussion and Analysis
The Compensation Committee (the Committee) of the
Board of Directors is generally charged with the oversight of
our executive compensation and rewards programs. The Committee
is currently composed of John P. Connaughton, James D.
Forbes and Michael W. Michelson. In early 2009, the Committee
also included George A. Bitar, and determinations with respect
to 2009 compensation were made by such Committee.
Responsibilities of the Committee include the review and
approval of the following items:
|
|
|
|
|
Executive compensation strategy and philosophy;
|
|
|
|
Compensation arrangements for executive management;
|
21
|
|
|
|
|
Design and administration of the annual cash-based Senior
Officer Performance Excellence Program (PEP);
|
|
|
|
Design and administration of our equity incentive plans;
|
|
|
|
Executive benefits and perquisites (including the HCA
Restoration Plan and the Supplemental Executive Retirement
Plan); and
|
|
|
|
Any other executive compensation or benefits related items
deemed appropriate by the Committee.
|
In addition, the Committee considers the proper alignment of
executive pay policies with Company values and strategy by
overseeing executive compensation policies, corporate
performance measurement and assessment, and Chief Executive
Officer performance assessment. The Committee may retain the
services of independent outside consultants, as it deems
appropriate, to assist in the strategic review of programs and
arrangements relating to executive compensation and performance.
The following executive compensation discussion and analysis
describes the principles underlying our executive compensation
policies and decisions as well as the material elements of
compensation for our named executive officers. Our named
executive officers for 2009 were:
|
|
|
|
|
Richard M. Bracken, Chairman and Chief Executive Officer;
|
|
|
|
R. Milton Johnson, Executive Vice President and Chief
Financial Officer;
|
|
|
|
Beverly B. Wallace, President Shared Services
Group;
|
|
|
|
Samuel N. Hazen, President Western Group;
|
|
|
|
W. Paul Rutledge, President Central
Group; and
|
|
|
|
Jack O. Bovender, Jr., Executive Chairman of the
Board (Retired).
|
Effective December 31, 2008, Mr. Bovender retired as
Chief Executive Officer but retained the role of executive
Chairman of the Board, and effective January 1, 2009,
Mr. Bracken was appointed to serve as Chief Executive
Officer and President of the Company. Mr. Bovender retired
as executive Chairman of the Board on December 15, 2009,
and Mr. Bracken assumed the additional responsibilities as
Chairman of the Board at such time.
As discussed in more detail below, the material elements and
structure of the named executive officers compensation
program were negotiated and determined in connection with the
Recapitalization, subject to annual adjustments in the
Committees discretion.
Compensation
Philosophy and Objectives
The core philosophy of our executive compensation program is to
support the Companys primary objective of providing the
highest quality health care to our patients while enhancing the
long term value of the Company to our stockholders.
Specifically, the Committee believes the most effective
executive compensation program (for all executives, including
named executive officers):
|
|
|
|
|
Reinforces HCAs strategic initiatives;
|
|
|
|
Aligns the economic interests of our executives with those of
our stockholders; and
|
|
|
|
Encourages attraction and long term retention of key
contributors.
|
The Committee is committed to a strong, positive link between
our objectives and our compensation and benefits practices.
Our compensation philosophy also allows for flexibility in
establishing executive compensation based on an evaluation of
information prepared by management or other advisors and other
subjective and objective considerations deemed appropriate by
the Committee, subject to any contractual agreements with our
executives. The Committee will also consider the recommendations
of our Chief Executive Officer. This
22
flexibility is important to ensure our compensation programs are
competitive and that our compensation decisions appropriately
reflect the unique contributions and characteristics of our
executives.
Compensation
Structure and Benchmarking
Our compensation program is heavily weighted towards
performance-based compensation, reflecting our philosophy of
increasing the long-term value of the Company and supporting
strategic imperatives. Total direct compensation and other
benefits consist of the following elements:
|
|
|
|
|
Total Direct Compensation
|
|
|
|
Base Salary
|
|
|
|
|
Annual Cash-Based Incentives (offered through our PEP)
|
|
|
|
|
Long-Term Equity Incentives (in the form of Stock Options)
|
|
|
|
|
|
Other Benefits
|
|
|
|
Retirement Plans
|
|
|
|
|
Limited Perquisites and Other Personal Benefits
|
|
|
|
|
Severance Benefits
|
The Committee does not support rigid adherence to benchmarks or
compensatory formulas and strives to make compensation decisions
which effectively support our compensation objectives and
reflect the unique attributes of the Company and each executive.
Our general practice, however, with respect to pay positioning,
is that executive base salaries and annual incentive (PEP)
target values should generally position total annual cash
compensation between the median and 75th percentile of
similarly-sized general industry companies. We utilize the
general industry as our primary source for competitive pay
levels because HCA is significantly larger than its industry
peers. See the discussion of benchmarking below for further
information. The named executive officers pay fell within
the range noted above for jobs with equivalent market
comparisons.
The cash compensation mix between salary and PEP has
historically been more weighted towards salary than competitive
practice among our general industry peers would suggest. Over
time, we have made steps towards a mix of cash compensation that
will place a greater emphasis on annual performance-based
compensation.
Although we look at competitive long-term equity incentive award
values in similarly-sized general industry companies when
assessing the competitiveness of our compensation programs, we
do not make annual executive option grants (and we did not base
our initial post-Recapitalization 2007 stock option grants on
these levels) since equity is structured differently in closely
held companies than in publicly-traded companies. As is typical
in similar situations, the Investors wanted to share a certain
percentage of the equity with executives shortly after the
consummation of the Recapitalization and establish performance
objectives and incentives up front in lieu of annual grants to
ensure our executives long-term economic interests would
be aligned with those of the Investors. This pool of equity was
then further allocated based on the executives
responsibilities and anticipated impact on, and potential for,
driving Company strategy and performance. The resulting total
direct pay mix on a cumulative basis, is heavily weighted
towards performance-based pay (PEP plus stock options) rather
than fixed pay, which the Committee believes reflects the
compensation philosophy and objectives discussed above.
In accordance with agreements entered into at the time of the
Recapitalization, our named executive officers received the 2x
Time Options (as defined below) in 2009 with an exercise price
equal to two times the share price at the Recapitalization (or
$102.00). The Committee allocated those options in consultation
with our Chief Executive Officer based on past executive
contributions and future anticipated impact on Company
objectives. For additional information regarding the 2x Time
Options, see Elements of
Compensation Long-Term Equity Incentive Awards:
Options below.
Compensation
Process
The Committee ensures executives pay levels are materially
consistent with the compensation strategy described above, in
part, by conducting annual assessments of competitive executive
compensation. Management (but no named executive officer), in
collaboration with the Committees independent consultant,
Semler
23
Brossy Consulting Group, LLC, collects and presents compensation
data from similarly-sized general industry companies, based to
the extent possible on comparable position matches and
compensation components. The following nationally recognized
survey sources were utilized in anticipation of establishing
2009 executive compensation:
|
|
|
Survey
|
|
Revenue Scope
|
|
Towers Perrin Executive Compensation Database
|
|
Greater than $20B
|
Hewitt Total Compensation Measurement
|
|
$10B - $25B
|
Hewitt Total Compensation Measurement
|
|
Greater than $25B
|
These particular revenue scopes were selected because they were
the closest approximations to HCAs revenue size. Each
survey that provided an appropriate position match and
sufficient sample size to be used in the compensation review was
weighted equally. For this purpose, the two Hewitt survey cuts
were considered as one survey, and we used a weighted average of
the two surveys (65% for the $10B $25B cut and 35%
for the Greater than $25B).
Data was also collected from health care providers within our
industry including Community Health Systems, Inc., Health
Management Associates, Inc., Kindred Healthcare, Inc., LifePoint
Hospitals, Inc., Tenet Healthcare Corporation and Universal
Health Services, Inc. These health care providers are used only
to obtain a general understanding of current industry
compensation practices since we are significantly larger than
these companies. CEO and CFO compensation data was also
collected and reviewed for large public health care companies
which included, in addition to health care providers, companies
in the health insurance, pharmaceutical, medical supplies and
related industries. This peer groups 2008 revenues ranged
from $7.2 billion to $81.2 billion with median
revenues of $21.3 billion. The companies in this analysis
included Abbott Laboratories, Aetna Inc., Amgen Inc., Baxter
International Inc., Boston Scientific Corporation, Bristol-Myers
Squibb Company, CIGNA Corporation, Coventry Health Care, Inc.,
Express Scripts, Inc., Humana Inc., Johnson & Johnson,
Eli Lilly and Company, Medco Health Solutions Inc.,
Merck & Co., Inc., Pfizer Inc., Quest Diagnostics
Incorporated, Schering-Plough Corporation, Tenet Healthcare
Corporation, Thermo Fisher Scientific Inc., UnitedHealth Group
Incorporated, WellPoint, Inc. and Wyeth.
Consistent with our flexible compensation philosophy, the
Committee is not required to approve compensation precisely
reflecting the results of these surveys, and may also consider,
among other factors (typically not reflected in these surveys):
the requirements of the applicable employment agreements, the
executives individual performance during the year, his or
her projected role and responsibilities for the coming year, his
or her actual and potential impact on the successful execution
of Company strategy, recommendations from our Chief Executive
Officer and compensation consultants, an officers prior
compensation, experience, and professional status, internal pay
equity considerations, and employment market conditions and
compensation practices within our peer group. The weighting of
these and other relevant factors is determined on a
case-by-case
basis for each executive upon consideration of the relevant
facts and circumstances.
Employment
Agreements
In connection with the Recapitalization, we entered into
employment agreements with each of our named executive officers
and certain other members of senior management to help ensure
the retention of those executives critical to the future success
of the Company. Among other things, these agreements set the
executives compensation terms, their rights upon a
termination of employment, and restrictive covenants around
non-competition, non-solicitation, and confidentiality. These
terms and conditions are further explained in the remaining
portion of this Compensation Discussion and Analysis and under
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Employment Agreements.
In light of Mr. Bovenders retirement from the
position of Chief Executive Officer, effective December 31,
2008, and continuing service to the Company as executive
Chairman until December 15, 2009, the Company entered into
an Amended and Restated Employment Agreement with
Mr. Bovender, effective December 31, 2008. The
material amendments to Mr. Bovenders prior employment
agreement as set forth in the Amended and Restated Employment
Agreement are described below under Severance
and Change in Control
24
Benefits Mr. Bovenders Continuing
Severance Benefits and under Narrative
Disclosure to Summary Compensation Table and 2009 Grants of
Plan-Based Awards Table Employment Agreements.
The Company also amended Mr. Brackens employment
agreement, effective January 1, 2009, to reflect his
appointment to the position of Chief Executive Officer.
Elements
of Compensation
Base
Salary
Base salaries are intended to provide reasonable and competitive
fixed compensation for regular job duties. The threshold base
salaries for our executives are set forth in their employment
agreements. We did not increase named executive officer base
salaries in 2009, other than an increase in
Mr. Johnsons base salary, as detailed below, in order
to better align his salary with market for his position as Chief
Financial Officer based on general industry surveys. In light of
Mr. Bovenders retirement from the position of Chief
Executive Officer and continuing role as executive Chairman and
Mr. Brackens assumption of the responsibilities of
Chief Executive Officer, Mr. Bovenders base salary
for 2009 was reduced to $1.144 million (as described
further in Narrative Disclosure to Summary
Compensation Table and 2009 Grants of Plan-Based Awards
Table Employment Agreements
Mr. Bovenders Employment Agreements), and
Mr. Brackens 2009 base salary was increased to
$1.325 million. Similarly, taking into consideration the
additional responsibilities being assumed by the position of
Executive Vice President and Chief Financial Officer and
relevant market comparables from the survey data,
Mr. Johnsons 2009 salary was set at $850,000,
reflecting an increase of approximately 7.6% from his 2008
salary. In light of actual total cash compensation realized for
2009 and current target cash compensation opportunities levels,
no merit base salary increases are planned for 2010 at this
time. Mr. Rutledges salary will be increased by 3.7%
effective April 1, 2010 as an internal equity adjustment to
internal peer roles.
Annual
Incentive Compensation: PEP
The PEP is intended to reward named executive officers for
annual financial performance, with the goals of providing high
quality health care for our patients and increasing stockholder
value. Accordingly, in 2008, the Companys
2008-2009
Senior Officer Performance Excellence Program, as amended (the
2008-2009
PEP), was approved by the Committee to cover annual cash
incentive awards for both 2008 and 2009. Each named executive
officer in the
2008-2009
PEP was initially assigned a maximum 2009 annual award target
expressed as a percentage of salary ranging from 72% to 132%,
which under the terms of the
2008-2009
PEP applies to the lesser of (a) the named executive
officers 2009 base salary, or (b) 125% of the named
executive officers 2008 base salary. The Committee had the
discretion to reduce, but not increase, the 2009 Threshold,
Target and Maximum percentages as set forth in the
2008-2009
PEP. Mr. Bovenders 2009 PEP target and an additional
one-time $250,000 bonus opportunity based on his contributions
to certain legislative initiatives as determined by the
Committee were set forth in his Amended Employment Agreement, as
described in Narrative Disclosure to Summary
Compensation Table and 2009 Grants of Plan-Based Awards
Table Employment Agreements
Mr. Bovenders Employment Agreement. The
Committee set Mr. Brackens 2009 target percentage at
130% of his 2009 base salary in connection with his appointment
as Chief Executive Officer and amended the
2008-2009
PEP to set Mr. Johnsons 2009 target percentage at 80%
of his 2009 base salary in light of the additional
responsibilities assumed by the position of Executive Vice
President and Chief Financial Officer. The 2009 target
percentage for each of Ms. Wallace and Messrs. Hazen
and Rutledge was set at 66% of their respective 2009 base
salaries (see individual targets in the table below). These
targets were intended to provide a meaningful incentive for
executives to achieve or exceed performance goals.
The
2008-2009
PEP was designed to provide 100% of the target award for target
performance, 50% of the target award for a minimum acceptable
(threshold) level of performance, and a maximum of 200% of the
target award for maximum performance, while no payments were to
be made for performance below threshold levels. The Committee
believes this payout curve is consistent with competitive
practice. More importantly, it
25
promotes and rewards continuous growth as performance goals have
consistently been set at increasingly higher levels each year.
Actual awards under the PEP are generally determined using the
following two steps:
1. The executives conduct must reflect our mission
and values by upholding our Code of Conduct and following our
compliance policies and procedures. This step is critical to
reinforcing our commitment to integrity and the delivery of high
quality health care. In the event the Committee determines the
participants conduct during the fiscal year is not in
compliance with the first step, he or she will not be eligible
for an incentive award.
2. The actual award amount is determined based upon Company
performance. In 2009, the PEP for all named executive officers,
other than Mr. Hazen and Mr. Rutledge, incorporated
one Company financial performance measure, EBITDA, defined in
the
2008-2009
PEP as earnings before interest, taxes, depreciation,
amortization, minority interest expense (now, net income
attributable to noncontrolling interests), gains or losses on
sales of facilities, gains or losses on extinguishment of debt,
asset or investment impairment charges, restructuring charges,
and any other significant nonrecurring non-cash gains or charges
(but excluding any expenses for share-based compensation under
ASC 718, Compensation-Stock Compensation (ASC
718)) (EBITDA). The Company EBITDA target for
2009, as adjusted, was $4.768 billion for the named
executive officers. Mr. Hazens 2009 PEP, as the
Western Group President, was based 50% on Company EBITDA and 50%
on Western Group EBITDA (with a Western Group EBITDA target for
2009 of $2.352 billion, as adjusted) to ensure his
accountability for his groups results. Similarly,
Mr. Rutledges 2009 PEP, as the Central Group
President, was based 50% on Company EBITDA and 50% on Central
Group EBITDA (with a Central Group EBITDA target for 2009 of
$1.137 billion, as adjusted). The Committee chose to base
annual incentives on EBITDA for a number of reasons:
|
|
|
|
|
It effectively measures overall Company performance;
|
|
|
|
It can be considered an important surrogate for cash flow, a
critical metric related to paying down the Companys
significant debt obligation;
|
|
|
|
It is the key metric driving the valuation in the internal
Company model, consistent with the valuation approach used by
industry analysts; and
|
|
|
|
It is consistent with the metric used for the vesting of the
financial performance portion of our option grants.
|
These EBITDA targets should not be understood as
managements predictions of future performance or other
guidance and investors should not apply these in any other
context. Our 2009 threshold and maximum goals were set at
approximately +/− 3.6% of the target goal to reflect
likely performance volatility. EBITDA targets were linked to the
Companys short-term and long-term business objectives to
ensure incentives are provided for appropriate annual growth.
Upon review of the Companys 2009 financial performance,
the Committee determined that Company EBITDA performance for the
fiscal year ended December 31, 2009 was above the maximum
performance levels as set by the Compensation Committee, as
adjusted; likewise, the EBITDA performance of the Western Group
and Central Group also exceeded the maximum performance targets,
as adjusted.
|
|
|
|
|
|
|
|
|
|
|
2009 Adjusted
|
|
2009 Actual
|
|
|
EBITDA Target
|
|
Adjusted EBITDA
|
|
Company
|
|
$
|
4.768 billion
|
|
|
$
|
5.512 billion
|
|
Western Group
|
|
$
|
2.352 billion
|
|
|
$
|
2.841 billion
|
|
Central Group
|
|
$
|
1.137 billion
|
|
|
$
|
1.325 billion
|
|
26
Accordingly, the 2009 PEP was paid out as follows to the named
executive officers (the actual 2009 PEP payout amounts are
included in the Non-Equity Incentive Plan
Compensation column of the Summary Compensation Table):
|
|
|
|
|
|
|
|
|
|
|
|
|
2009 Actual PEP
|
|
|
2009 Target PEP
|
|
Award
|
Named Executive Officer
|
|
(% of Salary)
|
|
(% of Salary)
|
|
Richard M. Bracken (Chairman and CEO)
|
|
|
130
|
%
|
|
|
260
|
%
|
R. Milton Johnson (Executive Vice President and CFO)
|
|
|
80
|
%
|
|
|
160
|
%
|
Beverly B. Wallace (President, Shared Services Group)
|
|
|
66
|
%
|
|
|
132
|
%
|
Samuel N. Hazen (President, Western Group)
|
|
|
66
|
%
|
|
|
132
|
%
|
W. Paul Rutledge (President, Central Group)
|
|
|
66
|
%
|
|
|
132
|
%
|
Jack O. Bovender, Jr. (Retired Chairman)
|
|
|
50
|
%
|
|
|
100
|
%
|
Mr. Bovender also received the additional bonus of $250,000
based upon his contributions to certain of the Companys
legislative initiatives as described above.
On March 31, 2010, the Committee adopted the 2010 Senior
Officer Performance Excellence Program (the 2010
PEP). Under the 2010 PEP, the named executive officers of
the Company shall be eligible to earn performance awards based
upon the achievement of certain specified performance targets.
The specified performance criteria for the Companys named
executive officers and other participants is EBITDA (as defined
in the 2010 PEP), and with respect to the Western and Central
Group Presidents, 50% of their respective award opportunities
are based on EBITDA for the Companys Western and Central
Groups, respectively. Target awards for the named executive
officers are the same as for 2009 and are as follows:
|
|
|
|
|
130% of base salary for Richard M. Bracken, our Chairman and CEO;
|
|
|
|
80% of base salary for R. Milton Johnson, our Executive Vice
President and CFO;
|
|
|
|
66% of base salary for Beverly B. Wallace, our
President Shared Services Group;
|
|
|
|
66% of base salary for Samuel N. Hazen, our
President Western Group; and
|
|
|
|
66% of base salary for W. Paul Rutledge, our
President Central Group.
|
Participants will receive 100% of the target award for target
performance, 25% of the target award for a minimum acceptable
(threshold) level of performance, and a maximum of 200% of the
target award for maximum performance. No payments will be made
for performance below specified threshold amounts. Payouts
between threshold and maximum will be calculated by the
Committee in its sole discretion using straight-line
interpolation. The Committee may make adjustments to the terms
and conditions of, and the criteria included in, awards under
the 2010 PEP in recognition of unusual or nonrecurring events
affecting a participant or the Company, or the financial
statements of the Company, or in certain other instances
specified in the 2010 PEP.
The Committee set the named executive officers 2010 target
performance goals under the PEP based on realistic expectations
of Company performance, ensuring successful execution of our
plans in order to realize the most value from these awards.
While we do not intend to disclose our 2010 PEP EBITDA target,
as an understanding of that target is not necessary for a fair
understanding of the named executive officers compensation
for 2009 and could result in competitive harm and market
confusion, we consistently set targets that require an increase
in EBITDA year over year to promote continuous growth consistent
with our business plan. For 2010, the Committee has the ability
to apply negative discretion based on performance of
company-wide quality metrics against industry benchmarks, and
for Ms. Wallace, negative discretion can be applied based
on performance of individual goals related to the operations of
the Shared Services Group.
Awards pursuant to the 2010 PEP that are attributable to the
performance goals being met at target level or below
will be paid solely in cash, and, in the event performance goals
are achieved above the target level, the amount of
an award attributable to performance results in excess of
target levels shall be payable 50% in cash and 50%
in restricted stock units.
27
The Company can recover (or clawback) incentive
compensation pursuant to our 2010 PEP that was based on
(i) achievement of financial results that are subsequently
the subject of a restatement due to material noncompliance with
any financial reporting requirement under either GAAP or federal
securities laws, other than as a result of changes to accounting
rules and regulations, or (ii) a subsequent finding that
the financial information or performance metrics used by the
Committee to determine the amount of the incentive compensations
are materially inaccurate, in each case regardless of individual
fault. In addition, the Company may recover any incentive
compensation awarded or paid pursuant to this policy based on
the participants conduct which is not in good faith and
which materially disrupts, damages, impairs or interferes with
the business of the Company and its affiliates. The Committee
may also provide for incremental additional payments to
then-current executives in the event any restatement or error
indicates that such executives should have received higher
performance-based payments. This policy is administered by the
Committee in the exercise of its discretion and business
judgment based on the relevant facts and circumstances.
Long-Term
Equity Incentive Awards: Options
In connection with the Recapitalization, the Board of Directors
approved and adopted the 2006 Stock Incentive Plan for Key
Employees of HCA Inc. and its Affiliates (the 2006
Plan). The purpose of the 2006 Plan is to:
|
|
|
|
|
Promote our long term financial interests and growth by
attracting and retaining management and other personnel and key
service providers with the training, experience and abilities to
enable them to make substantial contributions to the success of
our business;
|
|
|
|
Motivate management personnel by means of growth-related
incentives to achieve long range goals; and
|
|
|
|
Further the alignment of interests of participants with those of
our stockholders through opportunities for increased stock or
stock-based ownership in the Company.
|
In January 2007, pursuant to the terms of the named executive
officers respective employment agreements, the Committee
approved long-term stock option grants to our named executive
officers under the 2006 Plan consisting solely of a one-time,
multi-year stock option grant in lieu of annual long-term equity
incentive award grants (New Options). In addition to
the New Options granted in 2007, the Company committed to grant
the named executive officers 2x Time Options (as defined below)
in their respective employment agreements, as described in more
detail below under Narrative Disclosure to
Summary Compensation Table and 2009 Grants of Plan-Based Awards
Table Employment Agreements. The Committee
believes stock options are the most effective long-term vehicle
to directly align the interests of executives with those of our
stockholders by motivating performance that results in the
long-term appreciation of the Companys value, since they
only provide value to the executive if the value of the Company
increases. As is typical in leveraged buyout situations, the
Committee determined that granting all of the stock options
(except the 2x Time Options) up front rather than annually was
appropriate to aid in retaining key leaders critical to the
Companys success over the next several years and, coupled
with the executives significant personal investments in
connection with the Recapitalization, provide an equity
incentive and stake in the Company that directly aligns the
long-term economic interests of the executives with those of the
Investors.
The New Options have a ten year term and are divided so that 1/3
are time vested options, 1/3 are EBITDA-based performance vested
options and 1/3 are performance options that vest based on
investment return to the Sponsors, each as described below. The
combination of time, performance and investor return based
vesting of these awards is designed to compensate executives for
long term commitment to the Company, while motivating sustained
increases in our financial performance and helping ensure the
Sponsors have received an appropriate return on their invested
capital before executives receive significant value from these
grants.
The time vested options are granted to aid in retention.
Consistent with this goal, the time vested options granted in
2007 vest and become exercisable in equal increments of 20% on
each of the first five anniversaries of the grant date. The time
vested options have an exercise price equivalent to fair market
value on the date of
28
grant. Since our common stock is not currently traded on a
national securities exchange, fair market value was determined
reasonably and in good faith by the Board of Directors after
consultation with the Chief Executive Officer and other advisors.
The EBITDA-based performance vested options are intended to
motivate sustained improvement in long-term performance.
Consistent with this goal, the EBITDA-based performance vested
options granted in 2007 are eligible to vest and become
exercisable in equal increments of 20% at the end of fiscal
years 2007, 2008, 2009, 2010 and 2011 if certain annual EBITDA
performance targets are achieved. These EBITDA performance
targets were established at the time of the Recapitalization and
can be adjusted by the Board of Directors in consultation with
the Chief Executive Officer as described below. We chose EBITDA
(defined in the award agreements as earnings before interest,
taxes, depreciation, amortization, minority interest expense
(now, net income attributable to noncontrolling interests),
gains or losses on sales of facilities, gains or losses on
extinguishment of debt, asset or investment impairment charges,
restructuring charges, and any other significant nonrecurring
non-cash gains or charges (but excluding any expenses for
share-based compensation under ASC 718 with respect to any
awards granted under the 2006 Plan)) as the performance metric
since it is a key driver of our valuation and for other reasons
as described above in the Elements of
Compensation Annual Incentive Compensation:
PEP section of this Compensation Discussion and Analysis.
Due to the number of events that can occur within our industry
in any given year that are beyond the control of management but
may significantly impact our financial performance (e.g., health
care regulations, industry-wide significant fluctuations in
volume, etc.), we have incorporated vesting provisions. The
EBITDA-based performance vested options may vest and become
exercisable on a catch up basis, such that options
that were eligible to vest but failed to vest due to our failure
to achieve prior EBITDA targets will vest if at the end of any
subsequent year or at the end of fiscal year 2012, the
cumulative total EBITDA earned in all prior years exceeds the
cumulative EBITDA target at the end of such fiscal year.
As discussed above, we do not intend to disclose the
2010-2011
EBITDA performance targets as they reflect competitive,
sensitive information regarding our budget. However, we
deliberately set our targets at increasingly higher levels.
Thus, while designed to be attainable, target performance levels
for these years require strong, improving performance and
execution, which in our view, provides an incentive firmly
aligned with stockholder interests.
As with the EBITDA targets under our PEP, pursuant to the terms
of the 2006 Plan and the Stock Option Agreements governing the
2007 grants, the Board of Directors, in consultation with our
Chief Executive Officer, has the ability to adjust the
established EBITDA targets for significant events, changes in
accounting rules and other customary adjustment events. We
believe these adjustments may be necessary in order to
effectuate the intents and purposes of our compensation plans
and to avoid unintended consequences that are inconsistent with
these intents and purposes. For example, the Board of Directors
exercised its ability to make adjustments to the Companys
2009-2011
EBITDA performance targets (including cumulative EBITDA targets)
for facility dispositions and accounting changes occurring
during the 2009 fiscal year.
The options that vest based on investment return to the Sponsors
are intended to align the interests of executives with those of
our principal stockholders to ensure stockholders receive their
expected return on their investment before the executives can
receive their gains on this portion of the option grant. These
options vest and become exercisable with respect to 10% of the
common stock subject to such options at the end of fiscal years
2007, 2008, 2009, 2010 and 2011 if the Investor Return (as
defined below) is at least equal to two times the price paid to
stockholders in the Recapitalization (or $102.00), and with
respect to an additional 10% at the end of fiscal years 2007,
2008, 2009, 2010 and 2011 if the Investor Return is at least
equal to
two-and-a-half
times the price paid to stockholders in the Recapitalization (or
$127.50). Investor Return means, on any of the first
five anniversaries of the closing date of the Recapitalization,
or any date thereafter, all cash proceeds actually received by
affiliates of the Sponsors after the closing date in respect of
their common stock, including the receipt of any cash dividends
or other cash distributions (including the fair market value of
any distribution of common stock by the Sponsors to their
limited partners), determined on a fully diluted, per share
basis. The Sponsor investment return options also may become
vested and exercisable on a catch up basis if the
relevant Investor Return is achieved at any time occurring prior
to the expiration of such options.
29
Upon review of the Companys 2009 financial performance,
the Committee determined the Company achieved the 2009 EBITDA
performance target of $4.821 billion, as adjusted, under
the New Option awards; therefore, pursuant to the terms of the
2007 Stock Option Agreements, 20% of each named executive
officers EBITDA-based performance vested options vested as
of December 31, 2009. Further, 20% of each named executive
officers time vested options vested on the second
anniversary of their grant date, January 30, 2009. As of
the end of the 2009 fiscal year, no portion of the options that
vest based on Investor Return have vested; however, such options
remain subject to the catch up vesting provisions
described above.
In each of the employment agreements with the named executive
officers, we also committed to grant, among the named executive
officers and certain other executives, 10% of the options
initially authorized for grant under the 2006 Plan at some time
before November 17, 2011 (but with a good faith commitment
to do so before a change in control (as defined in
the 2006 Plan) or a public offering (as defined in
the 2006 Plan) and before the time when our Board of Directors
reasonably believes that the fair market value of our common
stock is likely to exceed the equivalent of $102.00 per share)
at an exercise price per share that is the equivalent of $102.00
per share (2x Time Options). On October 6,
2009, the 2x Time Options were granted. The Committee allocated
those options in consultation with our Chief Executive Officer
based on past executive contributions and future anticipated
impact on Company objectives. Forty percent of the 2x Time
Options were vested upon grant to reflect employment served
since the Recapitalization, an additional twenty percent of the
options vested on November 17, 2009, and twenty percent of
the options granted to each recipient will vest on
November 17, 2010 and November 17, 2011, respectively.
The terms of the 2x Time Options are otherwise consistent with
other time vesting options granted under the 2006 Plan.
For additional information concerning the options awarded in
2007 and 2009, see the 2009 Grants of Plan-Based Awards and
Outstanding Equity Awards at 2009 Fiscal Year-End Tables.
Ownership
Guidelines
While we have maintained stock ownership guidelines in the past,
as a non-listed company, we no longer have a policy regarding
stock ownership guidelines. However, we do believe equity
ownership aligns our executive officers interests with
those of the Investors. Accordingly, all of our named executive
officers were required to rollover at least half their
pre-Recapitalization equity and, therefore, maintain significant
stock ownership in the Company.
Retirement
Plans
We currently maintain one qualified retirement plan for which
the named executive officers are eligible, the HCA 401(k) Plan,
to aid in retention and to assist employees in providing for
their retirement. We also used to maintain the HCA Retirement
Plan, which as of April 1, 2008, merged into the HCA 401(k)
Plan resulting in one qualified retirement plan. Generally all
employees who have completed the required service are eligible
to participate in the HCA 401(k) Plan. Each of our named
executive officers participates in the plan. For additional
information on these plans, including amounts contributed by HCA
in 2009 to the named executive officers, see the Summary
Compensation Table and related footnotes and narratives and
2009 Pension Benefits.
Our key executives, including the named executive officers, also
participate in two supplemental retirement programs. The
Committee and the Board initially approved these supplemental
programs to:
|
|
|
|
|
Recognize significant long-term contributions and commitments by
executives to the Company and to performance over an extended
period of time;
|
|
|
|
Induce our executives to continue in our employ through a
specified normal retirement age (initially 62 through 65, but
reduced to 60 upon the change in control at the time of the
Recapitalization in 2006); and
|
|
|
|
Provide a competitive benefit to aid in attracting and retaining
key executive talent.
|
30
The Restoration Plan provides a benefit to replace a portion of
the contributions lost in the HCA 401(k) Plan due to certain IRS
limitations. Effective January 1, 2008, participants in the
SERP (described below) are no longer eligible for Restoration
Plan contributions; however, the hypothetical accounts
maintained for each named executive officer as of
January 1, 2008 will continue to be maintained and will be
increased or decreased with hypothetical investment returns
based on the actual investment return of the Mix B fund within
the HCA 401(k) Plan. For additional information concerning the
Restoration Plan, see 2009 Nonqualified
Deferred Compensation.
Key executives also participate in the Supplemental Executive
Retirement Plan (the SERP), adopted in 2001. The
SERP benefit brings the total value of annual retirement income
to a specific income replacement level. For named executive
officers with 25 years or more of service, this income
replacement level is 60% of final average pay (base salary and
PEP payouts) at normal retirement, a competitive level of
benefit at the time the plan was implemented. Due to the
Recapitalization, all participants are fully vested in their
SERP benefits and the plan is now frozen to new entrants. For
additional information concerning the SERP, see
2009 Pension Benefits.
In the event a participant renders service to another health
care organization within five years following retirement or
termination of employment, he or she forfeits the rights to any
further payment, and must repay any payments already made. This
non-competition provision is subject to waiver by the Committee
with respect to the named executive officers.
Personal
Benefits
Our executive officers receive limited, if any, benefits outside
of those offered to our other employees. Generally, we provide
these benefits to increase travel and work efficiencies and
allow for more productive use of the executives time.
Mr. Bracken is permitted to use the Company aircraft for
personal trips, subject to the aircrafts availability.
Prior to his retirement, Mr. Bovender was also permitted to
use the Company aircraft for personal trips, subject to the
aircrafts availability. The named executive officers may
have their spouses accompany them on business trips taken on the
Company aircraft, subject to seat availability. In addition,
there are times when it is appropriate for an executives
spouse to attend events related to our business. On those
occasions, we will pay for the travel expenses of the
executives spouse. We will, on an as needed basis, provide
mobile telephones and personal digital assistants to our
employees and certain of our executive officers have obtained
such devices through us. The value of these personal benefits,
if any, is included in the executive officers income for
tax purposes and, in certain limited circumstances, the
additional income attributed to an executive officer as a result
of one or more of these benefits will be grossed up to cover the
taxes due on that income. Except as otherwise discussed herein,
other welfare and employee-benefit programs are the same for all
of our eligible employees, including our executive officers. For
additional information, see footnote (4) to the Summary
Compensation Table.
Severance
and Change in Control Benefits
As noted above, all of our named executive officers have entered
into employment agreements, which provide, among other things,
each executives rights upon a termination of employment in
exchange for non-competition, non-solicitation, and
confidentiality covenants. We believe that reasonable severance
benefits are appropriate in order to be competitive in our
executive retention efforts. These benefits should reflect the
fact that it may be difficult for such executives to find
comparable employment within a short period of time. We also
believe that these types of agreements are appropriate and
customary in situations such as the Recapitalization wherein the
executives have made significant personal investments in the
Company and that investment is generally illiquid for a
significant period of time. Finally, we believe formalized
severance arrangements are common benefits offered by employers
competing for similar senior executive talent.
Severance
Benefits for Named Executive Officers (other than
Mr. Bovender)
If employment is terminated by the Company without
cause or by the executive for good
reason (whether or not the termination was in connection
with a
change-in-control),
the executive would be entitled
31
to accrued rights (cause, good reason and accrued
rights are as defined in Narrative Disclosure
to Summary Compensation Table and 2009 Grants of Plan-Based
Awards Table Employment Agreements) plus:
|
|
|
|
|
Subject to restrictive covenants and the signing of a general
release of claims, an amount equal to two times for
Ms. Wallace and Messrs. Hazen and Rutledge and three
times in the case of Messrs. Bracken and Johnson the sum of
base salary plus PEP paid or payable in respect of the fiscal
year immediately preceding the fiscal year in which termination
occurs, payable over a two year period;
|
|
|
|
Pro-rata bonus; and
|
|
|
|
Continued coverage under our group health plans during the
period over which the cash severance is paid.
|
Additionally, unvested options will be forfeited; however,
vested New Options (including 2x Time Options) will remain
exercisable until the first anniversary of the termination of
the executives employment.
Because we believe a termination by the executive for good
reason (a constructive termination) is conceptually the same as
an actual termination by the Company without cause, we believe
it is appropriate to provide severance benefits following such a
constructive termination of the named executive officers
employment. All of our severance provisions are believed to be
within the realm of competitive practice and are intended to
provide fair and reasonable compensation to the executive upon a
termination event.
Mr. Bovenders
Continuing Severance Benefits
In light of his long-term service to the Company and his
retirement from the position of Chief Executive Officer, the
Company entered into an Amended and Restated Employment
Agreement with Mr. Bovender, effective December 31,
2008 (the Amended Employment Agreement).
Mr. Bovenders Amended Employment Agreement provides
that, effective as of the expiration of the Employment Term (as
defined in Narrative Disclosure to Summary
Compensation Table and 2009 Grants of Plan-Based Awards
Table Employment Agreements),
Mr. Bovender was entitled to receive the accrued
rights as described above for the other named executive
officers. Mr. Bovender was also entitled to receive a pro
rata portion of his bonus under the
2008-2009
PEP based on the Companys actual results for 2009
(Mr. Bovenders Prorated Bonus).
Mr. Bovender is also entitled to continued coverage under
the Companys group health plans for Mr. Bovender and
his wife until age 65, reimbursement of any unreimbursed
business expenses properly incurred and such employee benefits,
if any, as to which Mr. Bovender would be entitled under
the Companys employee benefit plans.
The Amended Employment Agreement also provides that, effective
as of the expiration of the Employment Term (December 15,
2009), (i) neither Mr. Bovender nor the Company have
any put or call rights with respect to Mr. Bovenders
New Options or stock acquired upon the exercise of any such
options; (ii) Mr. Bovenders rollover
stock options will remain exercisable as if
Mr. Bovenders employment terminated by reason of
retirement in accordance with the terms of the
applicable equity plans and award agreements; (iii) the
unvested New Options (including the 2x Time Options) held by
Mr. Bovender that vest solely based on the passage of time
will vest as if Mr. Bovenders employment had
continued through the next three anniversaries of their date of
grant; (iv) the unvested New Options held by
Mr. Bovender that are EBITDA performance options will
remain outstanding and will vest, if at all, on the next four
dates that they would have otherwise vested had
Mr. Bovenders employment continued, based upon the
extent to which performance goals are met; (v) the unvested
New Options held by Mr. Bovender that are Investor
Return performance options will remain outstanding and
will vest, if at all, on the dates that they would have
otherwise vested had Mr. Bovenders employment
continued through the expiration of such options, based upon the
extent to which performance goals are met; and
(vi) Mr. Bovenders New Options will remain
exercisable until the second anniversary of the last date on
which his EBITDA performance options are eligible to vest (which
is December 31, 2014), except that
(a) Mr. Bovenders 2x Time Options will remain
exercisable until the fifth anniversary of the last date on
which his EBITDA performance options are eligible
32
to vest (which is December 31, 2017), and
(b) Mr. Bovenders Investor Return
performance options will remain exercisable until the expiration
of such options.
Change in
Control Benefits
Pursuant to the Stock Option Agreements governing the New
Options granted in 2007 and the 2x Time Options granted in 2009,
both under the 2006 Plan, upon a Change in Control of the
Company (as defined below), all unvested time vesting New
Options and 2x Time Options (that have not otherwise terminated
or become exercisable) shall become immediately exercisable.
Performance options that vest subject to the achievement of
EBITDA targets will become exercisable upon a Change in Control
of the Company if: (i) prior to the date of the occurrence
of such event, all EBITDA targets have been achieved for years
ending prior to such date; (ii) on the date of the
occurrence of such event, the Companys actual cumulative
total EBITDA earned in all years occurring after the performance
option grant date, and ending on the date of the Change in
Control, exceeds the cumulative total of all EBITDA targets in
effect for those same years; or (iii) the Investor Return
is at least
two-and-a-half
times the price paid to the stockholders in the Recapitalization
(or $127.50). For purposes of the vesting provision set forth in
clause (ii) above, the EBITDA target for the year in which
the Change in Control occurs shall be equitably adjusted by the
Board of Directors in good faith in consultation with the chief
executive officer (which adjustment shall take into account the
time during such year at which the Change in Control occurs).
Performance vesting options that vest based on the investment
return to the Sponsors will only vest upon the occurrence of a
Change in Control if, as a result of such event, the applicable
Investor Return (i.e., at least two times the price paid to the
stockholders in the Recapitalization for half of these options
and at least
two-and-one-half
times the price paid to the stockholders in the Recapitalization
for the other half of these options) is also achieved in such
transaction (if not previously achieved). Change in
Control means in one or more of a series of transactions
(i) the transfer or sale of all or substantially all of the
assets of the Company (or any direct or indirect parent of the
Company) to an Unaffiliated Person (as defined below);
(ii) a merger, consolidation, recapitalization or
reorganization of the Company (or any direct or indirect parent
of the Company) with or into another Unaffiliated Person, or a
transfer or sale of the voting stock of the Company (or any
direct or indirect parent of the Company), an Investor, or any
affiliate of any of the Investors to an Unaffiliated Person, in
any such event that results in more than 50% of the common stock
of the Company (or any direct or indirect parent of the Company)
or the resulting company being held by an Unaffiliated Person;
or (iii) a merger, consolidation, recapitalization or
reorganization of the Company (or any direct or indirect parent
of the Company) with or into another Unaffiliated Person, or a
transfer or sale by the Company (or any direct or indirect
parent of the Company), an Investor or any affiliate of any of
the Investors, in any such event after which the Investors and
their affiliates (x) collectively own less than 15% of the
common stock of and (y) collectively have the ability to
appoint less than 50% of the directors to the Board (or any
resulting company after a merger). For purposes of this
definition, the term Unaffiliated Person means a
person or group who is not an Investor, an affiliate of any of
the Investors or an entity in which any Investor holds, directly
or indirectly, a majority of the economic interest in such
entity.
Additional information regarding applicable payments under such
agreements for the named executive officers is provided under
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Employment Agreements and Potential
Payments Upon Termination or Change in Control.
Recoupment
of Compensation
Information regarding the Companys policy with respect to
recovery of incentive compensation is provided under
Elements of Compensation Annual
Incentive Compensation: PEP above.
Tax
and Accounting Implications
On April 29, 2008, we registered our common stock pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as
amended; and the Company became subject to Section 162(m)
of the Internal Revenue Code, as amended (the Code)
for fiscal year 2008 and beyond, so long as the Companys
stock remains registered
33
with the SEC. The Committee considers the impact of
Section 162(m) in the design of its compensation
strategies. Under Section 162(m), compensation paid to
executive officers in excess of $1,000,000 cannot be taken by us
as a tax deduction unless the compensation qualifies as
performance-based compensation. We have determined, however,
that we will not necessarily seek to limit executive
compensation to amounts deductible under Section 162(m) if
such limitation is not in the best interests of our
stockholders. While considering the tax implications of its
compensation decisions, the Committee believes its primary focus
should be to attract, retain and motivate executives and to
align the executives interests with those of our
stakeholders.
The Committee operates its compensation programs with the good
faith intention of complying with Section 409A of the
Internal Revenue Code. We account for stock based payments with
respect to our long term equity incentive award programs in
accordance with the requirements of ASC 718.
2009
Summary Compensation Table
The following table sets forth information regarding the
compensation earned by the Chief Executive Officer, the Chief
Financial Officer and our other three most highly compensated
executive officers during 2009 and Mr. Bovender, who would
have been one of our most highly compensated executive officers
had he not retired as an executive officer on December 15,
2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
Plan
|
|
Deferred
|
|
All Other
|
|
|
|
|
|
|
Salary
|
|
Awards
|
|
Compensation
|
|
Compensation
|
|
Compensation
|
|
|
Name and Principal Positions
|
|
Year
|
|
($)
|
|
($)(1)
|
|
($)(2)
|
|
Earnings ($)(3)
|
|
($)(4)
|
|
Total ($)
|
|
Richard M. Bracken
|
|
|
2009
|
|
|
$
|
1,324,975
|
|
|
$
|
3,361,016
|
|
|
$
|
3,445,000
|
|
|
$
|
4,096,368
|
|
|
$
|
25,532
|
|
|
$
|
12,252,891
|
|
Chairman and Chief
|
|
|
2008
|
|
|
$
|
1,060,872
|
|
|
|
|
|
|
$
|
694,370
|
|
|
$
|
1,740,620
|
|
|
$
|
31,781
|
|
|
$
|
3,527,643
|
|
Executive Officer
|
|
|
2007
|
|
|
$
|
1,060,872
|
|
|
$
|
5,560,666
|
|
|
$
|
1,909,570
|
|
|
$
|
590,370
|
|
|
$
|
142,932
|
|
|
$
|
9,264,410
|
|
R. Milton Johnson
|
|
|
2009
|
|
|
$
|
849,984
|
|
|
$
|
2,520,714
|
|
|
$
|
1,360,000
|
|
|
$
|
2,032,089
|
|
|
$
|
17,674
|
|
|
$
|
6,780,461
|
|
Executive Vice President,
|
|
|
2008
|
|
|
$
|
786,698
|
|
|
|
|
|
|
$
|
355,491
|
|
|
$
|
1,871,790
|
|
|
$
|
38,769
|
|
|
$
|
3,052,748
|
|
Chief Financial Officer and Director
|
|
|
2007
|
|
|
$
|
750,379
|
|
|
$
|
3,971,905
|
|
|
$
|
900,455
|
|
|
$
|
509,442
|
|
|
$
|
82,462
|
|
|
$
|
6,214,643
|
|
Beverly B. Wallace
|
|
|
2009
|
|
|
$
|
700,000
|
|
|
$
|
997,771
|
|
|
$
|
924,018
|
|
|
$
|
2,047,036
|
|
|
$
|
16,500
|
|
|
$
|
4,685,325
|
|
President Shared
|
|
|
2008
|
|
|
$
|
700,000
|
|
|
|
|
|
|
$
|
314,992
|
|
|
$
|
2,080,836
|
|
|
$
|
15,651
|
|
|
$
|
3,111,479
|
|
Services Group
|
|
|
2007
|
|
|
$
|
700,000
|
|
|
$
|
2,224,258
|
|
|
$
|
840,000
|
|
|
$
|
676,111
|
|
|
$
|
75,013
|
|
|
$
|
4,515,382
|
|
Samuel N. Hazen
|
|
|
2009
|
|
|
$
|
788,672
|
|
|
$
|
997,771
|
|
|
$
|
1,041,067
|
|
|
$
|
1,725,405
|
|
|
$
|
16,499
|
|
|
$
|
4,569,414
|
|
President Western Group
|
|
|
2008
|
|
|
$
|
788,672
|
|
|
|
|
|
|
$
|
350,807
|
|
|
$
|
810,462
|
|
|
$
|
15,651
|
|
|
$
|
1,965,592
|
|
|
|
|
2007
|
|
|
$
|
788,672
|
|
|
$
|
2,542,007
|
|
|
$
|
830,779
|
|
|
$
|
258,787
|
|
|
$
|
84,767
|
|
|
$
|
4,505,012
|
|
W. Paul Rutledge
|
|
|
2009
|
|
|
$
|
675,000
|
|
|
$
|
997,771
|
|
|
$
|
891,017
|
|
|
$
|
1,510,040
|
|
|
$
|
16,500
|
|
|
$
|
4,090,328
|
|
President Central Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jack O. Bovender, Jr.
|
|
|
2009
|
|
|
$
|
1,288,676
|
|
|
$
|
1,470,443
|
|
|
$
|
1,250,000
|
|
|
$
|
4,127,725
|
|
|
$
|
76,399
|
|
|
$
|
8,213,243
|
|
Executive Chairman*
|
|
|
2008
|
|
|
$
|
1,620,228
|
|
|
|
|
|
|
$
|
1,391,886
|
|
|
$
|
3,926,217
|
|
|
$
|
45,321
|
|
|
$
|
6,983,652
|
|
|
|
|
2007
|
|
|
$
|
1,620,228
|
|
|
$
|
6,355,038
|
|
|
$
|
3,888,547
|
|
|
|
|
|
|
$
|
197,092
|
|
|
$
|
12,060,905
|
|
|
|
|
* |
|
Mr. Bovender retired as executive Chairman of the Company
effective December 15, 2009. |
|
(1) |
|
Option Awards for 2007 and 2009 include the aggregate grant date
fair value of the stock option awards granted during fiscal
years 2007 and 2009, respectively, in accordance with
ASC 718 with respect to New Options (including the 2x Time
Options) to purchase shares of our common stock awarded to the
named executive officers in fiscal years 2007 and 2009,
respectively, under the 2006 Plan. See Note 2 to our
consolidated financial statements included in our Annual Report
on
Form 10-K
for the year ended December 31, 2009. |
|
(2) |
|
Non-Equity Incentive Plan Compensation for 2009 reflects amounts
earned for the year ended December 31, 2009 under the
2008-2009
PEP, which amounts were paid in the first quarter of 2010
pursuant to the terms of the
2008-2009
PEP. For 2009, the Company exceeded its maximum performance
level, as adjusted, with respect to the Companys EBITDA
and the Central and Western Group EBITDA; therefore, pursuant to
the terms of the
2008-2009
PEP, awards under the
2008-2009
PEP were paid out to the named executive officers, at the
maximum level of 200% of their respective target amounts.
Mr. Bovender |
34
|
|
|
|
|
was also awarded, pursuant to his Amended Employment Agreement,
an additional one-time bonus of $250,000 based upon his
contributions to certain legislative initiatives as determined
by the Committee. |
|
|
|
Non-Equity Incentive Plan Compensation for 2008 reflects amounts
earned for the year ended December 31, 2008 under the
2008-2009
PEP, which amounts were paid in the first quarter of 2009
pursuant to the terms of the
2008-2009
PEP. For 2008, the Company did not achieve its target
performance level, but exceeded its threshold performance level,
as adjusted, with respect to the Companys EBITDA;
therefore, pursuant to the terms of the
2008-2009
PEP, 2008 awards under the
2008-2009
PEP were paid out to the named executive officers at
approximately 68.2% of each such officers respective
target amount, with the exception of Mr. Hazen, whose award
was paid out at approximately 67.4% of his target amount, due to
the 50% of his PEP based on the Western Group EBITDA, which also
exceeded the threshold performance level but did not reach the
target performance level. |
|
|
|
Non-Equity Incentive Plan Compensation for 2007 reflects amounts
earned for the year ended December 31, 2007 under the 2007
PEP, which amounts were paid in the first quarter of 2008
pursuant to the terms of the 2007 PEP. For 2007, the Company
exceeded its maximum performance level, as adjusted, with
respect to the Companys EBITDA; therefore, pursuant to the
terms of the 2007 PEP, awards under the 2007 PEP were paid out
to the named executive officers, at the maximum level of 200% of
their respective target amounts, with the exception of
Mr. Hazen, whose award was paid out at 175.6% of the target
amount, due to the 50% of his PEP based on the Western Group
EBITDA, which exceeded the target but did not reach the maximum
performance level. |
|
(3) |
|
All amounts for 2009 are attributable to changes in value of the
SERP benefits. Assumptions used to calculate these figures are
provided under the table titled 2009 Pension
Benefits. The changes in the SERP benefit value during
2009 were impacted mainly by: (i) the passage of time which
reflects another year of pay and service plus actual investment
return, (ii) the discount rate changing from 6.25% to
5.00%, which resulted in an increase in the value and
(iii) the use of the actual 2009 interest rate of 4.24% for
Mr. Bovender who retired in 2009. The impact of these
events on the SERP benefit values was: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bracken
|
|
Johnson
|
|
Wallace
|
|
Hazen
|
|
Rutledge
|
|
Bovender
|
|
Passage of Time
|
|
$
|
1,655,097
|
|
|
$
|
618,320
|
|
|
$
|
788,376
|
|
|
$
|
343,653
|
|
|
$
|
420,979
|
|
|
$
|
2,053,402
|
|
Discount Rate Change
|
|
$
|
2,441,271
|
|
|
$
|
1,413,769
|
|
|
$
|
1,258,660
|
|
|
$
|
1,381,752
|
|
|
$
|
1,089,061
|
|
|
|
|
|
Actual Retirement
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,074,323
|
|
|
|
|
|
|
All amounts for 2008 are attributable to changes in value of the
SERP benefits. Assumptions used to calculate these figures are
provided under the table titled 2009 Pension
Benefits. The changes in the SERP benefit value during
2008 were impacted mainly by: (i) the passage of time which
reflects another year of pay and service plus actual investment
return, (ii) the discount rate changing from 6.00% to
6.25%, which resulted in a decrease in the value and
(iii) the opportunity for participants to change their
benefit election before 2009 for terminations and retirements
occurring after 2008. Mr. Bovender elected to change his
benefit payment from an annuity to a lump sum. The impact of
these events on the SERP benefit values was: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bracken
|
|
Johnson
|
|
Wallace
|
|
Hazen
|
|
Bovender
|
|
|
|
Passage of Time
|
|
$
|
2,142,217
|
|
|
$
|
2,100,290
|
|
|
$
|
2,301,107
|
|
|
$
|
1,037,631
|
|
|
$
|
1,432,831
|
|
|
|
|
|
Discount Rate Change
|
|
$
|
(401,597
|
)
|
|
$
|
(228,500
|
)
|
|
$
|
(220,271
|
)
|
|
$
|
(227,169
|
)
|
|
$
|
(467,374
|
)
|
|
|
|
|
Change in Election
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,960,760
|
|
|
|
|
|
|
|
|
|
|
All amounts for 2007 are attributable to changes in value of the
SERP benefits. Assumptions used to calculate these figures are
provided under the table titled 2009 Pension
Benefits. The changes in the SERP benefit value during
2007 were impacted mainly by: (i) the passage of time which
reflects another year of pay and service, (ii) the discount
rate changing from 5.75% to 6.00%, which resulted in a decrease
in the value and (iii) the use of the named executive
officers actual elections compared to 2006 when benefits
were valued assuming a 50% probability of electing a lump sum
and a 50% probability of electing an |
35
|
|
|
|
|
annuity. All named executive officers elected a lump sum payment
at retirement, with the exception of Mr. Bovender, who
elected an annuity. The impact of these events on the SERP
benefit values was: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bracken
|
|
Johnson
|
|
Wallace
|
|
Hazen
|
|
Bovender
|
|
|
|
Passage of Time
|
|
$
|
399,630
|
|
|
$
|
510,118
|
|
|
$
|
549,404
|
|
|
$
|
266,066
|
|
|
$
|
(966,974
|
)
|
|
|
|
|
Discount Rate Change
|
|
$
|
(351,603
|
)
|
|
$
|
(145,992
|
)
|
|
$
|
(165,945
|
)
|
|
$
|
(186,325
|
)
|
|
$
|
(542,195
|
)
|
|
|
|
|
Actual Election
|
|
$
|
542,343
|
|
|
$
|
145,315
|
|
|
$
|
292,652
|
|
|
$
|
179,046
|
|
|
$
|
(1,322,788
|
)
|
|
|
|
|
(4) 2009 amounts generally consist of:
|
|
|
|
|
Matching Company contributions to our 401(k) Plan as set forth
below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bracken
|
|
Johnson
|
|
Wallace
|
|
Hazen
|
|
Rutledge
|
|
Bovender
|
|
HCA 401(k) matching contribution
|
|
$
|
16,500
|
|
|
$
|
16,500
|
|
|
$
|
16,500
|
|
|
$
|
16,499
|
|
|
$
|
16,500
|
|
|
$
|
16,500
|
|
|
|
|
|
|
Personal use of corporate aircraft. In 2009,
Messrs. Bracken, Johnson and Bovender were allowed personal
use of Company aircraft with an estimated incremental cost of
$5,025, $1,129 and $13,141, respectively, to the Company.
Ms. Wallace and Messrs. Hazen and Rutledge did not
have any personal travel on Company aircraft in 2009. We
calculate the aggregate incremental cost of the personal use of
Company aircraft based on a methodology that includes the
average aggregate cost, on a per nautical mile basis, of
variable expenses incurred in connection with personal plane
usage, including trip-related maintenance, landing fees, fuel,
crew hotels and meals, on-board catering, trip-related hangar
and parking costs and other variable costs. Because our aircraft
are used primarily for business travel, our incremental cost
methodology does not include fixed costs of owning and operating
aircraft that do not change based on usage. We grossed up the
income attributed to Mr. Bracken with respect to certain
trips on Company aircraft. The additional income attributed to
him as a result of gross ups was $594. In addition, we will pay
the expenses of our executives spouses associated with
travel to
and/or
attendance at business related events at which spouse attendance
is appropriate. We paid approximately $2,477 and $13,327 for
travel
and/or other
expenses incurred by Messrs. Brackens and
Bovenders wives, respectively, for such business related
events, and additional income of $891 and $4,793 was attributed
to Messrs. Bracken and Bovender, respectively, as a result
of the gross up on such amounts.
|
|
|
|
Additional income of $28,638 was attributed to Mr. Bovender
for gifts received from the Company in connection with his
retirement.
|
2008 amounts consist of:
|
|
|
|
|
Company contributions to our former Retirement Plan and matching
Company contributions to our 401(k) Plan as set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bracken
|
|
|
Johnson
|
|
|
Wallace
|
|
|
Hazen
|
|
|
Bovender
|
|
|
HCA Retirement Plan
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
HCA 401(k) matching contribution
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
HCA Restoration Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective January 1, 2008, participants in the SERP are no
longer eligible for Restoration Plan contributions.
|
|
|
|
|
Personal use of corporate aircraft. In 2008,
Messrs. Bovender, Bracken and Johnson were allowed personal
use of Company aircraft with an estimated incremental cost of
$28,913, $15,233 and $4,546, respectively, to the Company.
Ms. Wallace and Mr. Hazen did not have any personal
travel on Company aircraft in 2008. We calculate the aggregate
incremental cost of the personal use of Company aircraft based
on a methodology that includes the average aggregate cost, on a
per nautical mile basis, of variable expenses incurred in
connection with personal plane usage, including trip-related
maintenance, landing fees, fuel, crew hotels and meals, on-board
catering, trip-related hangar and parking costs and other
variable costs. Because our aircraft are used primarily for
business travel, our incremental cost methodology does not
include fixed costs of owning and operating aircraft that do not
change based on usage. We grossed up the income attributed to
Messrs. Bovender and Bracken with respect to certain
|
36
|
|
|
|
|
trips on Company aircraft. The additional income attributed to
them as a result of gross ups was $588 and $599, respectively.
In addition, we will pay the expenses of our executives
spouses associated with travel to
and/or
attendance at business related events at which spouse attendance
is appropriate. We paid approximately $107, $189 and $13,660 for
travel
and/or other
expenses incurred by Messrs. Bovenders,
Brackens and Johnsons wives, respectively, for such
business related events, and additional income of $62, $109 and
$4,912 was attributed to Messrs. Bovender, Bracken and
Johnson, respectively, as a result of the gross up on such
amounts.
|
2007 amounts consist of:
|
|
|
|
|
Company contributions to our former Retirement Plan, matching
Company contributions to our 401(k) Plan and Company accruals
for our Restoration Plan as set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bracken
|
|
Johnson
|
|
Wallace
|
|
Hazen
|
|
Bovender
|
|
HCA Retirement Plan
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
HCA 401(k) matching contribution
|
|
$
|
3,375
|
|
|
$
|
3,375
|
|
|
$
|
3,375
|
|
|
$
|
3,375
|
|
|
$
|
2,250
|
|
HCA Restoration Plan
|
|
$
|
91,946
|
|
|
$
|
57,792
|
|
|
$
|
52,250
|
|
|
$
|
62,004
|
|
|
$
|
153,475
|
|
|
|
|
|
|
Personal use of corporate aircraft. In 2007,
Messrs. Bovender and Bracken were allowed personal use of
Company aircraft with an estimated incremental cost of $21,350
and $26,895, respectively, to the Company, calculated as
described above. Ms. Wallace and Mr. Hazen did not
have any personal travel on Companys aircraft in 2007. We
grossed up the income attributed to Messrs. Bovender and
Bracken with respect to certain trips on Company aircraft. The
additional income attributed to them as a result of gross ups
was $629 and $863, respectively. In addition, we will pay the
travel expenses of our executives spouses associated with
travel to business related events at which spouse attendance is
appropriate. We paid approximately $342 for travel by
Mr. Brackens wife on a commercial airline and related
expenses for such an event, and additional income of $123 was
attributed to Mr. Bracken as a result of the gross up on
such amount.
|
2009
Grants of Plan-Based Awards
The following table provides information with respect to awards
made under our 2006 Plan and
2008-2009
PEP during the 2009 fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
|
|
|
|
|
|
Estimated Possible Payouts
|
|
Estimated Possible Payouts
|
|
Awards:
|
|
Exercise or
|
|
|
|
|
|
|
Under Non-Equity Incentive
|
|
Under Equity Incentive
|
|
Number of
|
|
Base Price
|
|
Grant Date
|
|
|
|
|
Plan Awards ($)(1)
|
|
Plan Awards (#)
|
|
Securities
|
|
of Option
|
|
Fair Value
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Underlying
|
|
Awards
|
|
of Option
|
Name
|
|
Date
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
Options(2)
|
|
($/sh)
|
|
Awards
|
|
Richard M. Bracken
|
|
|
10/6/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
315,742
|
|
|
$
|
102.00
|
|
|
$
|
3,361,016
|
|
Richard M. Bracken
|
|
|
N/A
|
|
|
$
|
861,250
|
|
|
$
|
1,722,500
|
|
|
$
|
3,445,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R. Milton Johnson
|
|
|
10/6/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
236,802
|
|
|
$
|
102.00
|
|
|
$
|
2,520,714
|
|
R. Milton Johnson
|
|
|
N/A
|
|
|
$
|
340,000
|
|
|
$
|
680,000
|
|
|
$
|
1,360,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beverly B. Wallace
|
|
|
10/6/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93,733
|
|
|
$
|
102.00
|
|
|
$
|
997,771
|
|
Beverly B. Wallace
|
|
|
N/A
|
|
|
$
|
231,004
|
|
|
$
|
462,009
|
|
|
$
|
924,018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel N. Hazen
|
|
|
10/6/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93,733
|
|
|
$
|
102.00
|
|
|
$
|
997,771
|
|
Samuel N. Hazen
|
|
|
N/A
|
|
|
$
|
260,267
|
|
|
$
|
520,534
|
|
|
$
|
1,041,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
W. Paul Rutledge
|
|
|
10/6/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93,733
|
|
|
$
|
102.00
|
|
|
$
|
997,771
|
|
W. Paul Rutledge
|
|
|
N/A
|
|
|
$
|
222,754
|
|
|
$
|
445,509
|
|
|
$
|
891,017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jack O. Bovender, Jr.
|
|
|
10/6/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
138,137
|
|
|
$
|
102.00
|
|
|
$
|
1,470,443
|
|
Jack O. Bovender, Jr.
|
|
|
N/A
|
|
|
$
|
250,000
|
|
|
$
|
500,000
|
|
|
$
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Non-equity incentive awards granted to each of the named
executive officers pursuant to our
2008-2009
PEP for the 2009 fiscal year, as described in more detail under
Compensation Discussion and
Analysis Elements of Compensation Annual
Incentive Compensation: PEP. The amounts shown in the
Threshold column reflect the threshold payment,
which is 50% of the amount shown in the Target |
37
|
|
|
|
|
column. The amount shown in the Maximum column is
200% of the target amount. Mr. Bovenders Amended
Employment Agreement set forth his PEP target for the 2009
fiscal year. Pursuant to the terms of the
2008-2009
PEP, the Company exceeded its maximum performance level, as
adjusted, for 2009 with respect to the Companys EBITDA and
the Central and Western Group EBITDA; therefore, pursuant to the
terms of the
2008-2009
PEP, awards were paid out to the named executive officers, at
the maximum level of 200% of their respective target amounts for
2009. Messrs. Bracken, Johnson, Hazen, Rutledge and
Bovender and Ms. Wallace received $3,445,000, $1,360,000,
$1,041,067, $891,017, $1,000,000 and $924,018, respectively,
under the
2008-2009
Senior Officer PEP for the 2009 fiscal year. Such amounts are
reflected in the Non-Equity Incentive Plan
Compensation column of the Summary Compensation Table. |
|
(2) |
|
Stock options awarded under the 2006 Plan, pursuant to the named
executive officers respective employment agreements, by
the Compensation Committee as a part of the named executive
officers long term equity incentive award. The 2x Time
Options granted in 2009 are structured, pursuant to the named
executive officers respective employment agreements, so
that 40% were vested on the grant date to reflect employment
served since the Recapitalization, an additional 20% vested on
November 17, 2009 and an additional 20% will vest on each
of November 17, 2010 and November 17, 2011,
respectively. The terms of these option awards are described in
more detail under Compensation Discussion and
Analysis Elements of Compensation Long
Term Equity Incentive Awards: Options. The aggregate grant
date fair value of these option grants in accordance with
ASC 718 is reflected in the Option Awards
column of the Summary Compensation Table. |
Narrative
Disclosure to Summary Compensation Table and 2009 Grants of
Plan-Based Awards Table
Total
Compensation
In 2009, 2008 and 2007, total direct compensation, as described
in the Summary Compensation Table, consisted primarily of base
salary, annual PEP awards payable in cash, and, in 2007, long
term stock option grants designed to be one-time grants to cover
at least five years of service and, in 2009, 2x Time Option
grants as set forth in each named executive officers
employment agreement to be fully vested on the fifth anniversary
of the Recapitalization. This mix was intended to reflect our
philosophy that a significant portion of an executives
compensation should be equity-linked
and/or tied
to our operating performance. In addition, we provided an
opportunity for executives to participate in two supplemental
retirement plans; however, effective January 1, 2008,
participants in the SERP are no longer eligible for Restoration
Plan contributions, although Restoration Plan accounts will
continue to be maintained for such participants (for additional
information concerning the Restoration Plan, see
2009 Nonqualified Deferred Compensation).
Options
In January 2007, New Options to purchase common stock of the
Company were granted under the 2006 Plan to members of
management and key employees, including the named executive
officers. The New Options were designed to be long term equity
incentive awards, constituting a one-time stock option grant in
lieu of annual equity grants. The New Options granted in 2007
have a ten year term and are structured so that 1/3 are time
vested options (vesting in five equal installments on the first
five anniversaries of the grant date), 1/3 are EBITDA-based
performance vested options and 1/3 are performance options that
vest based on investment return to the Sponsors. The terms of
the New Options granted in 2007 are described in greater detail
under Compensation Discussion and
Analysis Elements of Compensation Long
Term Equity Incentive Awards: Options. The aggregate grant
date fair value of the New Options granted in 2007 in accordance
with ASC 718 is included under the Option
Awards column of the Summary Compensation Table.
In accordance with their employment agreements entered into at
the time of the Recapitalization, as each may have been or may
be subsequently amended, our named executive officers received
the 2x Time Options in October 2009 with an exercise price equal
to two times the share price at the Recapitalization (or
$102.00). The Committee allocated the 2x Time Options in
consultation with our Chief Executive Officer based on past
executive contributions and future anticipated impact on Company
objectives. The 2x Time Options have a ten
38
year term and are structured so that forty percent were vested
upon grant, an additional twenty percent of the options vested
on November 17, 2009, and twenty percent of the options
granted to each recipient will vest on November 17, 2010
and November 17, 2011, respectively. Thereby, a portion of
the grant was vested on the date of the grant based on
employment served since the Recapitalization. The terms of the
2x Time Options are otherwise consistent with other time vesting
options granted under the 2006 Plan. The terms of the 2x Time
Options granted in 2009 are described in greater detail under
Compensation Discussion and
Analysis Elements of Compensation Long
Term Equity Incentive Awards: Options. The aggregate grant
date fair value of the 2x Time Options granted in 2009 in
accordance with ASC 718 is included under the Option
Awards column of the Summary Compensation Table.
As a result of the Recapitalization, all unvested awards under
the HCA 2005 Equity Incentive Plan (the 2005 Plan)
(and all predecessor equity incentive plans) vested in November
2006. Generally, all outstanding options under the 2005 Plan
(and any predecessor plans) were cancelled and converted into
the right to receive a cash payment equal to the number of
shares of common stock underlying the option multiplied by the
amount by which the Recapitalization consideration of $51.00 per
share exceeded the exercise price for the options (without
interest and less any applicable withholding taxes). However,
certain members of management, including the named executive
officers, were given the opportunity to convert options held by
them prior to consummation of the Recapitalization into options
to purchase shares of common stock of the surviving corporation
(Rollover Options). Immediately after the
consummation of the Recapitalization, all Rollover Options
(other than those with an exercise price below $12.75) were
adjusted so that they retained the same spread value
(as defined below) as immediately prior to the Recapitalization,
but the new per share exercise price for all Rollover Options
would be $12.75. The term spread value means the
difference between (x) the aggregate fair market value of
the common stock (determined using the Recapitalization
consideration of $51.00 per share) subject to the outstanding
options held by the participant immediately prior to the
Recapitalization that became Rollover Options, and (y) the
aggregate exercise price of those options.
New Options, 2x Time Options and Rollover Options held by the
named executive officers are described in the Outstanding Equity
Awards at 2009 Fiscal Year-End Table.
Employment
Agreements
In connection with the Recapitalization, on November 16,
2006, Hercules Holding entered into substantially similar
employment agreements with each of the named executive officers
and certain other executives, which agreements were shortly
thereafter assumed by the Company and which agreements govern
the terms of each executives employment. However, in light
of Mr. Bovenders retirement from the positions of
Chief Executive Officer and Chairman, effective
December 31, 2008 and December 15, 2009, respectively,
the Company entered into an Amended and Restated Employment
Agreement with Mr. Bovender, effective December 31,
2008, the terms of which are described below. The Company also
entered into an amendment to Mr. Brackens employment
agreement, effective January 1, 2009, to reflect his
appointment to the position of Chief Executive Officer.
Executive
Employment Agreements (Other than
Mr. Bovenders)
The term of employment under each of these agreements is
indefinite, and they are terminable by either party at any time;
provided that an executive must give no less than 90 days
notice prior to a resignation.
Each employment agreement sets forth the executives annual
base salary, which will be subject to discretionary annual
increases upon review by the Board of Directors, and states that
the executive will be eligible to earn an annual bonus as a
percentage of salary with respect to each fiscal year, based
upon the extent to which annual performance targets established
by the Board of Directors are achieved. The employment
agreements committed us to provide each executive with annual
bonus opportunities in 2008 that were consistent with those
applicable to the 2007 fiscal year, unless doing so would be
adverse to our interests or the interests of our stockholders,
and for later fiscal years, the agreements provide that the
Board of Directors will set bonus opportunities in consultation
with our Chief Executive Officer. With respect to the 2009 and
2008 fiscal years and the 2007 fiscal year, each executive was
eligible to earn under the
2008-2009
39
PEP and the
2007-2008
PEP, respectively, (i) a target bonus, if performance
targets were met; (ii) a specified percentage of the target
bonus, if threshold levels of performance were
achieved but performance targets were not met; or (iii) a
multiple of the target bonus if maximum performance
goals were achieved, with the annual bonus amount being
interpolated, in the sole discretion of the Board of Directors,
for performance results that exceeded threshold
levels but do not meet or exceed maximum levels. The
annual bonus opportunities for 2009 were set forth in the
2008-2009
PEP, as described in more detail under Compensation
Discussion and Analysis Annual Incentive
Compensation: PEP. As described above, the Company
exceeded its maximum performance level, as adjusted, for 2009
with respect to the Companys EBITDA and the Central and
Western Group EBITDA; therefore, pursuant to the terms of the
2008-2009
PEP, awards were paid out to the named executive officers, at
the maximum level of 200% of their respective target amounts for
2009. As described above, awards under the 2008 PEP were paid
out to the named executive officers at approximately 68.2% of
each such officers respective target amount, with the
exception of Mr. Hazen, whose award was paid out at
approximately 67.4% of the target amount. Awards under the 2007
PEP were paid out to the named executive officers, at the
maximum level of 200% of their respective target amounts, with
the exception of Mr. Hazen, whose award was paid out at
175.6% of his target amount. Each employment agreement also sets
forth the number of options that the executive received pursuant
to the 2006 Plan as a percentage of the total equity initially
made available for grants pursuant to the 2006 Plan. Such option
awards, the New Options, were made January 30, 2007 and are
described above under Options.
In each of the employment agreements with the named executive
officers, we also committed to grant, among the named executive
officers and certain other executives, the 2x Time Options,
which were granted, as described above, on October 6, 2009.
Additionally, pursuant to the employment agreements, we agree to
indemnify each executive against any adverse tax consequences
(including, without limitation, under Section 409A and 4999
of the Internal Revenue Code), if any, that result from the
adjustment by us of stock options held by the executive in
connection with Recapitalization or the future payment of any
extraordinary cash dividends.
Pursuant to each employment agreement, if an executives
employment terminates due to death or disability, the executive
would be entitled to receive (i) any base salary and any
bonus that is earned and unpaid through the date of termination;
(ii) reimbursement of any unreimbursed business expenses
properly incurred by the executive; (iii) such employee
benefits, if any, as to which the executive may be entitled
under our employee benefit plans (the payments and benefits
described in (i) through (iii) being accrued
rights); and (iv) a pro rata portion of any annual
bonus that the executive would have been entitled to receive
pursuant to the employment agreement based upon our actual
results for the year of termination (with such proration based
on the percentage of the fiscal year that shall have elapsed
through the date of termination of employment, payable to the
executive when the annual bonus would have been otherwise
payable (the pro rata bonus)).
If an executives employment is terminated by us without
cause (as defined below) or by the executive for
good reason (as defined below) (each a
qualifying termination), the executive would be
(i) entitled to the accrued rights; (ii) subject to
compliance with certain confidentiality, non-competition and
non-solicitation covenants contained in his or her employment
agreement and execution of a general release of claims on behalf
of the Company, an amount equal to the product of (x) two
(three in the case of Richard M. Bracken and R. Milton Johnson)
and (y) the sum of (A) the executives base
salary and (B) annual bonus paid or payable in respect of
the fiscal year immediately preceding the fiscal year in which
termination occurs, payable over a two-year period;
(iii) entitled to the pro rata bonus; and
(iv) entitled to continued coverage under our group health
plans during the period over which the cash severance described
in clause (ii) is paid. The executives vested New
Options and 2x Time Options would also remain exercisable until
the first anniversary of the termination of the executives
employment. However, in lieu of receiving the payments and
benefits described in (ii), (iii) and (iv) immediately
above, the executive may instead elect to have his or her
covenants not to compete waived by us. The same severance
applies regardless of whether the termination was in connection
with a change in control of the Company.
Cause is defined as an executives
(i) willful and continued failure to perform his material
duties to the Company which continues beyond 10 business days
after a written demand for substantial performance is
40
delivered; (ii) willful or intentional engagement in
material misconduct that causes material and demonstrable
injury, monetarily or otherwise, to the Company or the Sponsors;
(iii) conviction of, or a plea of nolo contendere
to, a crime constituting a felony, or a misdemeanor for
which a sentence of more than six months imprisonment is
imposed; or (iv) willful and material breach of his
covenants under the employment agreement which continues beyond
the designated cure period or of the agreements relating to the
new equity. Good Reason is defined as (i) a
reduction in the executives base salary (other than a
general reduction that affects all similarly situated employees
in substantially the same proportions which is implemented by
the Board in good faith after consultation with the chief
executive officer and chief operating officer), a reduction in
the executives annual incentive compensation opportunity,
or the reduction of benefits payable to the executive under the
SERP; (ii) a substantial diminution in the executives
title, duties and responsibilities; or (iii) a transfer of
the executives primary workplace to a location that is
more than 20 miles from his or her current workplace (other
than, in the case of (i) and (ii), any isolated,
insubstantial and inadvertent failure that is not in bad faith
and is cured within 10 business days after the executives
written notice to the Company).
In the event of an executives termination of employment
that is not a qualifying termination or a termination due to
death or disability, he or she will only be entitled to the
accrued rights (as defined above).
Additional information with respect to potential payments to the
named executive officers pursuant to their employment agreements
and the 2006 Plan is contained in Potential
Payments Upon Termination or Change in Control.
Mr. Bovenders
Employment Agreement
The Company entered into the Amended Employment Agreement with
Jack O. Bovender, Jr. on October 27, 2008, which
became effective on December 31, 2008. Pursuant to the
terms of the Amended Employment Agreement, Mr. Bovender was
employed by HCA Management Services, L.P., an affiliate of the
Company, and served as executive Chairman of the Company for a
period commencing December 31, 2008 and ending
December 15, 2009 (the Employment Term).
The Amended Employment Agreement provided that Mr. Bovender
receive a base salary (i) at the monthly rate of $135,000
for the first three months of the Employment Term and
(ii) at the monthly rate of $86,957 for the next eight and
one-half months of the Employment Term
(Mr. Bovenders Base Salary).
Mr. Bovender was also entitled to the full amount of any
annual bonus earned, but unpaid, as of the effective date of the
Amended Employment Agreement for the year ended
December 31, 2008 under the Companys
2008-2009
PEP. For calendar year 2009, Mr. Bovender was eligible to
earn a bonus under the
2008-2009
PEP with a target bonus of $500,000.
Mr. Bovender had an additional 2009 bonus opportunity of up
to $250,000 based upon his contributions to certain legislative
initiatives as determined by the Committee
(Mr. Bovenders Additional Bonus).
Pursuant to the terms of the
2008-2009
PEP, the Company exceeded its maximum performance level, as
adjusted, for 2009 with respect to the Companys EBITDA;
therefore, pursuant to the terms of the
2008-2009
PEP, Mr. Bovenders award for the 2009 fiscal year was
paid out at the maximum level of 200% of his target amount.
Mr. Bovender was also awarded, pursuant to his Amended
Employment Agreement, an additional one-time bonus of $250,000
based upon his contributions to certain legislative initiatives
as determined by the Committee. The Amended Employment Agreement
generally provides for the provision of or reimbursement of
expenses associated with office space, shared clerical support
and office equipment until Mr. Bovender reaches age 70.
The terms of Mr. Bovenders employment agreement with
respect to termination of his employment are described in detail
under Compensation Discussion and Analysis
Severance and Change in Control Agreements
Mr. Bovenders Continuing Severance Benefits.
Additional information with respect to payments to
Mr. Bovender pursuant to his Amended Employment Agreement
and the 2006 Plan is contained in Potential
Payments Upon Termination or Change in Control.
41
Outstanding
Equity Awards at 2009 Fiscal Year-End
The following table includes certain information with respect to
options held by the named executive officers as of
December 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
|
|
|
|
Number of
|
|
Number of
|
|
Plan Awards:
|
|
|
|
|
|
|
Securities
|
|
Securities
|
|
Number of
|
|
|
|
|
|
|
Underlying
|
|
Underlying
|
|
Securities
|
|
|
|
|
|
|
Unexercised
|
|
Unexercised
|
|
Underlying
|
|
Option
|
|
|
|
|
Options
|
|
Options
|
|
Unexercised
|
|
Exercise
|
|
Option
|
|
|
Exercisable
|
|
Unexercisable
|
|
Unearned
|
|
Price
|
|
Expiration
|
Name
|
|
(#)(1)(2)(3)
|
|
(#)(2)(3)
|
|
Options (#)(2)
|
|
($)(4)(5)(6)
|
|
Date
|
|
Richard M. Bracken
|
|
|
8,052
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
Richard M. Bracken
|
|
|
26,248
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
7/26/2011
|
|
Richard M. Bracken
|
|
|
29,934
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Richard M. Bracken
|
|
|
40,490
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Richard M. Bracken
|
|
|
30,235
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Richard M. Bracken
|
|
|
10,739
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
Richard M. Bracken
|
|
|
7,095
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Richard M. Bracken
|
|
|
116,550
|
|
|
|
69,932
|
|
|
|
163,172
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Richard M. Bracken
|
|
|
189,444
|
|
|
|
126,298
|
|
|
|
|
|
|
$
|
102.00
|
|
|
|
10/6/2019
|
|
R. Milton Johnson
|
|
|
6,039
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
R. Milton Johnson
|
|
|
9,579
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
R. Milton Johnson
|
|
|
9,254
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
R. Milton Johnson
|
|
|
8,062
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
R. Milton Johnson
|
|
|
26,013
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
7/22/2014
|
|
R. Milton Johnson
|
|
|
6,441
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
R. Milton Johnson
|
|
|
4,301
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
R. Milton Johnson
|
|
|
83,250
|
|
|
|
49,951
|
|
|
|
116,552
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
R. Milton Johnson
|
|
|
142,080
|
|
|
|
94,722
|
|
|
|
|
|
|
$
|
102.00
|
|
|
|
10/6/2019
|
|
Beverly B. Wallace
|
|
|
6,039
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
Beverly B. Wallace
|
|
|
9,579
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Beverly B. Wallace
|
|
|
13,882
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Beverly B. Wallace
|
|
|
11,422
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Beverly B. Wallace
|
|
|
4,601
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
Beverly B. Wallace
|
|
|
3,559
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Beverly B. Wallace
|
|
|
46,620
|
|
|
|
27,973
|
|
|
|
65,268
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Beverly B. Wallace
|
|
|
56,238
|
|
|
|
37,495
|
|
|
|
|
|
|
$
|
102.00
|
|
|
|
10/6/2019
|
|
Samuel N. Hazen
|
|
|
6,039
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
Samuel N. Hazen
|
|
|
13,124
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
7/26/2011
|
|
Samuel N. Hazen
|
|
|
19,158
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Samuel N. Hazen
|
|
|
23,137
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Samuel N. Hazen
|
|
|
16,797
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Samuel N. Hazen
|
|
|
6,441
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
Samuel N. Hazen
|
|
|
4,301
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Samuel N. Hazen
|
|
|
53,280
|
|
|
|
31,969
|
|
|
|
74,592
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Samuel N. Hazen
|
|
|
56,238
|
|
|
|
37,495
|
|
|
|
|
|
|
$
|
102.00
|
|
|
|
10/6/2019
|
|
W. Paul Rutledge
|
|
|
8,381
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
W. Paul Rutledge
|
|
|
9,254
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
|
|
|
|
Number of
|
|
Number of
|
|
Plan Awards:
|
|
|
|
|
|
|
Securities
|
|
Securities
|
|
Number of
|
|
|
|
|
|
|
Underlying
|
|
Underlying
|
|
Securities
|
|
|
|
|
|
|
Unexercised
|
|
Unexercised
|
|
Underlying
|
|
Option
|
|
|
|
|
Options
|
|
Options
|
|
Unexercised
|
|
Exercise
|
|
Option
|
|
|
Exercisable
|
|
Unexercisable
|
|
Unearned
|
|
Price
|
|
Expiration
|
Name
|
|
(#)(1)(2)(3)
|
|
(#)(2)(3)
|
|
Options (#)(2)
|
|
($)(4)(5)(6)
|
|
Date
|
|
W. Paul Rutledge
|
|
|
5,375
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
W. Paul Rutledge
|
|
|
2,297
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
W. Paul Rutledge
|
|
|
5,395
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
10/1/2015
|
|
W. Paul Rutledge
|
|
|
4,301
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
W. Paul Rutledge
|
|
|
46,620
|
|
|
|
27,973
|
|
|
|
65,268
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
W. Paul Rutledge
|
|
|
56,238
|
|
|
|
37,495
|
|
|
|
|
|
|
$
|
102.00
|
|
|
|
10/6/2019
|
|
Jack O. Bovender, Jr.
|
|
|
133,200
|
|
|
|
79,922
|
|
|
|
186,482
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Jack O. Bovender, Jr.
|
|
|
82,881
|
|
|
|
55,256
|
|
|
|
|
|
|
$
|
102.00
|
|
|
|
10/6/2019
|
|
|
|
|
(1) |
|
Reflects Rollover Options, as further described under
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Options, the 40% of the named executive officers
time vested New Options, comprised of the 20% that vested as of
January 30, 2008 and January 30, 2009, respectively,
the 60% of the named executive officers EBITDA-based
performance vested New Options, comprised of the 20% that vested
as of December 31, 2007, December 31, 2008 and
December 31, 2009, respectively (upon the Committees
determination that the Company achieved the 2007, 2008 and 2009
EBITDA performance targets under the option awards, as adjusted,
as described in more detail under Compensation
Discussion and Analysis Elements of
Compensation Long Term Equity Incentive Awards:
Options) and the 60% of the named executive officers
vested 2x Time Options, comprised of the 40% that were vested on
the grant date and the 20% that vested on November 17, 2009. |
|
(2) |
|
Reflects New Options awarded in January 2007 under the 2006 Plan
by the Compensation Committee as part of the named executive
officers long term equity incentive award. The New Options
granted in 2007 are structured so that 1/3 are time vested
options (vesting in five equal installments on the first five
anniversaries of the January 30, 2007 grant date), 1/3 are
EBITDA-based performance vested options (vesting in equal
increments of 20% at the end of fiscal years 2007, 2008, 2009,
2010 and 2011 if certain annual EBITDA performance targets are
achieved, subject to catch up vesting, such that,
options that were eligible to vest but failed to vest due to our
failure to achieve prior EBITDA targets will vest if at the end
of any subsequent year or at the end of fiscal year 2012, the
cumulative total EBITDA earned in all prior years exceeds the
cumulative EBITDA target at the end of such fiscal year) and 1/3
are performance options that vest based on investment return to
the Sponsors (vesting with respect to 10% of the common stock
subject to such options at the end of fiscal years 2007, 2008,
2009, 2010 and 2011 if the Investor Return is at least $102.00
and with respect to an additional 10% at the end of fiscal years
2007, 2008, 2009, 2010 and 2011 if the Investor Return is at
least $127.50, subject to catch up vesting if the
relevant Investor Return is achieved at any time occurring prior
to January 30, 2017, so long as the named executive officer
remains employed by the Company). The time vested options are
reflected in the Number of Securities Underlying
Unexercised Options Unexercisable column (with the
exception of the 40% of the time vested options that were vested
as of December 31, 2009, which are reflected in the
Number of Securities Underlying Unexercised Options
Exercisable column), and the EBITDA-based performance
vested options and investment return performance vested options
are both reflected in the Equity Incentive Plan Awards:
Number of Securities Underlying Unexercised Unearned
Options column (with the exception of the 60% of the
EBITDA-based performance vested options that were vested as of
December 31, 2009, which are reflected in the Number
of Securities Underlying Unexercised Options Exercisable
column). The terms of these option awards are described in more
detail under Narrative Disclosure to Summary
Compensation Table and 2009 Grants of Plan-Based Awards
Table Options. |
|
(3) |
|
Reflects 2x Time Options awarded in October 2009 under the 2006
Plan by the Compensation Committee, pursuant to the named
executive officers employment agreement, as part of the
named executive officers |
43
|
|
|
|
|
long term equity incentive award. The 2x Time Options are
structured, pursuant to the named executive officers
respective employment agreements, so that 40% were vested on the
grant date, an additional 20% vested on November 17, 2009
and an additional 20% will vest on November 17, 2010 and
November 17, 2011, respectively. The 60% of the 2x Time
Options that were vested as of December 31, 2009 are
reflected in the Number of Securities Underlying
Unexercised Options Exercisable column, and the 40% of the
2x Time Options that were not vested as of December 31,
2009 are reflected in the Number of Securities Underlying
Unexercised Options Unexercisable column. The terms of
these option awards are described in more detail under
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Options. |
|
(4) |
|
Immediately after the consummation of the Recapitalization, all
Rollover Options (other than those with an exercise price below
$12.75) were adjusted such that they retained the same
spread value (as defined below) as immediately prior
to the Recapitalization, but the new per share exercise price
for all Rollover Options would be $12.75. The term spread
value means the difference between (x) the aggregate
fair market value of the common stock (determined using the
Recapitalization consideration of $51.00 per share) subject to
the outstanding options held by the participant immediately
prior to the Recapitalization that became Rollover Options, and
(y) the aggregate exercise price of those options. |
|
(5) |
|
The exercise price for the New Options granted under the 2006
Plan to the named executive officers on January 30, 2007
was equal to the fair value of our common stock on the date of
the grant, as determined by our Board of Directors in
consultation with our Chief Executive Officer and other
advisors, pursuant to the terms of the 2006 Plan. |
|
(6) |
|
The exercise price for the 2x Time Options granted under the
2006 Plan to the named executive officers on October 6,
2009 was $102.00, pursuant to the named executive officers
employment agreements. |
Option
Exercises and Stock Vested in 2009
The following table includes certain information with respect to
options exercised by the named executive officers during the
fiscal year ended December 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Number of Shares
|
|
|
|
|
Acquired on
|
|
Value Realized on
|
Name
|
|
Exercise(1)
|
|
Exercise ($)(2)
|
|
Jack O. Bovender, Jr.
|
|
|
188,340
|
|
|
$
|
21,243,911
|
|
|
|
|
(1) |
|
Mr. Bovender elected a cashless exercise of 360,494 stock
options resulting in net shares realized of 188,340. |
|
(2) |
|
Represents the difference between the exercise price of the
options and the fair market value of the common stock on the
date of exercise, as determined by our Board of Directors in
consultation with our Chief Executive Officer and other advisors. |
2009
Pension Benefits
Our SERP is intended to qualify as a top-hat plan
designed to benefit a select group of management or highly
compensated employees. There are no other defined benefit plans
that provide for payments or benefits to any of the named
executive officers. Information about benefits provided by the
SERP is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
Number of Years
|
|
Present Value of
|
|
Payments During
|
Name
|
|
Name
|
|
Credited Service
|
|
Accumulated Benefit
|
|
Last Fiscal Year
|
|
Richard M. Bracken
|
|
|
SERP
|
|
|
|
28
|
|
|
$
|
14,303,696
|
|
|
|
|
|
R. Milton Johnson
|
|
|
SERP
|
|
|
|
27
|
|
|
$
|
6,353,324
|
|
|
|
|
|
Beverly B. Wallace
|
|
|
SERP
|
|
|
|
26
|
|
|
$
|
8,696,543
|
|
|
|
|
|
Samuel N. Hazen
|
|
|
SERP
|
|
|
|
27
|
|
|
$
|
5,330,983
|
|
|
|
|
|
W. Paul Rutledge
|
|
|
SERP
|
|
|
|
28
|
|
|
$
|
5,504,026
|
|
|
|
|
|
Jack O. Bovender, Jr.
|
|
|
SERP
|
|
|
|
29
|
|
|
|
|
|
|
$
|
26,300,528
|
|
44
Mr. Bovender retired in 2009, and he received a SERP
payment in April 2009. Mr. Bracken and Ms. Wallace are
eligible for early retirement. The remaining named executive
officers have not satisfied the eligibility requirements for
normal or early retirement. All of the named executive officers
are 100% vested in their accrued SERP benefit.
Plan
Provisions
In the event the employees accrued benefits under
the Companys Plans (computed using actuarial
factors) are insufficient to provide the life
annuity amount, the SERP will provide a benefit equal to
the amount of the shortfall. Benefits can be paid in the form of
an annuity or a lump sum. The lump sum is calculated by
converting the annuity benefit using the actuarial
factors. All benefits with a present value not exceeding
one million dollars are paid as a lump sum regardless of the
election made.
Normal retirement eligibility requires attainment of age 60
for employees who were participants at the time of the change in
control which occurred as a result of the Recapitalization,
including all of the named executive officers. Early retirement
eligibility requires age 55 with 20 or more years of
service. The service requirement for early retirement is waived
for employees participating in the SERP at the time of its
inception in 2001, including all of the named executive
officers. The life annuity amount payable to a
participant who takes early retirement is reduced by three
percent for each full year or portion thereof that the
participant retires prior to normal retirement age.
The life annuity amount is the annual benefit
payable as a life annuity to a participant upon normal
retirement. It is equal to the participants accrual
rate multiplied by the product of the participants
years of service times the participants
pay average. The SERP benefit for each year equals
the life annuity amount less the annual life annuity amount
produced by the employees accrued benefit under the
Companys Plans.
The accrual rate is a percentage assigned to each
participant, and is either 2.2% or 2.4%. All of the named
executive officers are assigned a percentage of 2.4%.
A participant is credited with a year of service for
each calendar year that the participant performs
1,000 hours of service for HCA or one of our subsidiaries,
or for each year the participant is otherwise credited by us,
subject to a maximum credit of 25 years of service.
A participants pay average is an amount equal
to one-fifth of the sum of the compensation during the period of
60 consecutive months for which total compensation is greatest
within the 120 consecutive month period immediately preceding
the participants retirement. For purposes of this
calculation, the participants compensation includes base
compensation, payments under the PEP, and bonuses paid prior to
the establishment of the PEP.
The accrued benefits under the Companys Plans
for an employee equals the sum of the employer-funded benefits
accrued under the former HCA Retirement Plan, the HCA 401(k)
Plan and any other tax-qualified plan maintained by us or one of
our subsidiaries, the income/loss adjusted amount distributed to
the participant under any of these plans, the account credit and
the income/loss adjusted amount distributed to the participant
under the Restoration Plan and any other nonqualified retirement
plans sponsored by us or one of our subsidiaries.
The actuarial factors include (a) interest at
the long term Applicable Federal Rate under Section 1274(d)
of the Code or any successor thereto as of the first day of
November preceding the plan year in or for which a benefit
amount is calculated, and (b) mortality being the
applicable Section 417(e)(3) of the Code mortality table,
as specified and changed by the U.S. Treasury Department.
Credited service does not include any amount other than service
with us or one of our subsidiaries.
Assumptions
The Present Value of Accumulated Benefit is based on a
measurement date of December 31, 2009.
45
The assumption is made that there is no probability of
pre-retirement death or termination. Retirement age is assumed
to be the Normal Retirement Age as defined in the SERP for all
named executive officers, as adjusted by the provisions relating
to change in control, or age 60. Age 60 also
represents the earliest date the named executive officers are
eligible to receive an unreduced benefit.
All other assumptions used in the calculations are the same as
those used for the valuation of the plan liabilities in this
information statement.
Supplemental
Information
In the event a participant renders service to another health
care organization within five years following retirement or
termination of employment, he or she forfeits his rights to any
further payment, and must repay any benefits already paid. This
non-competition provision is subject to waiver by the Committee
with respect to the named executive officers.
2009
Nonqualified Deferred Compensation
Amounts shown in the table are attributable to the HCA
Restoration Plan, an unfunded, nonqualified defined contribution
plan designed to restore benefits under the HCA 401(k) Plan
based on compensation in excess of the Code
Section 401(a)(17) compensation limit ($245,000 in 2009).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
Registrant
|
|
Aggregate
|
|
|
|
Aggregate
|
|
|
Contributions
|
|
Contributions
|
|
Earnings
|
|
Aggregate
|
|
Balance
|
|
|
in Last
|
|
in Last
|
|
in Last
|
|
Withdrawals/
|
|
at Last
|
Name
|
|
Fiscal Year
|
|
Fiscal Year
|
|
Fiscal Year
|
|
Distributions
|
|
Fiscal Year End
|
|
Richard M. Bracken
|
|
|
|
|
|
|
|
|
|
$
|
267,148
|
|
|
|
|
|
|
$
|
1,418,398
|
|
R. Milton Johnson
|
|
|
|
|
|
|
|
|
|
$
|
109,549
|
|
|
|
|
|
|
$
|
581,639
|
|
Beverly B. Wallace
|
|
|
|
|
|
|
|
|
|
$
|
90,252
|
|
|
|
|
|
|
$
|
479,186
|
|
Samuel N. Hazen
|
|
|
|
|
|
|
|
|
|
$
|
146,239
|
|
|
|
|
|
|
$
|
776,440
|
|
W. Paul Rutledge
|
|
|
|
|
|
|
|
|
|
$
|
80,356
|
|
|
|
|
|
|
$
|
426,642
|
|
Jack O. Bovender, Jr.
|
|
|
|
|
|
|
|
|
|
$
|
498,306
|
|
|
|
|
|
|
$
|
2,692,051
|
|
The following amounts from the column titled Aggregate
Balance at Last Fiscal Year have been reported in the
Summary Compensation Tables in prior years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restoration Contribution
|
Name
|
|
2001
|
|
2002
|
|
2003
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
Richard M. Bracken
|
|
$
|
87,924
|
|
|
$
|
146,549
|
|
|
$
|
162,344
|
|
|
$
|
192,858
|
|
|
$
|
172,571
|
|
|
$
|
409,933
|
|
|
$
|
91,946
|
|
R. Milton Johnson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
71,441
|
|
|
$
|
212,109
|
|
|
$
|
57,792
|
|
Beverly B. Wallace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
52,250
|
|
Samuel N. Hazen
|
|
|
|
|
|
|
|
|
|
$
|
79,510
|
|
|
$
|
101,488
|
|
|
$
|
97,331
|
|
|
$
|
247,060
|
|
|
$
|
62,004
|
|
Jack O. Bovender, Jr.
|
|
$
|
187,193
|
|
|
$
|
268,523
|
|
|
$
|
289,899
|
|
|
$
|
363,481
|
|
|
$
|
295,062
|
|
|
$
|
856,424
|
|
|
$
|
153,475
|
|
Plan
Provisions
Until 2008, hypothetical accounts for each participant were
credited each year with a contribution designed to restore the
HCA Retirement Plan based on compensation in excess of the Code
Section 401(a)(17) compensation limit ($245,000 in 2009),
based on years of service. Effective January 1, 2008,
participants in the SERP are no longer eligible for Restoration
Plan contributions. However, the hypothetical accounts as of
January 1, 2008 will continue to be maintained and will be
increased or decreased with hypothetical investment returns
based on the actual investment return of the Mix B fund of the
HCA 401(k) Plan.
No employee deferrals are allowed under this or any other
nonqualified deferred compensation plan.
Prior to January 1, 2010, eligible employees make a one
time election prior to participation (or prior to
December 31, 2006, if earlier) regarding the form of
distribution of the benefit. Participants chose between a lump
sum and five or ten-year installments. Effective January 1,
2010, all distributions are paid in the form of
46
a lump-sum distribution unless the participant had submitted an
installment payment election prior to April 30, 2009.
Distributions are paid (or begin) during the July following the
year of termination of employment or retirement. All balances
not exceeding $500,000 are automatically paid as a lump sum.
Supplemental
Information
In the event a participant renders service to another health
care organization within five years following retirement or
termination of employment, he or she forfeits the rights to any
further payment, and must repay any payments already made. This
non-competition provision is subject to waiver by the Committee
with respect to the named executive officers.
Potential
Payments Upon Termination or Change in Control
The following tables show the estimated amount of potential cash
severance payable to each of the named executive officers
(except for Mr. Bovender) (based upon his or her 2009 base
salary and PEP payment received in 2009 for 2008 performance),
as well as the estimated value of continuing benefits, based on
compensation and benefit levels in effect on December 31,
2009, assuming the executives employment terminates or the
Company undergoes a Change in Control (as defined in the 2006
Plan and set forth above under Narrative
Disclosure to Summary Compensation Table and 2009 Grants of
Plan-Based Awards Table Options) effective
December 31, 2009. Due to the numerous factors involved in
estimating these amounts, the actual value of benefits and
amounts to be paid can only be determined upon an
executives termination of employment. Mr. Bovender
retired from the Company on December 15, 2009, and the
Normal Retirement column of the table relating to
Mr. Bovender shows the estimated value of continuing
benefits, as well as, where noted, actual amounts paid to
Mr. Bovender under his Amended Employment Agreement in
connection with his retirement. As noted above, in the event a
named executive officer breaches or violates those certain
confidentiality, non-competition
and/or
non-solicitation covenants contained in his or her employment
agreement, the SERP or the HCA Restoration Plan, certain of the
payments described below may be subject to forfeiture
and/or
repayment. See Narrative Disclosure to Summary
Compensation Table and 2009 Grants of Plan-Based Awards
Table Executive Employment Agreements,
2009 Pension Benefits Supplemental
Information, and 2009 Nonqualified Deferred
Compensation Supplemental Information.
Richard
M. Bracken
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
Early
|
|
|
Normal
|
|
|
Without
|
|
|
Termination
|
|
|
for Good
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
Termination
|
|
|
Retirement
|
|
|
Retirement
|
|
|
Cause
|
|
|
for Cause
|
|
|
Reason
|
|
|
Disability
|
|
|
Death
|
|
|
Control
|
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
6,058,110
|
|
|
|
|
|
|
$
|
6,058,110
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
3,445,000
|
|
|
$
|
3,445,000
|
|
|
$
|
3,445,000
|
|
|
$
|
3,445,000
|
|
|
|
|
|
|
$
|
3,445,000
|
|
|
$
|
3,445,000
|
|
|
$
|
3,445,000
|
|
|
$
|
3,445,000
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
8,622,517
|
|
SERP(4)
|
|
$
|
15,493,294
|
|
|
$
|
15,493,294
|
|
|
|
|
|
|
$
|
15,493,294
|
|
|
$
|
15,493,294
|
|
|
$
|
15,493,294
|
|
|
$
|
15,493,294
|
|
|
$
|
13,722,318
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
$
|
2,522,553
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,819,299
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,401,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
$
|
183,462
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
21,644,309
|
|
|
$
|
21,644,309
|
|
|
$
|
6,151,015
|
|
|
$
|
27,702,419
|
|
|
$
|
18,199,309
|
|
|
$
|
27,702,419
|
|
|
$
|
23,463,608
|
|
|
$
|
21,274,333
|
|
|
$
|
12,067,517
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Bracken would be entitled to receive
pursuant to his employment agreement. See
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Executive Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Bracken would be entitled to
receive for the 2009 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See
Narrative Disclosure to |
47
|
|
|
|
|
Summary Compensation Table and 2009 Grants of Plan-Based Awards
Table Executive Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Brackens unvested New Options and the fair value
price of our common stock on December 31, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2009 fiscal
year. The $102.00 per share exercise price of 2x Time Options
was greater than the December 31, 2009 fair value price;
therefore, this value does not include Mr. Brackens
unvested 2x Time Options. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2009
interest rate of 4.24%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Bracken would be
entitled. The value includes $1,104,155 from the HCA 401(k) Plan
(which represents the value of the Companys contributions)
and $1,418,398 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Bracken would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 66, and monthly benefits of $10,000 per month from our
Supplemental Insurance Program payable after the six-month
elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Bracken.
Mr. Brackens payment upon death while actively
employed includes $1,326,000 of Company-paid life insurance and
$75,000 from the Executive Death Benefit Plan. |
R.
Milton Johnson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
Early
|
|
|
Normal
|
|
|
Without
|
|
|
Termination
|
|
|
for Good
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
Termination
|
|
|
Retirement
|
|
|
Retirement
|
|
|
Cause
|
|
|
for Cause
|
|
|
Reason
|
|
|
Disability
|
|
|
Death
|
|
|
Control
|
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,616,473
|
|
|
|
|
|
|
$
|
3,616,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
1,360,000
|
|
|
$
|
1,360,000
|
|
|
$
|
1,360,000
|
|
|
$
|
1,360,000
|
|
|
|
|
|
|
$
|
1,360,000
|
|
|
$
|
1,360,000
|
|
|
$
|
1,360,000
|
|
|
$
|
1,360,000
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
6,158,946
|
|
SERP(4)
|
|
$
|
7,685,014
|
|
|
|
|
|
|
|
|
|
|
$
|
7,685,014
|
|
|
$
|
7,685,014
|
|
|
$
|
7,685,014
|
|
|
$
|
7,685,014
|
|
|
$
|
7,162,791
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
$
|
1,520,116
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,077,246
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
851,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
$
|
117,692
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
10,682,822
|
|
|
$
|
2,997,808
|
|
|
$
|
2,997,808
|
|
|
$
|
14,299,295
|
|
|
$
|
9,322,822
|
|
|
$
|
14,299,295
|
|
|
$
|
12,760,068
|
|
|
$
|
11,011,599
|
|
|
$
|
7,518,946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Johnson would be entitled to receive
pursuant to his employment agreement. See
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Executive Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Johnson would be entitled to
receive for the 2009 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Executive Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Johnsons unvested New Options and the fair value
price of our common stock on December 31, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of |
48
|
|
|
|
|
at least 2.5 times the Base Price of $51.00 at the end of the
2009 fiscal year. The $102.00 per share exercise price of 2x
Time Options was greater than the December 31, 2009 fair
value price; therefore, this value does not include
Mr. Johnsons unvested 2x Time Options. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2009
interest rate of 4.24%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Johnson would be
entitled. The value includes $938,477 from the HCA 401(k) Plan
(which represents the value of the Companys contributions)
and $581,639 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Johnson would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 66 and 4 months, and monthly benefits of $10,000
per month from our Supplemental Insurance Program payable after
the six-month elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Johnson.
Mr. Johnsons payment upon death while actively
employed with the Company includes $851,000 of Company-paid life
insurance. |
Beverly
B. Wallace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
Early
|
|
|
Normal
|
|
|
Without
|
|
|
Termination
|
|
|
for Good
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
Termination
|
|
|
Retirement
|
|
|
Retirement
|
|
|
Cause
|
|
|
for Cause
|
|
|
Reason
|
|
|
Disability
|
|
|
Death
|
|
|
Control
|
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,030,010
|
|
|
|
|
|
|
$
|
2,030,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
924,018
|
|
|
$
|
924,018
|
|
|
$
|
924,018
|
|
|
$
|
924,018
|
|
|
|
|
|
|
$
|
924,018
|
|
|
$
|
924,018
|
|
|
$
|
924,018
|
|
|
$
|
924,018
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,448,985
|
|
SERP(4)
|
|
$
|
8,658,884
|
|
|
$
|
8,658,884
|
|
|
|
|
|
|
$
|
8,658,884
|
|
|
$
|
8,658,884
|
|
|
$
|
8,658,884
|
|
|
$
|
8,658,884
|
|
|
$
|
7,794,032
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
$
|
938,279
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,354,785
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
701,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
$
|
96,925
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
10,618,106
|
|
|
$
|
10,618,106
|
|
|
$
|
1,959,222
|
|
|
$
|
12,648,116
|
|
|
$
|
9,694,088
|
|
|
$
|
12,648,116
|
|
|
$
|
11,972,891
|
|
|
$
|
10,454,254
|
|
|
$
|
4,373,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Ms. Wallace would be entitled to receive
pursuant to her employment agreement. See Narrative
Disclosure to Summary Compensation Table and 2009 Grants of
Plan-Based Awards Table Executive Employment
Agreements. |
|
(2) |
|
Represents the amount Ms. Wallace would be entitled to
receive for the 2009 fiscal year pursuant to the
2008-2009
PEP and her employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Executive Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Ms. Wallaces unvested New Options and the fair value
price of our common stock on December 31, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2009 fiscal
year. The $102.00 per share exercise price of 2x Time Options
was greater than the December 31, 2009 fair value price;
therefore, this value does not include Ms. Wallaces
unvested 2x Time Options. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2009
interest rate of 4.24%. |
49
|
|
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Ms. Wallace would be
entitled. The value includes $459,093 from the HCA 401(k) Plan
(which represents the value of the Companys contributions)
and $479,186 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Ms. Wallace would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 66, and monthly benefits of $10,000 per month from our
Supplemental Insurance Program payable after the six-month
elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Ms. Wallace.
Ms. Wallaces payment upon death while actively
employed includes $701,000 of Company-paid life insurance. |
Samuel
N. Hazen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
Early
|
|
|
Normal
|
|
|
Without
|
|
|
Termination
|
|
|
for Good
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
Termination
|
|
|
Retirement
|
|
|
Retirement
|
|
|
Cause
|
|
|
for Cause
|
|
|
Reason
|
|
|
Disability
|
|
|
Death
|
|
|
Control
|
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,278,988
|
|
|
|
|
|
|
$
|
2,278,988
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
1,041,067
|
|
|
$
|
1,041,067
|
|
|
$
|
1,041,067
|
|
|
$
|
1,041,067
|
|
|
|
|
|
|
$
|
1,041,067
|
|
|
$
|
1,041,067
|
|
|
$
|
1,041,067
|
|
|
$
|
1,041,067
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,941,691
|
|
SERP(4)
|
|
$
|
6,464,523
|
|
|
|
|
|
|
|
|
|
|
$
|
6,464,523
|
|
|
$
|
6,464,523
|
|
|
$
|
6,464,523
|
|
|
$
|
6,464,523
|
|
|
$
|
6,307,519
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
$
|
1,316,591
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,362,646
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
789,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
$
|
109,203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
8,931,384
|
|
|
$
|
2,466,861
|
|
|
$
|
2,466,861
|
|
|
$
|
11,210,372
|
|
|
$
|
7,890,317
|
|
|
$
|
11,210,372
|
|
|
$
|
11,294,030
|
|
|
$
|
9,563,380
|
|
|
$
|
4,982,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Hazen would be entitled to receive
pursuant to his employment agreement. See
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Executive Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Hazen would be entitled to
receive for the 2009 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See
Narrative Disclosure to Summary Compensation
Table and 2009 Grants of Plan-Based Awards Table
Executive Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Hazens unvested New Options and the fair value
price of our common stock on December 31, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2009 fiscal
year. The $102.00 per share exercise price of 2x Time Options
was greater than the December 31, 2009 fair value price;
therefore, this value does not include Mr. Hazens
unvested 2x Time Options. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2009
interest rate of 4.24%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Hazen would be
entitled. The value includes $540,152 from the HCA 401(k) Plan
(which represents the value of the Companys contributions)
and $776,440 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Hazen would be entitled to receive under
our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 67, and |
50
|
|
|
|
|
monthly benefits of $10,000 per month from our Supplemental
Insurance Program payable after the six-month elimination period
to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Hazen. Mr. Hazens
payment upon death while actively employed with the Company
includes $789,000 of Company-paid life insurance. |
W.
Paul Rutledge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
Early
|
|
|
Normal
|
|
|
Without
|
|
|
Termination
|
|
|
for Good
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
Termination
|
|
|
Retirement
|
|
|
Retirement
|
|
|
Cause
|
|
|
for Cause
|
|
|
Reason
|
|
|
Disability
|
|
|
Death
|
|
|
Control
|
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,653,768
|
|
|
|
|
|
|
$
|
1,653,768
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
891,017
|
|
|
$
|
891,017
|
|
|
$
|
891,017
|
|
|
$
|
891,017
|
|
|
|
|
|
|
$
|
891,017
|
|
|
$
|
891,017
|
|
|
$
|
891,017
|
|
|
$
|
891,017
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,448,985
|
|
SERP(4)
|
|
$
|
6,633,387
|
|
|
|
|
|
|
|
|
|
|
$
|
6,633,387
|
|
|
$
|
6,633,387
|
|
|
$
|
6,633,387
|
|
|
$
|
6,633,387
|
|
|
$
|
6,046,496
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
$
|
1,102,803
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,816,956
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
751,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
$
|
93,463
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
8,720,670
|
|
|
$
|
2,087,283
|
|
|
$
|
2,087,283
|
|
|
$
|
10,374,438
|
|
|
$
|
7,829,653
|
|
|
$
|
10,374,438
|
|
|
$
|
10,537,626
|
|
|
$
|
8,884,779
|
|
|
$
|
4,340,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Rutledge would be entitled to
receive pursuant to his employment agreement. See
Narrative Disclosure to Summary Compensation Table and 2009
Grants of Plan-Based Awards Table Executive
Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Rutledge would be entitled to
receive for the 2009 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See Narrative
Disclosure to Summary Compensation Table and 2009 Grants of
Plan-Based Awards Table Executive Employment
Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Rutledges unvested New Options and the fair value
price of our common stock on December 31, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2009 fiscal
year. The $102.00 per share exercise price of 2x Time Options
was greater than the December 31, 2009 fair value price;
therefore, this value does not include Mr. Rutledges
unvested 2x Time Options. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2009
interest rate of 4.24%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Rutledge would
be entitled. The value includes $676,161 from the HCA 401(k)
Plan (which represents the value of the Companys
contributions) and $426,642 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Rutledge would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 66 and 2 months, and monthly benefits of $10,000
per month from our Supplemental Insurance Program payable after
the six-month elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Rutledge.
Mr. Rutledges payment upon death while actively
employed includes $676,000 of Company-paid life insurance and
$75,000 from the Executive Death Benefit Plan. |
51
Jack
O. Bovender, Jr.
|
|
|
|
|
|
|
|
|
|
|
Normal
|
|
|
Change in
|
|
|
|
Retirement
|
|
|
Control
|
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(1)
|
|
$
|
1,250,000
|
|
|
$
|
1,250,000
|
|
Unvested Stock Options(2)
|
|
$
|
9,854,284
|
|
|
$
|
9,854,284
|
|
SERP(3)
|
|
$
|
26,300,528
|
|
|
|
|
|
Retirement Plans(4)
|
|
$
|
2,884,177
|
|
|
|
|
|
Health and Welfare Benefits(5)
|
|
$
|
6,234
|
|
|
|
|
|
Disability Income
|
|
|
|
|
|
|
|
|
Life Insurance Benefits
|
|
|
|
|
|
|
|
|
Accrued Vacation Pay(6)
|
|
$
|
144,485
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
40,439,708
|
|
|
$
|
11,104,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents the amount Mr. Bovender received for the 2009
fiscal year pursuant to the
2008-2009
PEP and his Amended Employment Agreement, which amount is also
included in the Non-Equity Incentive Plan
Compensation column of the Summary Compensation Table. See
Narrative Disclosure to Summary Compensation Table
and 2009 Grants of Plan-Based Awards Table
Mr. Bovenders Employment Agreement. |
|
(2) |
|
For the purposes of the Normal Retirement column,
represents the intrinsic value of all unvested stock options,
which, pursuant to Mr. Bovenders Amended Employment
Agreement, will continue to vest after his retirement,
calculated as the difference between the exercise price of
Mr. Bovenders unvested New Options and 2x Time
Options subject to such continued vesting provision and the fair
value price of our common stock on December 15, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the 2010 and 2011 EBITDA performance targets under
the option awards are achieved by the Company and that the
Company achieves an Investor Return of at least 2.5 times the
Base Price of $51.00 at the end of each of the 2010 and 2011
fiscal years, respectively. The $102.00 per share exercise price
of 2x Time Options was greater than the December 15, 2009
fair value price; therefore, this value does not include
Mr. Bovenders unvested 2x Time Options. See
Compensation Discussion and Analysis
Severance and Change in Control Agreements. |
|
|
|
For purposes of the Change in Control column,
represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Bovenders unvested New Options and the fair value
price of our common stock on December 31, 2009 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($87.99 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2009 fiscal
year. The $102.00 per share exercise price of 2x Time Options
was greater than the December 31, 2009 fair value price;
therefore, this value does not include Mr. Bovenders
unvested 2x Time Options. |
|
(3) |
|
Reflects the actual SERP lump sum paid in April 2009. |
|
(4) |
|
Reflects the estimated lump-sum present value of qualified and
nonqualified retirement plans to which Mr. Bovender is
entitled as of his retirement date of December 15, 2009.
The value includes $192,126 from the HCA 401(k) Plan (which
represents the value of the Companys contributions) and
$2,692,051 from the HCA Restoration Plan. |
|
(5) |
|
Reflects the present value of the medical premiums for
Mr. Bovender from termination to age 65 as required
pursuant to Mr. Bovenders Amended Employment
Agreement. See Narrative Disclosure to Summary
Compensation Table and 2009 Grants of Plan-Based Awards
Table Mr. Bovenders Employment Agreement. |
52
|
|
|
(6) |
|
Reflects the actual accrued vacation pay received by
Mr. Bovender in December 2009, which amount is also
included in the Salary column of the Summary
Compensation Table. |
Director
Compensation
During the year ended December 31, 2009, none of our
directors received compensation for their service as a member of
our Board. Our directors are reimbursed for any expenses
incurred in connection with their service. Upon completion of
the anticipated initial public offering of our common stock and
listing on the NYSE, we intend to establish a policy for
non-management director compensation consistent with our status
as a public company.
COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
During 2009, the Compensation Committee of the Board of
Directors was composed of John P. Connaughton, George A. Bitar
and Michael W. Michelson. Effective April 22, 2009,
Mr. Bitar retired from our Board of Directors, and James D.
Forbes joined our Board of Directors and was appointed as a
member of the Compensation Committee. None of the members of the
Compensation Committee have at any time been an officer or
employee of HCA or any of its subsidiaries. In addition, none of
our executive officers serves as a member of the board of
directors or compensation committee of any entity which has one
or more executive officers serving as a member of our Board of
Directors or Compensation Committee. Each member of the
Compensation Committee is also a manager of Hercules Holding,
and the Amended and Restated Limited Liability Company Agreement
of Hercules Holding requires that the members of Hercules
Holding take all necessary action to ensure that the persons who
serve as managers of Hercules Holding also serve on our Board of
Directors. Messrs. Michelson, Forbes and Connaughton are
affiliated with KKR, BAML Capital Partners (the private equity
division of Bank of America Corporation) and Bain Capital
Partners, LLC respectively, each of which is a party to the
sponsor management agreement with us. Mr. Bitar was
formerly associated with Merrill Lynch Global Private Equity.
The Amended and Restated Limited Liability Company Agreement of
Hercules Holding, the sponsor management agreement and certain
transactions with affiliates of BAML Capital Partners and KKR
are described in greater detail in Certain Relationships
and Related Party Transactions in our 2009 Annual Report
on
Form 10-K.
HOUSEHOLDING
OF MATERIALS
Some banks, brokers, and other nominee record holders may be
participating in the practice of householding
information statements. This means that only one copy of this
Notice of Action by Written Consent of Stockholders and
information statement may have been sent to multiple
stockholders in your household. If you would prefer to receive
separate copies of an information statement either now or in the
future, please contact your bank, broker or other nominee. Upon
written or oral request to the Office of the Corporate
Secretary, HCA Inc., One Park Plaza, Nashville, Tennessee 37203,
(615) 344-9551,
we will provide a separate copy of the information statement.
WHERE TO
FIND ADDITIONAL INFORMATION
We are subject to the informational requirements of the Exchange
Act and in accordance therewith, we file annual, quarterly and
current reports and other information with the SEC. This
information can be inspected and copied at the Public Reference
Room at the SECs office at 100 F Street, N.E.,
Washington, D.C. 20549. You may obtain information on the
operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330.
Such information may also be accessed electronically by means of
the SECs home page on the internet at
http://www.sec.gov.
We are an electronic filer, and the SEC maintains an Internet
site at
http://www.sec.gov
that contains the reports and other information we file
electronically. Our website address is www.hcahealthcare.com.
Please note that our website address is provided as an inactive
textual reference only. We make available free of charge,
through our website, our annual report on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K,
and all amendments to those reports as soon as
53
reasonably practicable after such material is electronically
filed with or furnished to the SEC. The information provided on
or accessible through our website is not part of this
information statement.
As a matter of regulatory compliance, we are furnishing you
this information statement which describes the purpose and
effect of the approval of the Amended and Restated Certificate
of Incorporation, the increase in authorized shares of Common
Stock and the Stock Incentive Plan. Your consent to the approval
of the Amended and Restated Certificate of Incorporation, the
increase in authorized shares of Common Stock and the Stock
Incentive Plan is not required and is not being solicited in
connection with this action. This information statement is
intended to provide our stockholders information required by the
rules and regulations of the Securities Exchange Act of 1934.
By order of the Board of Directors,
John M. Franck II
Vice President and Corporate Secretary
Nashville, TN
June 22, 2010
54
APPENDIX A
Amended and
Restated Certificate of Incorporation
A-1
AMENDED
AND RESTATED CERTIFICATE OF INCORPORATION
OF
HCA INC.
HCA INC. (the Corporation), a
corporation organized and existing under the General Corporation
Law of the State of Delaware, does hereby certify as follows:
FIRST: The name of the Corporation is
HCA Inc.
SECOND: The original Certificate of
Incorporation of the Corporation was filed with the Secretary of
State of the State of Delaware on July 7, 1993 under the
name Columbia Healthcare Corporation. The original Certificate
of Incorporation was most recently amended and restated on
March 27, 2008 (the Amended and Restated Certificate
of Incorporation).
THIRD: In an action taken by written
consent by the Board of Directors of the Corporation a
resolution was duly adopted pursuant to Sections 242 and
245 of the General Corporation Law of the State of Delaware,
setting forth this Amended and Restated Certificate of
Incorporation and declaring this Amended and Restated
Certificate of Incorporation to be advisable. The stockholders
of the Corporation duly approved and adopted this Amended and
Restated Certificate of Incorporation by written consent in
accordance with Sections 228, 242, and 245 of the General
Corporation Law of the State of Delaware.
FOURTH: The Amended and Restated
Certificate of Incorporation of the Corporation, as amended, is
hereby amended and restated in its entirety to read as follows:
ARTICLE I
NAME
The name of the Corporation is HCA Inc. (hereinafter, the
Corporation).
ARTICLE II
REGISTERED
OFFICE AND AGENT
The address of the Corporations registered office in the
State of Delaware is Corporation Trust Center, 1209 Orange
Street, Wilmington, New Castle County, Delaware 19801. The name
of its registered agent at such address is The Corporation
Trust Company.
ARTICLE III
PURPOSE
The nature of the business or purposes to be conducted or
promoted is to engage in any lawful act or activity for which
corporations may be organized under the General Corporation Law
of the State of Delaware (the DGCL).
ARTICLE IV
CAPITAL STOCK
The total number of shares of all classes of capital stock which
the Corporation shall have authority to issue is Two Billion
(2,000,000,000), of which:
(i) One Billion Eight Hundred Million (1,800,000,000)
shares shall be shares of common stock, par value $.01 per share
(the Common Stock); and
(ii) Two Hundred Million (200,000,000) shares shall be
shares of preferred stock, par value $.01 per share (the
Preferred Stock).
A-2
Such stock may be issued from time to time by the Corporation
for such consideration as may be fixed by the Board of Directors
of the Corporation.
Section 1. Stock
Split. Upon the filing and effectiveness of
this Amended and Restated Certificate of Incorporation with the
Secretary of State of the State of Delaware (the Effective
Time) each outstanding share (including shares held in
treasury) of Common Stock of the Corporation (the Old
Common Stock) shall be automatically split up,
reclassified and converted into 5.5 shares of Common Stock (the
New Common Stock). This stock split of the
outstanding shares of Common Stock shall not affect the total
number of shares of Common Stock that the Corporation is
authorized to issue, which shall remain as set forth in the
first sentence of this Article IV.
The forward split of the Old Common Stock effected by the
foregoing paragraph shall be referred to herein as the
Forward Split. The Forward Split shall occur without
any further action on the part of the Corporation or the holders
of shares of New Common Stock and whether or not certificates
representing such holders shares prior to the Forward
Split are surrendered for cancellation. No fractional interest
in a share of New Common Stock shall be deliverable upon the
Forward Split. Stockholders who otherwise would have been
entitled to receive any fractional interests in the New Common
Stock, in lieu of receipt of such fractional interest, shall be
entitled to receive from the Corporation an amount in cash equal
to the fair value of such fractional interest as of the
Effective Time. Except where the context otherwise requires, all
references to Common Stock in this Certificate of
Incorporation shall be to the New Common Stock.
The Forward Split will be effected on a
stockholder-by-stockholder
(as opposed to
certificate-by-certificate)
basis. Certificates or book-entries dated as of a date prior to
the Effective Time representing outstanding shares of Old Common
Stock shall, immediately after the Effective Time, represent a
number of shares equal to the same number of shares of New
Common Stock as is reflected on the face of such certificates or
book-entries, multiplied by 5.5 and rounded down to the nearest
whole number. The Corporation may, but shall not be obliged to,
issue new certificates evidencing the shares of New Common Stock
outstanding as a result of the Forward Split unless and until
the certificates evidencing the shares held by a holder prior to
the Forward Split are either delivered to the Corporation or its
transfer agent, or the holder notifies the Corporation or its
transfer agent that such certificates have been lost, stolen or
destroyed and executes an agreement satisfactory to the
Corporation to indemnify the Corporation from any loss incurred
by it in connection with such certificates. Every share number,
dollar amount and other provision contained in this Amended and
Restated Certificate of Incorporation have been adjusted for the
Forward Split, and there shall be no further adjustments made to
such share numbers, dollar amounts or other provisions, except
in the case of any stock splits, stock dividends,
reclassifications and the like occurring after the Effective
Time.
Section 2. Common
Stock. Except as (i) otherwise required
by law or (ii) expressly provided in this Amended and
Restated Certificate of Incorporation (as may be amended from
time to time), each share of Common Stock shall have the same
powers, rights, and privileges and shall rank equally, share
ratably, and be identical in all respects as to all matters.
(A) Dividends. Subject to
applicable law and the rights of the holders of any class or
series of Preferred Stock, and to the other provisions of this
Amended and Restated Certificate of Incorporation (as may be
amended from time to time), holders of Common Stock shall be
entitled to receive equally, on a per share basis, such
dividends and other distributions in cash, securities, or other
property of the Corporation as may be declared thereon by the
Board of Directors from time to time out of assets or funds of
the Corporation legally available therefor.
(B) Voting Rights. At every annual
or special meeting of stockholders of the Corporation, each
holder of Common Stock shall be entitled to cast one vote for
each share of Common Stock standing in such holders name
on the stock transfer records of the Corporation.
(C) Liquidation Rights. In the
event of any liquidation, dissolution, or winding up of the
affairs of the Corporation, whether voluntary or involuntary,
after payment or provision for payment of the Corporations
debts and amounts payable upon shares of any class or series of
Preferred Stock entitled to a preference, if any, over holders
of Common Stock upon such dissolution, liquidation, or winding
up, the remaining net assets
A-3
of the Corporation shall be distributed among holders of shares
of Common Stock equally on a per share basis. A merger or
consolidation of the Corporation with or into any other
corporation or other entity, or a sale or conveyance of all or
any part of the assets of the Corporation (which shall not in
fact result in the liquidation of the Corporation and the
distribution of assets to its stockholders) shall not be deemed
to be a voluntary or involuntary liquidation or dissolution or
winding up of the Corporation within the meaning of this
Paragraph (C).
(D) Conversion Rights. The Common
Stock shall not be convertible into, or exchangeable for, shares
of any other class or classes or of any other series of the same
class of the Corporations capital stock.
(E) Preemptive Rights. No holder
of Common Stock shall have any preemptive rights hereunder with
respect to the Common Stock or any other securities of the
Corporation, or to any obligations convertible (directly or
indirectly) into securities of the Corporation whether now or
hereafter authorized.
Section 3. Preferred
Stock. The Board of Directors is authorized,
subject to limitations prescribed by law, to provide by
resolution or resolutions for the issuance of all or any of the
shares of Preferred Stock in one or more class or series, to
establish the number of shares to be included in each such class
or series, and to fix the voting powers, designations, powers,
preferences, and relative, participating, optional, or other
rights, if any, of the shares of each such class or series, and
any qualifications, limitations, or restrictions thereof
including, without limitation, the authority to provide that any
such class or series may be (i) subject to redemption at
such time or times and at such price or prices;
(ii) entitled to receive dividends (which may be cumulative
or non-cumulative) at such rates, on such conditions, and at
such times, and payable in preference to, or in such relation
to, the dividends payable on any other class or classes or any
other series; (iii) entitled to such rights upon the
dissolution of, or upon any distribution of the assets of, the
Corporation; or (iv) convertible into, or exchangeable for,
shares of any other class or classes of stock, or of any other
series of the same or any other class or classes of stock, of
the Corporation at such price or prices or at such rates of
exchange and with such adjustments; all as may be stated in such
resolution or resolutions. Irrespective of the provisions of
Section 242(b)(2) of the DGCL, the number of authorized
shares of Preferred Stock may be increased or decreased (but not
below the number of shares thereof then outstanding) by the
affirmative vote of the holders of a majority in voting power of
the stock of the Corporation entitled to vote, without the
separate vote of the holders of the Preferred Stock as a class.
ARTICLE V
DURATION
The Corporation is to have perpetual existence.
ARTICLE VI
BOARD OF
DIRECTORS
Section 1. Number
Of Directors. Subject to any rights of the
holders of any class or series of Preferred Stock to elect
additional directors under specified circumstances as set forth
in a certificate of designation relating to any such class or
series of Preferred Stock, the number of directors which shall
constitute the Board of Directors shall be not less than three,
the exact number of which shall be fixed from time to time by
resolution adopted by the affirmative vote of a majority of the
total number of directors then in office.
Section 2. Term
of Office. Each director shall hold office
for a term expiring at the next annual meeting of stockholders
of the Corporation and until a successor is duly elected and
qualified or until his or her earlier death, resignation,
disqualification, or removal. Elections of directors need not be
by written ballot unless the Bylaws of the Corporation shall so
provide.
Section 3. Newly-Created
Directorships and Vacancies. Subject to the
rights of the holders of any series of Preferred Stock then
outstanding, newly created directorships resulting from any
increase in the number of directors or any vacancies in the
Board of Directors resulting from death, resignation,
retirement,
A-4
disqualification, removal from office, or any other cause may be
filled, so long as there is at least one remaining director,
only by the Board of Directors, provided that a quorum is then
in office and present, or by a majority of the directors then in
office, if less than a quorum is then in office, or by the sole
remaining director. Directors elected to fill a newly created
directorship or other vacancies shall hold office until such
directors successor has been duly elected and qualified or
until his or her earlier death, resignation, disqualification or
removal as hereinafter provided.
Section 4. Removal
of Directors. Subject to the rights of the
holders of any series of Preferred Stock then outstanding, any
director may be removed from office at any time, either with or
without cause, at a meeting of the stockholders called for that
purpose.
Section 5. Rights
of Holders of Preferred
Stock. Notwithstanding the provisions of this
Article VI, whenever the holders of one or more
series of Preferred Stock issued by the Corporation shall have
the right, voting separately or together by series, to elect
directors at an annual or special meeting of stockholders, the
election, term of office, filling of vacancies, and other
features of such directorship shall be governed by the rights of
such Preferred Stock as set forth in the certificate of
designations governing such series.
Section 6. Bylaws. The
Board of Directors is expressly authorized to make, alter,
amend, change, add to or repeal the Bylaws of the Corporation by
the affirmative vote of a majority of the total number of
directors then in office. Prior to the Trigger Date (as defined
below), any amendment, alteration, change, addition or repeal of
the Bylaws of the Corporation by the stockholders of the
Corporation shall require the affirmative vote of the holders of
a majority of the outstanding shares of the Corporation entitled
to vote on such amendment, alteration, change, addition or
repeal. On or following the Trigger Date, any amendment,
alteration, change, addition or repeal of the Bylaws of the
Corporation by the stockholders of the Corporation shall require
the affirmative vote of the holders of at least seventy-five
percent (75%) of the outstanding shares of the Corporation,
voting together as a class, entitled to vote on such amendment,
alteration, change, addition or repeal.
For purposes of this Amended and Restated Certificate of
Incorporation, (i) Trigger Date shall mean the
first date on which Hercules Holding II, LLC (or its successor)
ceases, or in the event of a liquidation of Hercules Holding II,
LLC, the Equity Sponsors (as defined below) and their
affiliates, collectively, cease, to beneficially own (directly
or indirectly) shares representing a majority of the then issued
and outstanding shares of Common Stock of the Corporation (it
being understood that the retention of either direct or indirect
beneficial ownership of a majority of the then issued and
outstanding shares of Common Stock by Hercules Holding II, LLC
(or its successor) or the Equity Sponsors and their affiliates,
as applicable, shall mean that the Trigger Date has not
occurred) and (ii) the Equity Sponsors shall
mean each of Bain Capital Partners, Kohlberg Kravis
Roberts & Co., BAML Capital Partners, Citigroup Inc.,
Bank of America Corporation, and Dr. Thomas F. Frist, Jr.
and their respective affiliates, subsidiaries, successors and
assignees (other than the Corporation and its subsidiaries).
ARTICLE VII
LIMITATION
OF LIABILITY
To the fullest extent permitted by the DGCL as it now exists or
may hereafter be amended, no director of the Corporation shall
be liable to the Corporation or its stockholders for monetary
damages arising from a breach of fiduciary duty owed to the
Corporation or its stockholders. Any repeal or modification of
this Article VII shall not adversely affect any
right or protection of a current or former director of the
Corporation existing at the time of such repeal or modification.
ARTICLE VIII
INDEMNIFICATION;
ADVANCEMENT OF EXPENSES
Section 1. Right
To Indemnification. Each person who was or is
made a party or is threatened to be made a party to or is
involved (including, without limitation, as a witness) in any
actual or threatened action, suit, or proceeding, whether civil,
criminal, administrative, or investigative, including any appeal
therefrom (hereinafter a proceeding), by reason of
the fact that he or she is or was, or has agreed to become, a
director or officer of the Corporation or, while a director or
officer of the Corporation, is or was serving at the request
A-5
of the Corporation as a director, officer, employee, or agent of
another corporation or of a partnership, limited liability
company, joint venture, trust, or other enterprise, including
service with respect to an employee benefit plan (hereinafter an
Indemnitee), shall be indemnified and held harmless
by the Corporation to the full extent authorized by the DGCL, as
the same exists or may hereafter be amended, or by other
applicable law as then in effect, against all expense,
liability, and loss (including attorneys fees and related
disbursements, judgments, fines, excise taxes and penalties
under the Employee Retirement Income Security Act of 1974, as
amended from time to time (ERISA), other penalties,
and amounts paid or to be paid in settlement) actually and
reasonably incurred or suffered by such Indemnitee in connection
therewith, and such indemnification rights shall continue as to
a person who has ceased to be a director or officer of the
Corporation or serving as a director, officer, employee or agent
of another corporation, partnership, limited liability company,
joint venture, trust or other enterprise at the request of the
Corporation. Service by a director or officer of the Corporation
shall be deemed to be at the request of the Corporation if he or
she is or was serving as a director, officer, employee, or agent
of a subsidiary of the Corporation or an employee benefit plan
of the Corporation or subsidiary of the Corporation.
Notwithstanding the first sentence of this Section 1,
except as otherwise provided in Section 3 of this
Article VIII, the Corporation shall be required to
indemnify an Indemnitee in connection with a proceeding (or part
thereof) commenced by such Indemnitee only if the commencement
of such proceeding (or part thereof) by the Indemnitee was
authorized in advance by the Corporations Board of
Directors.
Section 2. Advancement
Of Expenses. Expenses (including
attorneys fees, costs, and charges) incurred by an
Indemnitee in defending a proceeding or, pursuing a claim
described in Section 3 of this Article VIII or
the last sentence of Section 1 of this
Article VIII shall be paid by the Corporation in
advance of the final disposition of such proceeding, within
twenty (20) days of the Corporations receipt of a
request therefor and an undertaking by or on behalf of the
Indemnitee to repay all amounts so advanced in the event that it
shall ultimately be determined that such Indemnitee is not
entitled to be indemnified by the Corporation.
Section 3. Procedure
For Indemnification. If a determination is
required by the DGCL, any indemnification (but not advancement
of expenses) under this Article VIII (unless ordered
by a court) shall be made by the Corporation only as authorized
in the specific case upon a determination that indemnification
of the Indemnitee is proper in the circumstances because he or
she has met the applicable standard of conduct set forth in the
DGCL, as the same exists or hereafter may be amended. Such
determination shall be made with respect to a person who is a
director or officer of the Corporation at the time of such
determination (a) by a majority vote of the directors who
are not parties to such proceeding (the Disinterested
Directors), even though less than a quorum, (b) by a
committee of Disinterested Directors designated by a majority
vote of Disinterested Directors, even though less than a quorum,
(c) if there are no such Disinterested Directors, or if
such Disinterested Directors so direct, by independent legal
counsel in a written opinion, or (d) by the stockholders.
Any indemnification under this Article VIII shall be
made promptly, and in any event within sixty (60) days
after the Corporations receipt of a written request
therefor, provided that the Corporation shall not be required to
pay a claim for indemnification prior to the final disposition
of the proceeding from which the claim arose. The right to
indemnification or advancement of expenses as granted by this
Article VIII shall be enforceable by the Indemnitee
in any court of competent jurisdiction, if the Corporation
denies such request, in whole or in part, or if a claim for
indemnification or advancement of expenses is not timely paid in
full. Such persons reasonable costs and expenses incurred
in connection with successfully establishing his or her right to
indemnification or advancement of expenses, in whole or in part,
in any such action shall also be indemnified by the Corporation.
In any such action the Corporation shall have the burden of
proving that the claimant is not entitled to the requested
indemnification or advancement of expenses under applicable law.
Neither the failure of the Corporation (including its Board of
Directors, its independent legal counsel, and its stockholders)
to have made a determination prior to the commencement of such
action that indemnification of the claimant is proper in the
circumstances because he or she has met the applicable standard
of conduct set forth in the DGCL, as the same exists or
hereafter may be amended, nor the fact that there has been an
actual determination by the Corporation (including its Board of
Directors, its independent legal counsel, and its stockholders)
that the claimant has not met such applicable standard of
conduct, shall be a defense to the action or create a
presumption that the claimant has not met the applicable
standard of conduct. The termination of any proceeding by
judgment, order, settlement, conviction, or upon a plea of
nolo contendere or
A-6
its equivalent, shall not, of itself, create a presumption that
the Indemnitee did not act in good faith and in a manner that he
or she reasonably believed to be in or not opposed to the best
interests of the Corporation, and, with respect to any criminal
proceeding, had reasonable cause to believe that his or her
conduct was unlawful.
Section 4. Other
Rights; Continuation of Right to Indemnification and
Advancement. The rights to indemnification
and advancement of expenses provided by this
Article VIII shall not be deemed exclusive of, and
shall be in addition to, any other rights to which a person
seeking indemnification or advancement of expenses may be
entitled under any law (common or statutory), provision of this
Amended and Restated Certificate of Incorporation, bylaw,
agreement, vote of stockholders or Disinterested Directors, or
otherwise, and shall inure to the benefit of the estate, heirs,
executors, and administrators of such person. All rights to
indemnification and advancement of expenses conferred on any
person under this Article VIII shall be deemed to be
contract rights and be retroactive and available with respect to
events occurring prior to the adoption of this Amended and
Restated Certificate of Incorporation. Any repeal or
modification of this Article VIII or, to the fullest
extent permitted by applicable law, any repeal or modification
of relevant provisions of the DGCL or any other applicable laws
shall not in any way diminish any rights to indemnification or
advancement of expenses of such person or the obligations of the
Corporation arising hereunder with respect to any proceeding
arising out of, or relating to, any actions, omissions,
transactions, or facts occurring prior to the final adoption of
such modification or repeal. For the purposes of this
Article VIII, references to the
Corporation include all constituent corporations
(including any constituent of a constituent) absorbed in a
consolidation or merger as well as the resulting or surviving
corporation, so that any person who is or was a director or
officer of such a constituent corporation or, while a director
or officer of such constituent corporation, is or was serving at
the request of such constituent corporation as a director,
officer, employee, or agent of another corporation, partnership,
limited liability company, joint venture, trust, or other
enterprise, shall stand in the same position under the
provisions of this Article VIII, with respect to the
resulting or surviving corporation, as he or she would if he or
she had served the resulting or surviving corporation in the
same capacity.
Section 5. Insurance. The
Corporation may purchase and maintain insurance on its own
behalf and on behalf of any person who is or was a director,
officer, employee, or agent of the Corporation or is or was
serving at the request of the Corporation as a director,
officer, employee, or agent of another corporation, partnership,
limited liability company, joint venture, trust, or other
enterprise against any expense, liability, or loss asserted
against him or her and incurred by him or her in any such
capacity, or arising out of his or her status as such, whether
or not the Corporation would have the power to indemnify such
person against such expense, liability, or loss under the DGCL.
Section 6. Reliance. Persons
who after the date of the adoption of this Amended and Restated
Certificate of Incorporation become or remain directors or
officers of the Corporation or who, while a director or officer
of the Corporation, become or remain a director, officer,
employee, or agent of a subsidiary, shall be conclusively
presumed to have relied on the rights to indemnity, advancement
of expenses, and other rights contained in this
Article VIII in entering into or continuing such
service. The rights to indemnification and to the advancement of
expenses conferred in this Article VIII shall apply
to claims made against an Indemnitee arising out of acts or
omissions that occurred or occur both prior and subsequent to
the adoption hereof.
Section 7. Savings
Clause. If this Article VIII or
any portion hereof shall be invalidated on any ground by any
court of competent jurisdiction, then the Corporation shall
nevertheless (i) indemnify each person entitled to
indemnification under the first paragraph of this
Article VIII as to all expense, liability, and loss
(including attorneys fees and related disbursements,
judgments, fines, ERISA excise taxes and penalties, other
penalties, and amounts paid or to be paid in settlement)
actually and reasonably incurred or suffered by such person and
for which indemnification is available to such person pursuant
to this Article VIII and (ii) advance expenses
to each Indemnitee entitled to advancement of expenses under
Section 2 of this Article VIII in
accordance therewith, in each case to the full extent permitted
by any applicable portion of this Article VIII that
shall not have been invalidated and to the full extent permitted
by applicable law.
Section 8. Other
Sources of Payment. Except as may be
otherwise agreed to by the Corporation and the Indemnitee (or
any entity which has designated the nomination or appointment of
such Indemnitee), in the event of any payment under this
Article VIII, the Corporation shall be subrogated to
the extent of such
A-7
payment to all of the rights of recovery of such Indemnitee,
who shall execute all papers required and take all action
necessary to secure such rights, including execution of such
documents as are necessary to enable the Corporation to bring
suit to enforce such rights. Except as may be otherwise agreed
to by the Corporation and the Indemnitee (or any entity which
has designated the nomination or appointment of such
Indemnitee), the Corporation shall not be obligated to an
Indemnitee under this Article VIII to make any
payment of amounts otherwise indemnifiable hereunder if and to
the extent that such Indemnitee has otherwise actually received
such payment under any insurance policy maintained by the
Corporation, contract, agreement or otherwise, and in the event
that the Corporation makes any payment to an Indemnitee under
this Article VIII and such Indemnitee subsequently
otherwise receives such payment under any insurance policy
maintained by the Corporation, contract, agreement or otherwise,
such Indemnitee shall promptly refund such amounts to the
Corporation. Except as may be otherwise agreed to by the
Corporation and the Indemnitee (or any entity which has
designated the nomination or appointment of such Indemnitee),
the Corporations obligations under this
Article VIII to an Indemnitee who while a director
or officer of the Corporation is or was serving at the request
of the Corporation as a director, officer, employee or agent of
any other corporation, limited liability company, partnership,
joint venture, trust or other enterprise shall be reduced by any
amount such Indemnitee has actually received as indemnification
or advancement of expenses from such other corporation, limited
liability company, partnership, joint venture, trust or other
enterprise.
Section 9. Partial
Indemnification. If an Indemnitee is entitled
under any provision of this Article VIII to
indemnification by the Corporation for some or a portion of the
expenses (including attorneys fees), judgments, fines or
amounts paid in settlement actually and reasonably incurred by
him or her or on his or her behalf in connection with any
proceeding, but not, however, for the total amount thereof, the
Corporation shall nevertheless indemnify the Indemnitee for the
portion of such expenses (including attorneys fees),
judgments, fines or amounts paid in settlement to which the
Indemnitee is entitled.
Section 10. Successful
Defense. In the event that any proceeding to
which an Indemnitee is a party is resolved in any manner other
than by adverse judgment against the Indemnitee (including,
without limitation, settlement of such proceeding with or
without payment of money or other consideration) it shall be
presumed that the Indemnitee has been successful on the merits
or otherwise in such proceeding pursuant to Section 145(c)
of the DGCL. Anyone seeking to overcome this presumption shall
have the burden of proof and the burden of persuasion by clear
and convincing evidence.
ARTICLE IX
SPECIAL
MEETINGS OF STOCKHOLDERS; ADVANCE NOTICE; ACTION BY WRITTEN
CONSENT
Special meetings of stockholders of the Corporation may be
called only by either the Board of Directors pursuant to a
resolution adopted by the affirmative vote of the majority of
the total number of directors then in office or by the Chairman
of the Board or the Chief Executive Officer of the Corporation;
provided that, prior to the Trigger Date, special meetings of
stockholders of the Corporation may also be called by the
Secretary of the Corporation at the request of the holders of a
majority of the outstanding shares of Common Stock. Advance
notice of stockholder nominations for the election of directors
and of business to be brought by stockholders before any meeting
of the stockholders of the Corporation shall be given in the
manner provided in the Bylaws of the Corporation. Prior to the
Trigger Date, any action required or permitted to be taken at
any annual or special meeting of stockholders of the Corporation
may be taken without a meeting, without prior notice and without
a vote, if a consent or consents in writing, setting forth the
action so taken, shall be signed by the holders of outstanding
stock having not less than the minimum number of votes that
would be necessary to authorize or take such action at a meeting
at which all shares entitled to vote thereon were present and
voted and shall be delivered to the Corporation by delivery to
its registered office in the State of Delaware, its principal
place of business, or an officer or agent of the Corporation
having custody of the books in which proceedings of meetings of
the stockholders are recorded. On or following the Trigger Date,
any action required or permitted to be taken at any annual or
special meeting of the stockholders of the Corporation may be
taken only upon the vote of the stockholders at an annual or
special meeting duly called and may not be taken by written
consent of the stockholders.
A-8
ARTICLE X
CORPORATE
OPPORTUNITIES
To the fullest extent permitted by applicable law, the
Corporation, on behalf of itself and its subsidiaries, renounces
any interest or expectancy of the Corporation and its
subsidiaries in, or in being offered an opportunity to
participate in, business opportunities that are from time to
time presented to any of the Equity Sponsors or any of their
respective officers, directors, agents, shareholders, members,
partners, affiliates and subsidiaries (other than the
Corporation and its subsidiaries) (each, a Specified
Party), even if the opportunity is one that the
Corporation or its subsidiaries might reasonably be deemed to
have pursued or had the ability or desire to pursue if granted
the opportunity to do so and each such Specified Party shall
have no duty to communicate or offer such business opportunity
to the Corporation and, to the fullest extent permitted by
applicable law, shall not be liable to the Corporation or any of
its subsidiaries for breach of any fiduciary or other duty, as a
director or officer or otherwise, by reason of the fact that
such Specified Party pursues or acquires such business
opportunity, directs such business opportunity to another person
or fails to present such business opportunity, or information
regarding such business opportunity, to the Corporation or its
subsidiaries. Notwithstanding the foregoing, a Specified Party
who is a director or officer of the Corporation and who is
offered a business opportunity expressly in his or her capacity
as a director or officer of the Corporation (a Directed
Opportunity) shall be obligated to communicate such
Directed Opportunity to the Corporation; provided, however, that
all of the protections of this Article X shall
otherwise apply to the Specified Parties with respect to such
Directed Opportunity, including, without limitation, the ability
of the Specified Parties to pursue or acquire such Directed
Opportunity or to direct such Directed Opportunity to another
person.
Neither the amendment nor repeal of this Article X,
nor the adoption of any provision of this Amended and Restated
Certificate of Incorporation or the Bylaws of the Corporation,
nor, to the fullest extent permitted by Delaware law, any
modification of law, shall adversely affect any right or
protection of any person granted pursuant hereto existing at, or
arising out of or related to any event, act or omission that
occurred prior to, the time of such amendment, repeal, adoption
or modification (regardless of when any proceeding (or part
thereof) relating to such event, act or omission arises or is
first threatened, commenced or completed).
If any provision or provisions of this Article X
shall be held to be invalid, illegal or unenforceable as applied
to any circumstance for any reason whatsoever: (a) the
validity, legality and enforceability of such provisions in any
other circumstance and of the remaining provisions of this
Article X (including, without limitation, each
portion of any paragraph of this Article X
containing any such provision held to be invalid, illegal or
unenforceable that is not itself held to be invalid, illegal or
unenforceable) shall not in any way be affected or impaired
thereby and (b) to the fullest extent possible, the
provisions of this Article X (including, without
limitation, each such portion of any paragraph of this
Article X containing any such provision held to be
invalid, illegal or unenforceable) shall be construed so as to
permit the Corporation to protect its directors, officers,
employees and agents from personal liability in respect of their
good faith service to or for the benefit of the Corporation to
the fullest extent permitted by law.
This Article X shall not limit any protections or
defenses available to, or indemnification or advancement rights
of, any director or officer of the Corporation under this
Amended and Restated Certificate of Incorporation or applicable
law.
Any person or entity purchasing or otherwise acquiring any
interest in any securities of the Corporation shall be deemed to
have notice of and to have consented to the provisions of this
Article X.
A-9
ARTICLE XI
AMENDMENT
The Corporation reserves the right to amend, alter, change or
repeal any provision contained in this Amended and Restated
Certificate of Incorporation, in the manner now or hereafter
prescribed by the DGCL, and all rights conferred upon
stockholders herein are granted subject to this reservation.
Notwithstanding any other provision of this Amended and Restated
Certificate of Incorporation or the Bylaws of the Corporation,
and notwithstanding the fact that a lesser percentage or
separate class vote may be specified by law, this Amended and
Restated Certificate of Incorporation, the Bylaws of the
Corporation, or otherwise, but in addition to any affirmative
vote of the holders of any particular class or series of the
capital stock required by law, this Amended and Restated
Certificate of Incorporation, the Bylaws of the Corporation, or
otherwise, on or following the Trigger Date, the affirmative
vote of the holders of at least seventy-five percent (75%) of
the voting power of all outstanding shares of the Corporation
entitled to vote generally in the election of directors, voting
together as a single class, shall be required to adopt any
provision inconsistent with, to amend or repeal any provision
of, or to adopt a bylaw inconsistent with,
Articles III, V, VI, VII,
VIII, IX, X and XI of this Amended
and Restated Certificate of Incorporation.
[Remainder
of page intentionally left blank.]
A-10
IN WITNESS WHEREOF, this Amended and Restated Certificate
of Incorporation, which restates, integrates, and amends and
restates the Amended and Restated Certificate of Incorporation
of the Corporation, and which has been duly adopted in
accordance with Sections 228, 242, and 245 of the General
Corporation Law of the State of Delaware, has been executed on
behalf of HCA Inc. by the undersigned officer, thereunto duly
authorized, this day
of ,
2010.
HCA INC.
John M. Franck II
Vice President Legal and Corporate Secretary
A-11
APPENDIX B
2006 Stock
Incentive Plan for Key Employees of HCA Inc.
and its Affiliates, as Amended and Restated
B-1
2006
STOCK INCENTIVE PLAN
FOR KEY EMPLOYEES OF
HCA INC. AND ITS AFFILIATES,
AS AMENDED AND RESTATED
1. Purpose of Plan
The 2006 Stock Incentive Plan for Key Employees of HCA Inc. and
its Affiliates, as amended and restated (the
Plan) is designed:
(a) to promote the long term financial interests and growth
of HCA Inc. (the Company) and its
Subsidiaries by attracting and retaining management and other
personnel and key service providers with the training,
experience and ability to enable them to make a substantial
contribution to the success of the Companys business;
(b) to motivate management personnel by means of
growth-related incentives to achieve long range goals; and
(c) to further the alignment of interests of participants
with those of the stockholders of the Company through
opportunities for increased stock, or stock-based ownership in
the Company.
2. Definitions
As used in the Plan, the following words shall have the
following meanings:
(a) Affiliate means with respect
to any Person, any entity directly or indirectly controlling,
controlled by or under common control with such Person.
(b) Board means the Board of
Directors of the Company.
(c) Change in Control means in
one or more of a series of transactions (i) the transfer or
sale of all or substantially all of the assets of the Company
(or any direct or indirect parent of the Company) to an
Unaffiliated Person (as defined below); (ii) a merger,
consolidation, recapitalization or reorganization of the Company
(or any direct or indirect parent of the Company) with or into
another Unaffiliated Person, or a transfer or sale of the voting
stock of the Company (or any direct or indirect parent of the
Company), an Investor, or any Affiliate of any of the Investors
to an Unaffiliated Person, in any such event that results in
more than 50% of the common stock of the Company (or any direct
or indirect parent of the Company) or the resulting company
being held by an Unaffiliated Person; or (iii) a merger,
consolidation, recapitalization or reorganization of the Company
(or any direct or indirect parent of the Company) with or into
another Unaffiliated Person, or a transfer or sale by the
Company (or any direct or indirect parent of the Company), an
Investor or any Affiliate of any of the Investors, in any such
event after which the Investors and their Affiliates
(x) collectively own less than 15% of the Common Stock of
and (y) collectively have the ability to appoint less than
50% of the directors to the Board (or any resulting company
after a merger). For purposes of this definition, the term
Unaffiliated Person means a Person or Group
who is not an Investor, an Affiliate of any of the Investors or
an entity in which any Investor holds, directly or indirectly, a
majority of the economic interest in such entity.
(d) Code means the United States
Internal Revenue Code of 1986, as amended.
(e) Committee means either
(i) the Compensation Committee of the Board or,
(ii) the Board, if the Board takes an action in place of
the Compensation Committee.
(f) Common Stock or
Share means the common stock, par
value $0.01 per share, of the Company, which may be authorized
but unissued, or issued and reacquired.
(g) Employee means a person,
including an officer, in the regular employment of the Company
or any other Service Recipient who, in the opinion of the
Committee, is, or is expected to have involvement in the
management, growth or protection of some part or all of the
business of the Company or any other Service Recipient.
B-2
(h) Exchange Act means the
Securities Exchange Act of 1934, as amended.
(i) Fair Market Value means, on a
per Share basis, on any given date, the closing trading price of
the Common Stock on the New York Stock Exchange, unless
otherwise determined by the Board.
(j) Grant means an award made to
a Participant pursuant to the Plan and described in
Section 5, including, without limitation, an award of a
Stock Option, Stock Appreciation Right, Other Stock-Based Award,
Dividend Equivalent Right, Non-Employee Director Grants or
Performance-Based Awards (as such terms are defined in
Section 5), or any combination of the foregoing.
(k) Grant Agreement means an
agreement between the Company and a Participant that sets forth
the terms, conditions and limitations applicable to a Grant.
(l) Group means
group, as such term is used for purposes of
Section 13(d) or 14(d) of the Exchange Act.
(m) Investors means,
collectively, Bain Capital Fund IX, L.P., KKR Millennium
Fund, L.P., and ML Global Private Equity Fund, L.P.
(n) Management Stockholders
Agreement shall mean that certain Management
Stockholders Agreement between the applicable Participant
and the Company.
(o) Participant means an
Employee, non-employee member of the Board, consultant or other
person having a service relationship with the Company or any
other Service Recipient, to whom one or more Grants have been
made and remain outstanding.
(p) Person means
person, as such term is used for purposes of
Section 13(d) or 14(d) of the Exchange Act.
(q) Public Offering means any
registered public offering of the Common Stock on the New York
Stock Exchange or the NASDAQ National Market or other nationally
recognized stock exchange or listing system.
(r) Sale Participation Agreement
shall mean that certain Sale Participation Agreement between
the applicable Participant and Hercules Holdings II, LLC.
(s) Service Recipient shall mean,
the Company, any Subsidiary of the Company, or any Affiliate of
the Company that satisfies the definition of service
recipient within the meaning of Proposed Treasury
Regulation Section 1.409A-1(g)
(or any successor regulation), with respect to which the person
is a service provider (within the meaning of
Proposed Treasury
Regulation Section 1.409A-1(f)
(or any successor regulation).
(t) Subsidiary means any
corporation or other entity in an unbroken chain of corporations
or other entities beginning with the Company if each of the
corporations or other entities, or group of commonly controlled
corporations or other entities, other than the last corporation
or other entity in the unbroken chain then owns stock or other
equity interests possessing 50% or more of the total combined
voting power of all classes of stock or other equity interests
in one of the other corporations or other entities in such chain.
3. Administration of Plan
(a) The Plan shall be administered by the Committee, which
may delegate its duties and powers in whole or in part to any
subcommittee thereof consisting solely of at least two
individuals who are intended to qualify as Non-Employee
Directors within the meaning of
Rule 16b-3
under the Exchange Act (or any successor rule thereto),
independent directors within the meaning of the New
York Stock Exchange listed company rules and outside
directors within the meaning of Section 162(m) of the
Code (or any successor section thereto), to the extent
Rule 16b-3
under the Exchange Act and Section 162(m) of the Code,
respectively, are applicable to the Company and the Plan;
provided, however, that the Board may, in its sole
discretion, take any action designated to the Committee under
this Plan as it may deem necessary. The Committee may delegate
to the Chief Executive Officer and to other senior officers of
the Company its duties under the Plan,
B-3
subject to applicable law and such conditions and limitations as
the Committee shall prescribe, except that only the Committee
may designate and make Grants to Participants.
(b) The Committee may adopt its own rules of procedure, and
action of a majority of the members of the Committee taken at a
meeting, or action taken without a meeting by unanimous written
consent, shall constitute action by the Committee. The Committee
shall have the power and authority to administer, construe and
interpret the Plan, and to make rules for carrying it out and to
make changes in such rules. The Committee may correct any defect
or supply any omission or reconcile any inconsistency in the
Plan in the manner and to the extent the Committee deems
necessary or desirable. Any such interpretations, rules, and
administration shall be consistent with the basic purposes of
the Plan. The Committee shall have the full power and authority
to establish the terms and conditions of any Grant consistent
with the provisions of the Plan and to waive any such terms and
conditions at any time (including, without limitation,
accelerating or waiving any vesting conditions).
(c) The Committee may employ counsel, consultants,
accountants, appraisers, brokers or other persons. The
Committee, the Company, and the officers and directors of the
Company shall be entitled to rely upon the advice, opinions or
valuations of any such persons. All actions taken and all
interpretations and determinations made by the Committee in good
faith shall be final and binding upon all Participants and their
beneficiaries or successors. No member of the Committee, nor
employee or representative of the Company shall be personally
liable for any action, determination or interpretation made in
good faith with respect to the Plan or the Grants, and all such
members of the Committee, employees and representatives shall be
fully protected and indemnified to the greatest extent permitted
by applicable law by the Company with respect to any such
action, determination or interpretation.
4. Eligibility
The Committee may from time to time make Grants under the Plan
to such Employees, or other persons having a relationship with
Company or any other Service Recipient, and in such form and
having such terms, conditions and limitations as the Committee
may determine. The terms, conditions and limitations of each
Grant under the Plan shall be set forth in a Grant Agreement, in
a form approved by the Committee, consistent, however, with the
terms of the Plan; provided, however, that such
Grant Agreement shall contain provisions dealing with the
treatment of Grants in the event of the termination of
employment or other service relationship, death or disability of
a Participant, and may also include provisions concerning the
treatment of Grants in the event of a Change in Control of the
Company.
5. Grants
From time to time, the Committee will determine the forms and
amounts of Grants for Participants. Such Grants may take the
following forms in the Committees sole discretion:
(a) Stock Options These are
options to purchase Common Stock (Stock
Options). At the time of Grant the Committee shall
determine, and shall include in the Grant Agreement or other
Plan rules, the option exercise period, the option exercise
price, vesting requirements, and such other terms, conditions or
restrictions on the grant or exercise of the option as the
Committee deems appropriate including, without limitation, the
right to receive dividend equivalent payments on vested options.
Notwithstanding the foregoing, the exercise price per Share of a
Stock Option shall in no event be less than the Fair Market
Value on the date the Stock Option is granted (subject to later
adjustment pursuant to Section 8 hereof). In addition to
other restrictions contained in the Plan, a Stock Option granted
under this Section 5(a) may not be exercised more than
10 years after the date it is granted. Payment of the Stock
Option exercise price shall be made (i) in cash,
(ii) with the consent of the Committee, in Shares (any such
Shares valued at Fair Market Value on the date of exercise)
having an aggregate Fair Market Value equal to the aggregate
exercise price for the Shares being purchased and that the
Participant has held for at least six months (or such other
period of time as may be required to attain tax or financial
reporting treatments that are not considered to be adverse to
the Company), (iii) through the withholding of Shares (any
such Shares valued at Fair Market Value on the date of exercise)
otherwise issuable upon the exercise of the Stock Option in a
manner that is compliant with applicable law, (iv) if there
is a public
B-4
market for the Shares at such time, to the extent permitted by,
and subject to such rules as may be established by the
Committee, through delivery of irrevocable instructions to a
broker to sell Shares obtained upon the exercise of the Option
and to deliver promptly to the Company an amount out of the
proceeds of such sale equal to the aggregate exercise price for
the Shares being purchased, or (v) a combination of the
foregoing methods, in each such case in accordance with the
terms of the Plan, the Grant Agreement and of any applicable
guidelines of the Committee in effect at the time.
(b) Stock Appreciation
Rights The Committee may grant
Stock Appreciation Rights (as hereinafter
defined) independent of, or in connection with, the grant of a
Stock Option or a portion thereof. Each Stock Appreciation Right
shall be subject to such other terms as the Committee may
determine. The exercise price per Share of a Stock Appreciation
Right shall in no event be less than the Fair Market Value on
the date the Stock Appreciation Right is granted. Each
Stock Appreciation Right granted independent of a
Stock Option shall be defined as a right of a Participant, upon
exercise of such Stock Appreciation Right, to receive an amount
equal to the product of (i) the excess of (A) the Fair
Market Value on the exercise date of one Share over (B) the
exercise price per Share of such Stock Appreciation Right,
multiplied by (ii) the number of Shares covered by the
Stock Appreciation Right. Payment of the Stock Appreciation
Right shall be made in Shares or in cash, or partly in Shares
and partly in cash (any such Shares valued at the Fair Market
Value on the date of the payment), all as shall be determined by
the Committee.
(c) Other Stock-Based
Awards The Committee may grant or sell
awards of Shares, awards of restricted Shares and awards that
are valued in whole or in part by reference to, or are otherwise
based on the Fair Market Value of, Shares (including, without
limitation, restricted stock units). Such Other
Stock-Based Awards shall be in such form, and dependent on
such conditions, as the Committee may determine, including,
without limitation, the right to receive, or vest with respect
to, one or more Shares (or the equivalent cash value of such
Shares) upon the completion of a specified period of service,
the occurrence of an event
and/or the
attainment of performance objectives. Other Stock-Based Awards
may be granted alone or in addition to any other Grants under
the Plan. Subject to the provisions of the Plan, the Committee
shall determine to whom and when Other Stock-Based Awards will
be made, the number of Shares to be awarded under (or otherwise
related to) such Other Stock-Based Awards; whether such Other
Stock-Based Awards shall be settled in cash, Shares or a
combination of cash and Shares; and all other terms and
conditions of such awards (including, without limitation, the
vesting provisions thereof and provisions ensuring that all
Shares so awarded and issued shall be fully paid and
non-assessable).
(d) Dividend Equivalent
Rights The Committee may grant Dividend
Equivalent Rights either alone or in connection with the grant
of a Stock Option, SAR, Other Stock Based Award, or other grant
provided for in Section 5(e) below. A Dividend
Equivalent Right shall be the right to receive a payment
in respect of one Share (whether or not subject to a Stock
Option) equal to the amount of any dividend paid in respect of
one Share held by a shareholder in the Company. Each Dividend
Equivalent Right shall be subject to such terms as the Committee
may determine. All dividend or dividend equivalents which are
not paid currently may, at the Committees discretion,
accrue interest, be reinvested into additional Shares, or, in
the case of dividends or dividend equivalents credited in
connection with Performance-Based Awards be credited as
additional Performance-Based Awards and paid to the Participant
if and when, and to the extent that, payment is made pursuant to
such Grant. The total number of Shares available for grant under
Section 6 shall not be reduced to reflect any dividends or
dividend equivalents that are reinvested into additional Shares
or credited as Performance-Based Awards.
(e) Director Grants. The Board may
provide that all or a portion of any member of the Boards
annual retainer, meeting fees
and/or other
awards or compensation as determined by the Board, be payable
(either automatically or at the election of such member) in the
form of non-qualified Stock Options, restricted shares,
restricted share units
and/or Other
Stock-Based Awards, including unrestricted Shares. The Board
shall determine the terms and conditions of any such Grants,
including the terms and conditions which shall apply upon a
termination of such Board members service as a member of
the Board, and shall have full power and authority in its
discretion to administer such Grants, subject to the terms of
the Plan and applicable law.
B-5
(f) Performance-Based Awards.
(i) During any period when Section 162(m) of the Code
is applicable to the Company and the Plan, the Committee, in its
sole discretion, may grant Grants which are denominated in
Shares or cash (which, for the avoidance of doubt, may include a
Grant of Stock Options, Stock Appreciation Rights, Other
Stock-Based Awards or Dividend Equivalent Rights) (such Grants,
Performance-Based Awards), which Grants may,
but for the avoidance of doubt are not required to, be granted
in a manner which is intended to be deductible by the Company
under Section 162(m) of the Code (or any successor section
thereto). Such Performance-Based Awards shall be in such form,
and dependent on such conditions, as the Committee shall
determine, including, without limitation, the right to receive,
or vest with respect to, one or more Shares or the cash value of
the Grant upon the completion of a specified period of service,
the occurrence of an event
and/or the
attainment of performance objectives. Performance-Based Awards
may be granted alone or in addition to any other Grants granted
under the Plan. Subject to the provisions of the Plan, the
Committee shall determine to whom and when Performance-Based
Awards will be made, the number of Shares or aggregate amount of
cash to be awarded under (or otherwise related to) such
Performance-Based Awards, whether such Performance-Based Awards
shall be settled in cash, Shares or a combination of cash and
Shares, and all other terms and conditions of such Grants
(including, without limitation, the vesting provisions thereof
and provisions ensuring that all Shares so awarded and issued,
to the extent applicable, shall be fully paid and
non-assessable).
(ii) A Participants Performance-Based Award shall be
determined based on the attainment of written performance goals
approved by the Committee for a performance period established
by the Committee (A) while the outcome for that performance
period is substantially uncertain and (B) no more than
90 days after the commencement of the performance period to
which the performance goal relates or, if less, the number of
days which is equal to 25 percent of the relevant
performance period. The performance goals, which must be
objective, shall be based upon one or more of the following
criteria: (i) consolidated income before or after taxes
(including income before interest, taxes, depreciation and
amortization); (ii) EBITDA; (iii) adjusted EBITDA;
(iv) operating income; (v) net income; (vi) net
income per Share; (vii) book value per Share;
(viii) return on members or shareholders
equity; (ix) expense management; (x) return on
investment; (xi) improvements in capital structure;
(xii) profitability of an identifiable business unit or
product; (xiii) maintenance or improvement of profit
margins; (xiv) stock price; (xv) market share;
(xvi) revenue or sales; (xvii) costs;
(xviii) cash flow; (xix) working capital;
(xx) multiple of invested capital; (xxi) total return;
and (xxii) such other objective performance criteria as
determined by the Committee in its sole discretion, to the
extent such criteria would be a permissible performance criteria
under Section 162(m) of the Code. The foregoing criteria
may relate to the Company, one or more of its Subsidiaries or
one or more of its or their divisions or units, or any
combination of the foregoing, and may be applied on an absolute
basis and/or
be relative to one or more peer group companies or indices, or
any combination thereof, all as the Committee shall determine.
The Committee may appropriately adjust any evaluation of
performance under criteria set forth in this Section 5(f)
to exclude any of the following events that occurs during a
performance period: (1) gains or losses on sales of assets
(2) asset impairments or write-downs, (3) litigation
or claim judgments or settlements, (4) the effect of
changes in tax law, accounting principles or other such laws or
provisions affecting reported results, (5) accruals for
reorganization and restructuring programs, (6) any
extraordinary non-recurring items as described in Financial
Accounting Standards Board (FASB) Accounting
Standards Codification (ASC) Topic
225-20
and/or in
managements discussion and analysis of financial condition
and results of operations appearing in the Companys annual
report to stockholders for the applicable year, and (7) the
effect of adverse or delayed federal, state or local
governmental or regulatory action; provided that the Committee
commits to make any such adjustments within the 90 days
following the commencement of each performance period (or such
other time as may be required or permitted by
Section 162(m) of the Code).
(iii) The maximum amount of a Performance-Based Award
during a fiscal year to any Participant shall be: (x) with
respect to Performance-Based Awards that are denominated in
Shares, 1,000,000 per fiscal year and (y) with respect to
Performance-Based Awards that are denominated in cash,
$5,000,000
B-6
per fiscal year. To the extent that a Performance-Based Award
may be earned over a period that is longer than one fiscal year,
the foregoing limitations shall apply to each full or partial
fiscal year during or in which such Grant may be earned.
(iv) The Committee shall determine whether, with respect to
a performance period, the applicable performance goals have been
met with respect to a given Participant and, if they have,
during any period when Section 162(m) of the Code is
applicable to the Company and the Plan and such
Performance-Based Award is intended to be deductible by the
Company under Section 162(m) of the Code, shall so certify
and ascertain the amount of the applicable Performance-Based
Award. No Performance-Based Awards will be paid for such
performance period until such certification, to the extent
applicable, is made by the Committee. The amount of the
Performance-Based Award actually paid to a given Participant may
be less than the amount determined by the applicable performance
goal formula, at the discretion of the Committee. The amount of
the Performance-Based Award determined by the Committee for a
performance period shall be paid to the Participant at such time
as determined by the Committee in its sole discretion after the
end of such performance period; provided, however, that a
Participant may, if and to the extent permitted by the Committee
and consistent with the provisions of Sections 162(m) and
409A of the Code, to the extent applicable, elect to defer
payment of a Performance-Based Award.
6. Limitations and Conditions
(a) The number of Shares available for Grants under this
Plan shall be the sum of (i) 40,000,000 and (ii) the number
of shares available for grant under the Plan as of the end of
the day that is the Effective Date of the amendment and
restatement of this Plan, subject to adjustment as provided for
in Sections 8 and 9, unless restricted by applicable law.
The number of Shares with respect to which Incentive Stock
Options may be granted after the Effective Date shall be no more
than 1,000,000 per fiscal year. Shares related to Grants that
are forfeited, terminated, settled for cash, canceled without
the delivery of Shares, expire unexercised, withheld to satisfy
tax withholding obligations or exercise prices, or are
repurchased by the Company shall immediately become available
for new Grants.
(b) Grants may, in the discretion of the Committee, be made
under the Plan in assumption of, or in substitution for,
outstanding awards previously granted by the Company or any of
its Subsidiaries or a company acquired by the Company or with
which the Company combines. The number of Shares underlying
awards made in assumption of, or in substitution for,
outstanding awards previously granted by a company acquired by
the Company or any of its Subsidiaries or with which the Company
or any of its Subsidiaries combines shall not be counted against
the aggregate number of Shares available for Grants under the
Plan, nor shall the Shares subject to such substitute awards
become available for new Grants under the circumstances
described in the prior paragraph of this Section 3. In
addition, in the event that a company acquired by the Company or
any of its Subsidiaries or with which the Company or any of its
Subsidiaries combines has shares available under a pre-existing
plan approved by shareholders and not adopted in contemplation
of such acquisition or combination, the shares available for
grant pursuant to the terms of such pre-existing plan (as
adjusted, to the extent appropriate, using the exchange ratio or
other adjustment or valuation ratio or formula used in such
acquisition or combination to determine the consideration
payable to the holders of common stock of the entities party to
such acquisition or combination) may be used for Grants and
shall not reduce the Shares authorized for issuance under the
Plan; provided that Grants using such available shares shall not
be made after the date awards or grants could have been made
under the terms of the pre-existing plan, absent the acquisition
or combination, and shall only be made to individuals who were
not employees or directors of the Company or any of its
Subsidiaries prior to such acquisition or combination.
(c) No Grants shall be made under the Plan beyond ten years
after the Effective Date, but the terms of Grants made on or
before the expiration of the Plan may extend beyond such
expiration. At the time a Grant is made or amended or the terms
or conditions of a Grant are changed in accordance with the
terms of the Plan or the Grant Agreement, the Committee may
provide for limitations or conditions on such Grant.
(d) Nothing contained herein shall affect the right of the
Company or any other Service Recipient to terminate any
Participants employment or other service relationship at
any time or for any reason.
B-7
(e) Other than as specifically provided in the Management
Stockholders Agreement or Sale Participation Agreement, if
applicable to a Grant, no benefit under the Plan shall be
subject in any manner to anticipation, alienation, sale,
transfer, assignment, pledge, encumbrance, or charge, and any
attempt to do so shall be void. If no Management
Stockholders Agreement or Sale Participation Agreement is
applicable to a Grant, then except as otherwise provided in the
Plan, a Grant Agreement, or by the Committee at or after grant,
no Grant shall be assigned, alienated, pledged, attached, sold
or otherwise transferred or encumbered by a Participant, except
by will or the laws of descent and distribution;
provided, however, that no such transfer of a Grant by
will or by laws of descent and distribution shall be effective
to bind the Company unless the Company shall have been furnished
with written notice thereof and an authenticated copy of the
will and/or
such other evidence as the Committee may deem necessary or
appropriate to establish the validity of the transfer. No
benefit under the Plan shall, prior to receipt thereof by the
Participant, be in any manner liable for or subject to the
debts, contracts, liabilities, engagements, or torts of the
Participant.
(f) Participants shall not be, and shall not have any of
the rights or privileges of, stockholders of the Company in
respect of any Shares purchasable or deliverable in connection
with any Grant unless and until certificates representing any
such Shares have been issued by the Company to such Participants
(or book entry representing such Shares has been made and such
Shares have been deposited with the appropriate registered
book-entry custodian). All certificates, if any, evidencing
Shares or other securities of the Company delivered under the
Plan pursuant to any Grant or the exercise thereof shall be
subject to such stop transfer orders and other restrictions as
the Committee may deem advisable under the Plan or the rules,
regulations, and other requirements of the Securities and
Exchange Commission or other applicable governmental authority,
any stock exchange or market upon which such securities are then
listed, admitted or quoted, as applicable, and any applicable
Federal, state or any other applicable laws, and the Committee
may cause a legend or legends to be put on any such certificates
to make appropriate reference to such restrictions.
(g) No election as to benefits or exercise of any Grant may
be made during a Participants lifetime by anyone other
than the Participant except by a legal representative appointed
for or by the Participant.
(h) Absent express provisions to the contrary, any Grant
under this Plan shall not be deemed compensation for purposes of
computing benefits or contributions under any retirement or
severance plan of the Company or other Service Recipient and
shall not affect any benefits under any other benefit plan of
any kind now or subsequently in effect under which the
availability or amount of benefits is related to level of
compensation. This Plan is not a Retirement Plan or
Welfare Plan under the Employee Retirement Income
Security Act of 1974, as amended.
(i) Unless the Committee determines otherwise, no benefit
or promise under the Plan shall be secured by any specific
assets of the Company or any other Service Recipient, nor shall
any assets of the Company or any other Service Recipient be
designated as attributed or allocated to the satisfaction of the
Companys obligations under the Plan. Neither the Plan nor
any Grant shall create or be construed to create a fiduciary
relationship between the Company or any Subsidiary or Affiliate
and a Participant or any other Person. To the extent that any
Person acquires a right to receive payments from the Company or
any Subsidiary or Affiliate pursuant to a Grant, such right
shall be no greater than the right of any unsecured general
creditor of the Company or any Subsidiary or Affiliate.
(j) The Committee may, in its sole discretion, specify in
any Grant made on or after the Effective Date of the amendment
and restatement of the Plan that the Participants rights,
payments, and benefits shall be subject to reduction,
cancellation, forfeiture or recoupment upon the occurrence of
certain specified events, in addition to any otherwise
applicable vesting or performance conditions of a Grant. Such
events may include, but shall not be limited to, termination of
Employment for cause, termination of the Participants
provision of services to the Company or any of its Subsidiaries,
breach of noncompetition, confidentiality, or other restrictive
covenants that may apply to the Participant, or restatement of
the Companys financial statements to reflect adverse
results from those previously released financial statements, as
a consequence of errors, omissions, fraud, or misconduct.
B-8
7. Transfers and Leaves of Absence
For purposes of the Plan, unless the Committee determines
otherwise: (a) a transfer of a Participants
employment without an intervening period of separation among the
Company and any other Service Recipient shall not be deemed a
termination of employment, and (b) a Participant who is
granted in writing a leave of absence or who is entitled to a
statutory leave of absence shall be deemed to have remained in
the employ of the Company (and other Service Recipient) during
such leave of absence.
8. Adjustments
In the event after the Effective Date, any Share dividend, Share
split, extraordinary distribution, reorganization,
recapitalization, merger, consolidation, spin-off, combination,
combination or transaction or exchange of Shares, any equity
restructuring (as defined under FASB ASC Topic 718) or
other corporate change, or any distribution to Shareholders
other than regular cash dividends, or any transaction similar to
any of the foregoing, the Committee shall, in an equitable and
proportionate manner as it deems reasonably necessary to address
on an equitable basis the effect of such event, and in such
manner as is consistent with Sections 162(m), 422, and 409A
of the Code and the regulations thereunder, make such
substitution or adjustment, if any, (a) as to the number
and kind of shares subject to the Plan and available for or
covered by Grants; (b) as to share prices related to
outstanding Grants (including, without limitation, the exercise
price of Stock Options), or by providing for an equivalent award
in respect of securities of the surviving entity of any merger,
consolidation, or other transaction or event having a similar
effect; or (c) by providing for a cash payment to the
holder of an outstanding Grant, and shall make such other
revisions to outstanding Grants as it deems, in good faith, are
equitably required.
9. Change in Control
(a) Generally. In the event of a
Change in Control: (i) if determined by the Committee in
the applicable Grant Agreement or otherwise determined by the
Committee in its sole discretion, any outstanding Grants then
held by Participants which are unexercisable or otherwise
unvested or subject to lapse restrictions may automatically be
deemed exercisable or otherwise vested or no longer subject to
lapse restrictions, as the case may be, as of immediately prior
to such Change in Control and (ii) the Committee may, to
the extent determined by the Committee to be permitted under
Section 409A of the Code, but shall not be obligated to:
(A) cancel such awards for fair value (as determined in the
sole discretion of the Committee) which, in the case of Stock
Options and Stock Appreciation Rights, may equal the excess, if
any, of the value of the consideration to be paid in the Change
in Control transaction to holders of the same number of Shares
subject to such Stock Options or Stock Appreciation Rights (or,
if no consideration is paid in any such transaction, the Fair
Market Value of the Shares subject to such Stock Options or
Stock Appreciation Rights) over the aggregate option price of
such Stock Options or the aggregate exercise price of such Stock
Appreciation Rights, as the case may be; (B) provide for
the issuance of substitute awards that will substantially
preserve the otherwise applicable terms of any affected Grants
previously granted hereunder, as determined by the Committee in
its sole discretion; or (C) provide that for a period of at
least 15 days prior to the Change in Control, any Stock
Options or Stock Appreciation Rights shall be exercisable as to
all Shares subject thereto and that upon the occurrence of the
Change in Control, such Stock Options or Stock Appreciation
Rights shall terminate and be of no further force and effect:
provided, however, that subpart (ii) shall not apply
to a Change in Control under clause (C) of such
definition that occurs due to a gradual sell down of voting
stock of the Company by the Investors or their Affiliates.
(b) Performance-Based Awards. In
connection with the foregoing, the Committee may, in its
discretion, provide that in the event of a Change in Control,
(i) any outstanding Performance-Based Awards relating to
performance periods ending prior to the Change in Control which
have been earned but not paid shall become immediately payable
and (ii) all
then-in-progress
performance periods for Performance-Based Awards that are
outstanding shall end, and either (A) any or all
Participants shall be deemed to have earned an award equal to
the relevant target award opportunity for the performance period
in question, or (B) at the Committees discretion, the
Committee shall determine the extent to which performance
criteria have been met with respect to each such
Performance-Based Award.
B-9
10. Amendment and Termination; Section 409A
of the Code
(a) The Committee shall have the authority to make such
amendments to any terms and conditions applicable to outstanding
Grants as are consistent with this Plan, provided that no
amendment may modify Grants that disadvantages Participants in
more than a de minimis way but less than a material way without
approval by a majority of affected Participants; and
provided, further, that no such action shall
modify any Grant in a manner that materially disadvantages a
Participant with respect to any outstanding Grants, other than
pursuant to Section 8 or 9 hereof, without the
Participants consent, except as such modification is
provided for or contemplated in the terms of the Grant or this
Plan.
(b) The Board may amend, suspend or terminate the Plan,
except that no such action, other than an action under
Section 8 or 9 hereof, may be taken which would, without
stockholder approval, increase the aggregate number of Shares
available for Grants under the Plan, decrease the price of
outstanding Grants, change the requirements relating to the
Committee, extend the term of the Plan, or otherwise require the
approval of the stockholder of the Company to the extent such
approval is (i) required by or (ii) desirable to
satisfy the requirements of, in each case, any applicable law,
regulation or other rule, including, the listing standards of
the securities exchange, which is, at the applicable time, the
principal market for the Shares. However, no amendment,
suspension or termination of the Plan may disadvantage
Participants in more than a de minimis way but less than a
material way without approval by a majority of affected
Participants, and no such action shall materially disadvantage a
Participant with respect to any outstanding Grants, other than
pursuant to Section 8 or 9 hereof, without the
Participants consent, except as otherwise contemplated in
the terms of the Grant or the Plan.
(c) This Plan and all Grants granted hereunder are intended
to comply with Section 409A of the Code and will be
interpreted in a manner intended to comply with
Section 409A of the Code. References under the Plan or any
Grants to the Participants termination of Employment shall
be deemed to refer to the date upon which the Participant has
experienced a separation from service within the
meaning of Section 409A of the Code. Notwithstanding
anything herein to the contrary, (a) if at the time of the
Participants separation from service with any Service
Recipient the Participant is a specified employee as
defined in Section 409A of the Code, and the deferral of
the commencement of any payments or benefits otherwise payable
hereunder as a result of such separation from service is
necessary in order to prevent the imposition of any accelerated
or additional tax under Section 409A of the Code, then the
Company will defer the commencement of the payment of any such
payments or benefits hereunder (without any reduction in such
payments or benefits ultimately paid or provided to the
Participant) until the date that is six months and one day
following the Participants separation from service with
all Service Recipients (or the earliest date as is permitted
under Section 409A of the Code), if such payment or benefit
is payable upon a termination of Employment and (b) if any
other payments of money or other benefits due to the Participant
hereunder would cause the application of an accelerated or
additional tax under Section 409A of the Code, such
payments or other benefits shall be deferred, if deferral will
make such payment or other benefits compliant under
Section 409A of the Code, or otherwise such payment or
other benefits shall be restructured, to the minimum extent
necessary, in a manner, reasonably determined by the Board, that
does not cause such an accelerated or additional tax or result
in an additional cost to the Company (without any reduction in
such payments or benefits ultimately paid or provided to the
Participant). Unless otherwise provided in a Grant Agreement or
any other agreement between the Company or any of its
Subsidiaries and any Participant, the Company shall not be
liable to any Participant for any tax, interest, or penalties
that Participant might owe as a result of the grant, holding,
vesting, exercise, or payment of any Grant under the Plan.
11. Governing Law; International Participants
(a) This Plan shall be governed by and construed in
accordance with the laws of Delaware applicable therein.
(b) With respect to Participants who reside or work outside
the United States of America, the Committee may, in its sole
discretion, amend the terms of the Plan or awards with respect
to such Participants in order to conform such terms with the
requirements of local law or to obtain more favorable tax or
other treatment for a Participant, the Company or any other
Service Recipient.
B-10
12. Withholding Taxes
The Company shall have the right to deduct from any payment made
under the Plan any federal, state or local income or other taxes
required by law to be withheld with respect to such payment. It
shall be a condition to the obligation of the Company to deliver
Shares upon the exercise of a Stock Option that the Participant
pays to the Company such amount as may be requested by the
Company for the purpose of satisfying any liability for such
withholding taxes; provided, however, that a Participant
may satisfy the statutory amount of such taxes due upon exercise
of any Stock Option through the withholding of Shares (valued at
Fair Market Value on the date of exercise) otherwise issuable
upon the exercise of such Stock Option. For awards other than
Stock Options, the Committee may in its discretion permit a
Participant to satisfy or arrange to satisfy, in whole or in
part, the tax obligations incident to an Grant by:
(a) electing to have the Company withhold Shares or other
property otherwise deliverable to such Participant pursuant to
the Grant (provided, however, that the amount of any Shares so
withheld shall not exceed the amount necessary to satisfy
required federal, state local and foreign withholding
obligations using the minimum statutory withholding rates for
federal, state, local
and/or
foreign tax purposes, including payroll taxes, that are
applicable to supplemental taxable income)
and/or
(b) tendering to the Company Shares owned by such
Participant (or by such Participant and his or her spouse
jointly) and purchased or held for the requisite period of time
as may be required to avoid the Companys or the
Affiliates or Subsidiaries incurring an adverse
accounting charge, based, in each case, on the Fair Market Value
of the Shares on the payment date as determined by the
Committee. All such elections shall be irrevocable, made in
writing, signed by the Participant, and shall be subject to any
restrictions or limitations that the Committee, in its sole
discretion, deems appropriate.
13. Effective Date and Termination Dates
The Plan shall be effective on [ ], 2010 (the
Effective Date), and shall terminate ten
years later, subject to earlier termination by the Board
pursuant to Section 10. Unless otherwise expressly provided
in the Plan or in an applicable Grant Agreement, any Grant made
hereunder may, and the authority of the Board or the Committee
to amend, alter, adjust, suspend, discontinue or terminate any
such Grant or to waive any conditions or rights under any such
Grant shall, continue after the tenth anniversary of the
Effective Date.
B-11